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INTRODUCTION 
 Every system of medicine can help us to live a healthy, natural life by preventing 
diseases. It is well known that all the eyes of the world are turning to the natural 
medicine, especially indigenous system of medicine to find out a more acceptable drug 
for incurable diseases.Siddha system is one of the traditional systems of medicine well 
practiced in Tamil Nadu. Medicine is an ever-changing science. As new research and 
clinical experience broaden our knowledge, changes in treatment and drug therapy are 
required. 
According to Siddha system of medicine five elements of nature, such as Earth, 
Water, Fire, Air, and Space combined with each other in an appropriate ratio constitutes 
three vital humors. 
As per siddha science the physical functions of the body are mediated and 
maintained by three vital humors (Uyir thathukkal) Vali, Azal and Iyam. In normal state 
they are called Muthathu that sustain and nourish the body. In a diseased state the three 
vital humors are vitiated and become Mukkutram. 
 Siddha‟s fundamental principles never differentiated man from the universe. 
Siddha treats man as a 'whole' - a combination of body, mind and soul. Therefore, it is a 
truly holistic and integral medical system.  
                        “czNt kUe;J> kUe;Nj czT” 
Food habits,daily activities and mental status of an individual play a major role in 
causing diseases.  
 The diagnosis of disease in siddha system of medicine relies on eight diagnostic 
tools called Envagai Thervu such as Naadi, Sparisam, Naa, Niram, Mozhi, Vizhi, 
Malam, and Moothiram which are evaluated in terms of the three humors. Saint 
Agasthiyar identified 4448 diseases and one among them is Eruvai Mulai 
noi(Moolam).Any derangements in humors results in development of 4448 diseases. 
This disease is mainly due to aggravated vatha pitha humors which are evident from the 
quote mentioned below.  
 mdp;y gpj;j njhe;jkyhJ %yk; tuhJ 
- Njiuah;  
In Moola noi, increased keelvaikanal stimulates vatha humor which in turn 
stimulates pitha humor resulting in Moolam.So the symptoms like Constipation, bleeding 
during defecation, Pain in umbilical region,Pallor of the body, Headache,Giddiness are 
` 
2 
 
developed. In treatment aspect in order to suppress vatha humor and Pitha humor, 
prescribe cooling agents to suppress keelvaikanal. 
 
As per siddha, siddhars notify moolatharam is a seat of kundalini sakthi (Energy 
point).Any irregular practice of yoga,food and lifestyle modification may disturb the 
moolatharam there by kundalini and results in disease called Moolam. As per saint Yugi 
“Ratha Moolam” is one among the 21 types pf moolam.The signs and symptoms are 
closely correlated with that of “Internal haemorrhoids-Bleeding piles” in modern 
scientific system of medicine. 
 
In India approximately 40,723,288 people are reported to have hemorrhoids. 1 
million new cases are reported annually, it is estimated that 50-85% of people around the 
world have hemorrhoids and in India 75% of the population is estimated. Current 
statistics suggest that almost half of people in their fifties have piles.  
 
In the text of Anoboga vaithya navaeedham drug KUKKILATHY 
CHOORANAM, a Siddha formulation has been specifically indicated for Ratha 
MoolamThe main ingredients of the above said formulation are Kukkil (Shorea robusta), 
Purified Parangipattai (Smilax china), Purified Gandhagam (Sulfur), Arisithippili (Fruit 
of Piper longam), Kandathippili (Root of Piper longam), Vetpalaiarisi 
(Wrightiatinctoria),Vaividangam (Embelia ribes)is well known for its anti- Vatha and  
anti-Pitha properties, astringent (Thuvarpi), Anti inflammatory (Veekamurukki), 
Anthelmitic (Puzhukolli), Laxative activities (Malam ilakki) and Styptic (Kuruthi 
Pokkadakki) actions as per Siddha literature.  
 
In National Institute of Siddha considerable number of cases of Ratha Moolam  
reported daily. With this background I have chosen “Ratha Moolam” for my clinical 
study. The above said drug KUKKILATHY CHOORANAM had been evaluate for its 
safety earlier,the clinical study on Ratha moolam has get to be evaluate. The mode of 
preparation seems to be simple and cost effective. Hence, I have selected this Siddha 
formulation KUKKILATHY  CHOORANAM for clinical evaluation in Ratha Moolam.  
` 
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AIM AND OBJECTIVE 
Aim: 
To document and evaluate the efficacy of the siddha formulation KUKKILATHY 
CHOORANAM (Internal medicine) in the treatment of  Ratha Moolam. 
 
Objective: 
Primary Objective: 
To evaluate the therapeutic efficacy of Siddha formulation KUKKILATHY 
CHOORANAM in the treatment of Ratha moolam.  
 
Secondary Objective: 
 To authenticate and prepare the trialdrug as per standard operating procedure.  
 To analyze the prevalence of Ratha moolam in the society in respect of age, sex, 
occupation, place and dietary influence etc.,  
 To study the physico chemical analysis of the trial Drug. 
 
  
` 
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REVIEW OF LITERATURE – RATHA MOOLAM 
Siddhar Agasthiyar classified diseases into 4, 448 and described each one 
separately and elaborately. They classified the diseases on the basis of TRIDHOSHIC 
THEORY.  
 
MOOLA NOIGAL 
“Anila pitha thondhamalathu moolam varaathu” (Anilam-Vaatham, Pitha-
Pitham)As per saint theraiyar derangement of vatham and pitha humor due to lifestyle 
changes diet and deeds resulting moolam. The main vatha humor and pitha humor get 
affected cause in moola noi (Haemorrhoids). Moola noigal are diseases that occur in and 
around the Moolatharam. They include a wide varity of ano rectal diseases. Moolatharam 
area has been given maximum importance in Siddha system as it is the energy center of 
the body, the Kundalini. Although there are other Moolatharam areas in the body this 
area is the foremost energy centre, this is explained as follows,  
“ghq;fhd Fz;lypfFs; %ynkhd;W 
ghug;gh fz;lj;jpy; %ynkhd;W 
Nghq;fhd GUtika %ynkhd;W 
Gfohd tpe;JtpNy %ynkhd;W 
thq;fhd rf;jpapNy %ynkhd;W 
kUtpepd;w guhguj;jpy; %ynkhd;W 
Njq;fhk ypijahUq; fz;lQhdp 
Nru;e;J epd;w Kk;%y NahfpahNk” 
- rl;lKdpQhdk; 
 
This verse stands as an evidence to mark the importance of Moolatharam, among 
other Aathaarams namely, Swathittanam, Manippuragam. Anagatham, Vishuthi and 
Aagkini.  
 
 
 
 
 
 
  
` 
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Hemorrhoids  
It is characterized by presence of muscular mass like tuber in anal region. A 
disease of the lower part of the rectum near the anus. There are three rings in the rectum 
at a distance of two or three inches above the anal orifice called as Pravagini, 
Visarchini and Sambavani when the three humors are vitiated causing fleshy 
excrescences to grow from the above three rings, known as piles which may be internal 
or external. When the growth projects outside, it is called external piles. But if it is inside 
it is called internal piles. Constipation of the bowels, difficulty in defecation, discharge 
of blood from the fleshy growths due to hard stools and pressure exerted are the general 
symptoms bleeding may also occur while passing urine due to pressure.  
-   T.V Sambasivam pillai agarathi 
 
NOI VARUM VAZHI (ETIOLOGY)  
Saint Yugi elaborately describes the various causes for all Moola noigal. 
Although the text does not mention about the causes separately for each type, it deals 
collectively within two verses the psychological aspects, Karmas, intrinsic and extrinsic 
factors of aetiology for all moola noigal. With this and other Siddha texts we can lay 
down the causes of the disease as,  
 Karmas and psychological causes  
 Due to inappropriate diets and acts 
 Due to maintaining wrong postures in Yogasanam 
 
According to Yugi vaithiya chinthamani 
“Kidahf %j;Njhiu itjyhYk; 
Nkhrq;fs; gz;zpNa fw;gopj;Jk; 
epidahf epidtpnyhd;Wk; thf;fpnyhd;Wk; 
Neu;e;jgb nrhy;Yfpd;w epl;L uu;f;Fk; 
Gidahf guNjrp ge;JthNdhu; 
grpj;jpUf;f cz;lNjhu; ghjfu;f;Fk; 
jidahfr; rkhjhde; jtpf;fpd;Nwhu;f;Fk; 
rz;lhs %yk; te;J rdpf;Fe;jhNd” 
- A+fp itj;jpa rpe;jhkzp 
  
` 
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 Scolding elders 
 Doing harm to others  
 Indulging in rape 
 Pretending good with sweet words harboring grudge at the back of the mind.  
 Leading an extravagant life while neighbors‟ and the relatives are pining with 
hunger.  
 Always quarrelling with others.  
 
“jj;ijah kjpfkhq; FspupdhYk; 
jupahj jor;rpahw; fpue;jp ahYk; 
Gj;ijahk; nghUe;jhj c\;zj;jhYk; 
Gzu;r;rpaha;f; Nfhgj;jhw; rypg;gpdhYk; 
fj;ijahk; ntFfhkk; Ntz;lhYk; 
fbdkh Kg;ghYq; fhuj;jhYk; 
nkhj;ijahk; ntFjdq;fs; NghdjhYk; 
%yk;te; Jw;gj;jp KidAe;jhNd” 
- A+fp itj;jpa rpe;jhkzp 
 
As started above, the vali humour, especially Abana vayu is predominantly 
vitiated. The above song describes the aetiology of moolam, these are,  
 Exposure to excessive heat and excessive cold 
 Anger and frustration 
 Anxiety and depression 
  Increased sexual desire 
 Heavy intake of salt and pungent food  
 Scolding the elder people.  
 
According to Agasthiyar Kanmakandam 
“ePq;fhj %yNeha; fd;kj;jhNy 
epiynfl;l mghdj;jpy; neUg;NghkPwp 
thf;fhNy aghdj;jpy; thry; jd;dpy; 
te;J Kis Nkfj;jhy; #l;lhy; fhZk; 
jhf;Nfh yhyilj; jhw;Nghy thA epd;W 
jd;ikAs;s kykjid twl;bj; jPa;e;J  
` 
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Nga;Nfhyk; gz;Zklh %y Nuhfk; 
Gyj;jpaNd gotpidfsp dq;fNs” 
- mfj;jpahu; fd;k fhz;lk; 
According to karma hereditary factor plays an important role in the genesis of 
this disease. Karma theory is based on the belief that one is not dissociated from the 
fruits of the actions in the previous births. The intrinsic causes of inappropriate diet and 
acts  
 
Adopting wrong yogic postures 
During practice of Yogasanas continuing in prolonged sitting and straining postures 
predispose to vitiation of Vali humour, Azhal and moolaakkini leading to moola noigal. 
 
According due to deranged varma nilai 
If any injury to the utchi varman cause immediate collapse. If the trauma happens 
to be mild, the patient may develop difficulty in micturition and defecation. Persistent 
constipation leads to moola noi.  
 
ACCORDING TO NOI VILAKKAM 
 There are 21 types of Moola Noigal; Ratha Moolam is one of the types of Moola 
Noigal.  
 
FUjp vUtha;Kis (,uj;j%yk;)  
 
“Nrjpaha; njhg;Gs;jz;zpy; typj;J nehe;J 
rpWfjpu;Nghw; gPwpl;L uj;jk; tPOk; 
Nkjpaha; Nkdptw;wp ntSj;Jg; NghFk; 
kpf;fiffh yre;JNk Nrhif ahFk; 
khjpaha; khu;gpsf;Fe; jiyNeh Tz;lhk; 
kaf;fe;jhd; kpFjpaha;j; js;spg; NghLk; 
ehjpaha;f; fz;zpuz;L kQ;rs; Nghyhk; 
eypAk;uj;j %yj;jpd; gz;G jhNd” 
- A+fp itj;jpa rpe;jhkzp 
  
` 
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RATHA MOOLAM: 
 Pain in umbilical region 
 Pallor of the body 
 Edema in both upper and lower limbs 
 Chest pain 
 Headache  
 Giddiness 
 Yellowish decoloration of eyes 
 
NOI ENN (CLASSIFICATION)  
Moolam has been classified into various types by different authors. Some of the 
types are described below.  
 
Types of Moola noigal 
According to Yugi vaithiya Chinthamani, Moolam is 21 types 
 Neer Moolam 
 Sendu Moolam 
 Mulai Moolam 
 Siru Moolam 
 Varal Moolam 
 Ratha Moolam 
 Seezh Moolam 
 Aazhi Moolam 
 Thamaraga Moolam 
 Kiranthi Moolam 
 Kalappu Moolam 
 Kutha Moolam 
 Veli Moolam 
 Churukku Moolam 
 Savvu Moolam 
 Vali Moolam 
 Azhal Moolam 
 Iyya Moolam 
 Vinai Moolam 
 Mega Moolam 
 Pouthira Moolam 
 
In Anubava vaithiya deva ragasiyam types of moolam described below  
 
 Vali Moolam 
 Azhal Moolam  
 Iyya Moolam 
 Thontha Moolam 
 Thrithoda Moolam 
 Ratha Moolam 
 
  
` 
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Agasthiyar paripooranam describes nine types Moolam. The types are,  
 
 Ul Moolam  
 Pura Moolam 
 Mulai Moolam 
 Ratha Moolam 
 Seezh Moolam  
 Vali Moolam 
 Azhal Moolam 
 Iyya Moolam 
 Moola Paandu 
 
Therayar describes ten types of Moola Noigal  
“rPnahO fpAJG zPNuhopfpaJ gtp 
dPnahO fpajw NynahOfpajj NsnahO fpaJ jirf; 
fhnahOfpa jONkhnuhOfpa jlu; fhnyhO fpaJ Kis 
NanahO fpajpit %yk; jha;newp Nau;ngW Nkhg+Nj”.  
- Njiuau; Nrfug;gh 
The types are,  
 Seezh Moolam 
 Pun Moolam 
 Thee Moolam  
 Neer Moolam 
 Mulai Moolam 
 Sathai Moolam 
 Kaduppu Moolam 
 Veluppu Moolam 
 Kattru Moolam 
 PerumulaiMoolam
 
In Agasthiyar Ayul veetham, moolam classified into 6 types 
 
 Vatha Moolam 
 Pitha Moolam 
 Kaba Moolam 
 Ratha Moolam 
 Thontha Moolam 
 Vayu Moolam 
 
Naadi Chakkaram, moolam classified into types,  
 Vatha Moolam 
 Pitha Moolam 
 Kaba Moolam 
 Ratha Moolam 
 Thontha Moolam 
 
  
` 
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Sootha muni sutthitam, moolam classified into 6 types,  
 Vatha Moolam 
 Pitha Moolam 
 Kaba Moolam 
 Ratha Moolam 
 Thontha Moolam 
 Thirithosa Moolam
` 
11 
 
 
thj%yk;: 
“jd;ikNfhitg;gok; Fjk;rptg;Gj; 
jdpylg; gk;G+g;Nghy Kis tsh;e;J 
fz;ik fWg;gha;kp UJthapUf;Fk; 
fLg;NghL jpdTFw;wy; jpkph;j;jyhFk; 
tz;ik kaph; jhd;Kisj;J kyQ;rpf; nfd;W 
kfj;jhff; fWj;Jnkj;j jpuz;L fhZk; 
ntz;ik tapw;tpl;LNk FlYs; typahFk; 
kpf;f jiytypthj %ykhNk” 
- A+fp itj;jpa rpe;jhkzp 
 
VATHAMOOLAM: 
 Pile is like almond flower and red ivy gourd fruit in colour.  
 Inflammation of the anus.  
 Pain in anus 
 Itching  
 Retention of feaces 
  constipation  
 Headache  
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gpj;j %yk;: 
“jiytypjhd; kpfTz;lhk; gUj;jpf; nfhl;il 
jd;NghY new;NghYK isAz;lhFk; 
kiytypaha; kyQ;rpf;fp cUz;L Uz;L 
khTz;il jphpjphpaha; uj;jQ; rPaha; 
Fytypaha; Fjq;fLj;J vhpT khfpf; 
$r;rkha; jhfnkhL tpah;it ahFk; 
Jiytypah aj;Jaf;Fkha;f; Nfhg khFk; 
nrhw;gy tPdKk;gpj;j %y khNk” 
- A+fp itj;jpa rpe;jhkzp 
 
 
 
 
 
 
 
PITHA MOOLAM: 
 Pile mass present like a cotton seed  and paddy 
 Constipation and stools passed like flour ball with blood and pus 
 Inflammation and burning sensation in anus  
 Thirst  
 Perspiration  
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Ia vUtha; Neha; (rpNyj;Jk %yk;)  
“<dkhq; Fjj;jpy; Kis nts;is ahFk; 
ve;Neue; jpdtjpf nkupT khFk; 
fhdkhq; fLg;GlNd rPOe; jz;zPu; 
fdkhd typahfp kye;jh Ndhq;Fk; 
J}dkh %j;jpue;jhd; #Lz; lhFk; 
nrhw;Fz NgjkhFe; jhJ el;lk; 
ghdkhk; ghz;LnthL mUrp ahFk; 
guTNrj; Jk%yg; ghq;F jhNd” 
- A+fp itj;jpa rpe;jhkzp 
 
 
 
 
 
 
 
 
SILAETHUMA MOOLAM: 
 A mass looks white in colour 
 Burning sensation in anus 
 Anal irritation 
 Watery and pus discharge 
 Painful defecation 
 Mood swings 
 Constipation 
 Tastelessness 
 Anaemia  
 
 
` 
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OTHER LITERTURE REVIEWS ABOUT MOOLAM 
According to thirumoolar Karukkadai vaithiyam – 600 
“fhaj;jpy; %yNuhfk; 
fz;bLk; tpjq;fs; Nfsha; 
ghnahj;j grpapy;yhky; 
gl;rpf;fpy; mlf;fy; thA 
khaj;jpy; ,Uj;jpf; nfhz;L 
kykij mlf;Fk; NghJk; 
Xa;j;j Fz;lypf;Fs; 
cl;GFk; thA fhNz” 
-jpU%yu; fUf;fil itj;jpak; 600 
It describes the pathology of Moolam, 
 Suppression of appetite and defecation leads to derangement of Vayu. 
 This vayu enters into Kundalini. Here, the Vayu combines with them and causes 
formation of moola noigal.  
 When excess Vayu excerts pressure in them, and they produce external mass on 
straining i. e. while defecation.  
 
Vitiated Vayu leads to constipation. In addition to this there is increased 
moolaakkini.  
 
According to Therayar Segarappa 
“nfhba nghy;yhj %y Fzj;ij 
nad; nrhy;Ntd; gue;j 
epbapdp nyhLq;Fk; khNw 
natiuAq; frq;fr; nra;J 
FbnfLkhW nra;Aq; 
nfhz;gt uhAy; nra;J 
Kbtj dhNy nad;W 
nkhope;jdu; jioe;j E}Nyhu;” 
- Njiuau; Nrfug;gh 
 
Moola noi is an irritating cruel disorder of human being and the affected 
person‟s looks like a “Scared serpent due to rumbling thunder”.  
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According to Thanvanthiri vaithiyam 
“FU gpjhu;j;jj;jpdhYk; nfhba rQ;rhuj;jpdhYk; 
ngU&l;r gjhu;j;jhYk; Ngr;R %r;rlf;fhYk; 
jUG+kpir ele;J rQ;rpupj;jpLjyd;wp 
,U euthfdj;jpy; nad;dhUkpUf;ifahYk; 
mghddhk; thA nkw;nfhz;l Fjpdhy; %yNuhfk; 
mghdthy; jd;dpyz;bailj;jpL kJTkd;wp 
Rghky %j;jpuj;jpy; Njh\Kz;lhFq; fz;lhy; 
Mghd thjj;jpd; nra;if kpJntd twpFtPNu” 
- jd;te;jpup itj;jpak; - Kjy; ghfk; 
 
Thanvanthiri vaithiyam describes the causes of moolam as follows,  
 Consumption of hard Diet foods 
 Roaming restlessly 
 Eating dry food stuff 
 Restraining of speech and respiration 
 Always walking and wishing to be carried by others.  
The above song said, causes leads of Abana vayu which in turn leads to the causation 
of Moolam.  
 
According to Therayar Vagadam 
“Nej;jpukhk; gpj;jkJ tUFk;NghJ epiyahd 
jiy Nehthy; ruPuk; newpj;J 
Njhj;jpukha; nka; ntJk;gp %f;Fthapy; 
Rfkhd mghdj;jpypuj;jk; tPUk; 
Mj;jpukha; gpwthjk; Neha; nfhs;Sk; gpj;jk; 
Mupjhd Nkfk; cz;lha; ehupau;f;F 
Ntu;j;Jwf;f khdJNghy; nka; ntJk;gp 
Nkypthd mbtapW Gz;Nghy; NehFk;. ” 
- Njiuau; thflk; 
 
High levels of pitham reflecting bodyache, headache, Bleeding per rectum, 
epistasis, haemoptysis, venereal discharges, nagging pain in the lower abdomen are the 
features of increased Vatham.   
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DIAGNOSTIC METHODOLOGY 
 The methodology of diagnosing disease in Siddha system shows uniqueness in its 
principle. The principle comprises of examination of Tongue, Complexion and 
Modulation in speech. Inspection of eyes and findings by palpation. It also includes 
examination of urine and Stool. The reinforcement of diagnosis is based on Naadi 
(Pulse) examinations. All these together constitute “Envagai Thervugal” which forms 
the basis of diagnostic methodology in Siddha system of medicine.   
 These tools not only help in diagnosis but also to observe the prognosis of the 
diseases and for reassuring the patient and to be informed about the nature of disease.  
The Diagnostic methodology in siddha system is unique as it is made purely on 
the basis of clinical acumen of the physician. The diagnosis is arrived from,  
 Poriyal arithal and pulanal arithal (examination of sense organs)  
 Vinaathal (Interrogation)  
 Envagai thervu (eight diagnostic tools)  
 
Poriyal Aridhal: 
The physician should examine the patient‟s porigal by his porigal.  
 Mei –To feel all types of sensation 
 Vaai – for Knowing taste 
 Kan – For vision 
 Mooku – for knowing the smell 
 Sevi – For hearing 
 
Pulanaal Arithal: 
The physician should examine the patient „s pulangal by his porigal & Pulangal  
 Hearing – Ear 
 Vision – Eye 
 Taste-tongue 
 Sensation-skin 
 Smell-Nose 
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Vinaadhal (Interrogation): 
The physician should interrogate the patient‟s name, age, occupation, native 
place, socio economic status, dietary habits, present complication, history of present 
illness, aggravating factors, history of previous illness etc., 
 
ENVAGAI THERVUGAL: 
“mfj;JW Nehia fuj;jhk yfk;Nghy; 
gFj;jwptPu; ehbg; guprk; - njhFj;j epwk; 
fl;Ltifr; nrhy;nkhopfz; fz;l ky %j;jpuk; eh 
vl;Ltif ahY kwptPu;” 
- mfj;jpau; itj;jpa rpe;jhkzp ntz;gh 4000 
 
“ehb guprk; ehepwk; nkhoptpop 
kyk; %j;jpuk; kUj;JtuhAjk;” 
- Njiuau; 
 
According to Agathiyar Vaithiya Sinthaamani Venba – 4000and saint theraiyar 
the Envagaithervu (Eight types of diagnostic tools) .  
Includes Naadi (Pulse), Naa (Tongue), Niram (Colour), Mozhi (Voice), Vizhi 
(Eyes), Malam (Faeces), Neer(Urine) and Sparisam (Touch & Palpation) .  
 
NAADI: 
The „Pulse Diagnosis‟ is a unique method in Siddha Medicine. The pulse should 
be examined in the Right hand for male and the left hand for female. The pulse can be 
recorded at the radial artery. By keenly observing the pulsation, the diagnosis of disease 
as well as its prognosis can have basseted clearly.  
Naadi is nothing but the manifestation of the vital energy that sustains the life 
with in our body. Naadi plays a most important role in Envagai thervu and it has been 
considered as foremost thing in assessing the prognosis and diagnosis of various 
diseases. Any variation that occurs in the three humors is reflected in the naadi. These 
three humors organize, regularize and integrate basic functions of the human body. So, 
naadi serves as a good indicator of all ailments.  
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ehb ghu;f;Fk; tif:  
Naadi is felt by,  
 Vali – Tip of index finger 
 Azhal – Tip of middle finger 
 Iyyam – Tip of ring finger 
 
RATHA MOOLAM results basically from derangement of Vatham and 
Pitham.  
%tifAk; khj;jpiu msTk;: 
“toq;fpa thjk; khj;jpiu xd;whfpy; 
toq;fpa gpj;jk; jd;dpy; miuthrp 
moq;Fk; fge;jhd; mlq;fpNa fhNyhby; 
gpwq;fpa rPtw;Fg; gprnfhd;W kpy;iyNa” 
- Neha; ehly; Kjy; ghfk; 
 
The pulse is measured in wheat/grain expansible heights. The normal unit of 
pulse diagnosis is 1 mathirai for Vali (Vatham),½ mathirai for Azhal (Pitham) and ¼ 
mathirai for Iyyam (Kapham).  
 
THE PULSE PLAY: 
Compared to the gait of various animals, reptiles and birds,  
 Vali – Movement of Swan and Peacock 
 Azhal – Movement of Tortoise and Leech 
 Iyyam – Movement of Frog and Serpent.  
 
Naadi Nadai in Ratha moolam 
 “mdpy gpj;j njhe;jkyhJ %yk; tuhJ” 
 - Njiuau; 
 
In Ratha moolam, the normal 1:1\2:1\4 mathirai pattern or gait pattern of hen 
turtle and frog of vatham, pitham and kapam respectively are affected giving rise to 
elevated maththirai of vatham and pitham than normal. This is often said in vallathi naadi 
as gait patterns of animals having speedy and forceful gait patterns such as cock for 
pitham. This is given in the verse as follows.  
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  “jhndd;w thjkJ Nfhop Nghy 
   rhtiyg; Nghy; gpj;jkJ jhz;Lkhfpy; 
  Nfhndd;w thjgpj;j njhe;jp;g;ghFk;” 
- ty;yhjp ehb 
  
 “thjnkDk; ehbaJ Njhd;wpy; 
   rPjke;jnkhL tapWnghUky; jpul;rptha;T 
 rPjKWq; fpuhzp kNfhjuk; ePuhik 
   jpus;tha;T #iy typfLg;Gj; jPiu 
 ePjKWq; fpUkpFd;kk; mz;l thjk; 
   epiyAk;ePu;f; fpupr;ruq;fs; je;J Nkfk; 
 Ngjfkh Kjug;gpzp%y Nuhfk; 
   NgrntF gpzpfSNk nghUsjhNk” 
  - rjf ehb 
SPARISM (Palpation)  
Body is said to stay in ushnam or hyper thermic state. This is due to the combined 
attraction of vatham and pitham.  
 
TONGUE EXAMINATION (ehj;Nju;T) : 
In Vali deranged persons, tongue will be cold, rough, furrowed and pungent taste. 
In azhal, it will be red or yellow and kaippu taste will be sensed. In Iyyam, it is pale. 
Sticky and sweet taste will be lingering. In depletion of thontham, tongue will be dark 
with raised papillae and dryness.  
 
 If the disease process takes a long course, then the naa become coated and pale. 
Except this all other qualities of naa are usually normal.  
 
NIRAM (COLOUR OF THE BODY) : 
 Because vatham and pitham are affected the colour of the body is as in vatha 
pitha thontham i. e. slight dark or yellowish in colour. The colour change is due to 
veluppu noi which ensues after a long course of Ratha moolam.  
 In follows Vali, Azhal and Iyyam vitiations, the colour of the body will be dark, 
yellow or red and fair respectively  
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VOICE EXAMINATION (xyp Njh;T) :; 
 In vitamin of Vali, Azhal and Iyyam the voice will is medium pitched base and 
shrill or low pitched respectively and by the voice, the strength of the body can be 
assessed.  
 
MOZHI (Speech)  
 Due to the affection of vatham and pitham patients look anxious and the person‟s 
speech reflects his anxiety.  
 
THE EYE EXAMINATION (fz; Nju;T) :; 
 In Vali disease the tears are darkened, in Azhal disease they are yellow, in Iyya 
disease they are whitish in color and in thontha disease the tears are multi colored. In 
Vali disease there will be excessive tears (epiphora). In disturbance of three humors, eyes 
will be inflammed and reddish.  
 
FAECES EXAMINATION (ky Nju;T) : 
“Xf;FNk thj Neha; kyj;ijg; ghu;f;fpy; 
cfe;jkyk; fWfpNa fWj;jpUf;Fk; 
kpf;fgpj;j Neha;kyj;ij Aw;Wg; ghu;f;fpy; 
kpFe;jrptg;Gld; gRik jhDe; Njhw;wk; 
ikf;Ftis kNdNr isa Nuhfk; 
kykJjhd; ntz;ikdpw khapUf;Fk; 
gf;Ftkh apk;%d;We; njhe;jpg; ghfpy; 
gfUkpd; epwq;fs;tif gupe;J fhZk;” 
- fz;Zrhkp guk;giu 
itj;jpak;.  
 
 In exacerbated Vali – faeces is hard, dry and black in colour 
 In Azhal vitiation, it is Yellow 
 In Iyyam disturbance it is pale. 
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MALAM (Motion examination)  
 The amount of feces is reduced. The consistency becomes hard. There is no 
frothy or mucous. The colour is usually reddish yellow or dark. Constipation is usually 
encountered.  
URINE EXAMINATION (ePu; Nju;T) : 
„Neer‟ refers to urine „Kuri‟ refers to sign. Theraiyar, one of the renowned 
authors of siddha medicine described urine examination and stages of health. He had 
explained about the colour and consistency of the urine in vitiated humor and disease. He 
also emphasized the spreading nature of a single drop of oil on the surface of the urine 
indicating the imbalance of specific dosha and prognosis of disease. Normal urine is 
straw coloured and odorless. The time of the day and food taken will have an impact on 
the colour of the urine.  
 
Neer Kuri (ePh; Fwp)  
 The amount is usually normal but when veluppu and sobai develops,the amount 
is reduced. There is no froth. The colour is usually light reddish yellow.  
 
NEI KURI (nea;f;Fwp) : 
“muntd ePz;bdNj thjk; 
MopNghy; gutpd; m/Nj gpj;jk; 
Kj;njhj;J epw;fpd; nkhoptnjd; fgNk” 
- mfj;jpah; itj;jpa uj;jpd RUf;fk; 
 
The spreading pattern of oil drop is the indicative of Vali, Azhal and Iyyam disease e. g,  
 Aravu (Snake pattern of spread) indicates Vali disease 
 Mothiram (Ring Pattern of spread) indicates Azhal disease 
 Muthu (Pearl Pattern of spread) indicates Iyya disease 
In Neikkuri, the rapid spread of oil drop; Pearl beaded and Sieve type of 
spreading pattern indicates incurable state of the disease. From this, we can assess the 
prognosis by the Neikkuri.  
 
Nei Kuri 
Due to the vatha pitha thontham involvement the nei kuri is, serpent and ring shaped.  
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kUj;Jtk; (Line of Treatment) : 
“itj;jpar; nray; itj;jpaNk” 
- jpU%yh; 800 
 
The main object of treatment is to bring down the deranged mukkutrams to 
natural equilibrium by giving purgatives, which cure derangement of Vatham; this is one 
of the causes for Ratha Moolam.  
“Ngjpahy; thjk; jhOk;” 
“the;jpahy; gpj;jk; jhOk;” 
“mQ;rdj;jhy; fgk; jhOk;” 
- tpahr gfthd; ruPu #j;jpuk; 
 
As per the above-mentioned poem, the author gives purgation Agasthiyar 
Kuzhambu 130 mg with ginger juice to all patients as per their body condition.  
 
SUGGESTED LINE OF TREATMENT 
Line of treatment for Ratha moolam consist of Purgation and Emetic should be 
given as the first line of treatment. Administration of internal medicine to stop bleeding 
to reduce inflammation  and  relieve constipation.  
 
PINI NEEKKAM (TREATMENT)  
Siddha system of medicine is able to cure disease by rooting out them once for 
all. This system envisages methods for prevention of diseases and it treats not only the 
disease but the person as a whole.  
These include,  
 Kaappu 
 Neekkam 
 Niraivu 
 Kaappu (Prevention)  
“%yQ;Nru; fwpEfNuhk; %j;jjapu; cz;Nghk; 
Kjdhspw; rikj;jfwp aKnjdpD kUe;Njhk; 
Qhye;jhd; te;jpbDk; grpj;Njhopa Tz;Nzhk; 
ekdhu;f;fpq; NfJit ehkpUf;F kplj;Nj” 
- gjhu;jFz rpe;jhkzp 
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Above verse explain,  
 Tubers which induce haemorrhoids should be avoided.  
 Sour curd to be taken 
 Food prepared in the previous day is to be avoided even though it is delicious.  
 Avoid eating food while angry. 
 Among tubers, only yam is to be taken.  
 Mild work is to be done after eating.  
These are some instructions to be followed, to be free from the disease.  
 
Neekkam (Treatment)  
According to “Anubava vatihiya deva ragasiyam” Moolam treatment is 
divided into a type‟s namely, 
 Internal medicine (oushadham) 
 External medicine 
 Surgery (Sasthiram) 
 Cauterization (Akkni) 
Depending upon the body, any type of treatment is prescribed among those 4 
types Siddhars prefer internal medicine for moola noigal in their texts.  
Line of treatment: 
 Administration of Internal medicine  
 To stop bleeding and to relieve the constipation 
 To extenuate the derangement or morbid condition of Vatha pitha humour 
 Pranayamam therapy to normalize the thathuvam 
 Yoga theropy to normalize the bowel habits 
 
Pranayama therapy 
The basic vitality which is the key to life is what we term prana.  
 Prana is the basic life principle.  
 We believe that everything in creation had prana.  
 Growth of prana from lower strata to higher strata is the process that 
characterizes life.  
In man, this process is being accelerated by the conscious discrimination faculty 
and is called “Pranayama”.  
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 During inhalation, oxygen enters the blood stream through the lungs. Once the air 
has circulated through the body, waste air in the form of carbon dioxide is ejected from 
the body during the exhalation process.  
 
Yoga therapy 
Yoga therapy is great help to prevent and control haemorrhoids from getting 
worse.Practice yoga cleansing technique keeps the body purified and prevent digestive 
and intestinal problems. 
The following aasanas are prescribed to prevent constipation.  
All inverted aasana like sarvangasana and sirasasana helps to drain the stagnant 
blood from the anus and may reduce or abolish the symptoms of this disease.  
 
Aswini mudra 
Practice of this mudra in various seated postures will strengthen the rectum & 
muscles and nerves surrounding the anal sphincter  
Other recommended posture as follows,  
 GOMUKHASANA 
 SALABASANA 
 DHANURASANA 
 PUYANGASANA 
 ARAI MATCHENDRASANAM 
 SARVANGASANA 
 
NIRAIVU (Life style modifications)  
Advised to  
 Avoid emotional stress 
 Avoid strenuous work load 
 Avoid sedentary life style 
 Avoid smoking and alcohol 
 Avoid tobacco chewing 
 Avoid fast food & spicy items 
 Advised to take plenty of fiber rich foods like fruits, greens, and vegetables.  
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DIET ADVICE: 
“khWgh by;yh cz;b kWj;Jz;zpd; 
CWgh by;iyA apu;f;F” 
- jpUf;Fws;. 
 
“kUe;Nj czT> czNt kUe;J” 
- jpU%yu;. 
Do’s 
 Drink 3 to 4 liters of Water, a day.  
 Take more amount ofTender coconut 
  Cow‟s butter milk, Cow‟s ghee, 
 Fresh vegetables, Fiber content vegetables.  
 Fruits: Water melon, Cucumber.  
 Advice to do pranayamam, Yoga for mental stress.  
 Arai keerai, Thuthi keerai, Siru keerai 
 Asafoetida 
 Castor oil 
 
Don’ts 
 Cauliflower, Coffee, Tea, Chocolate, Meat, Fish, Bitter ground, Brinjal, Tubers, 
Egg, Oil foods, Maize, Caustic soda, Tamarind, Tobacco, Liquor 
 Preserved beverages, Foods rich in salts, Spicy and fried foods 
 Prolonged sitting, Excessive sexual inter course.  
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MODERN ASPECTS 
 
ANATOMY OF RECTUM  
The rectum is the penultimate part of the alimentary system. It acts primary to 
receive stool from colon.  
SYNONYM: 
Rectum in Latin means “Straight” 
SITUATION 
The rectum is an 8-inch (15cms) chamber that connects the colon to the anus. It 
lies in the true pelvis, more or less in the middle line.  
EXTENT 
The rectum is a chamber that begins at the end of the large intestine, immediately 
following the sigmoid colon, and ends at the anus.  
 
COURSE AND DIRECTION 
The rectum commences as the downward continuation of the sigmoid colon. It 
runs anterior to the sacrum. It passes downward and backwards and then downwards and 
forwards. Itends by piercing the levator ani muscle. It terminates by becoming the anal 
canal.  
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EXTERNAL FEATURES 
The rectum has the following features,  
 Ampulla of rectum 
 Ampulla is the terminal part of the rectum. It is situated above the levator ani 
muscle.  
 Curves of the rectum 
 The rectum has an anteroposterior curve corresponding to that of the sacrum and 
coccyx.  
 The rectum also has 3 lateral curves 
 At the commencement it is convex to the right side.  
 At the level of sacro coccygeal joint it is convex to the left side.  
 At the level of the tip of the coccyx itis again convex to the right rectum.  
 
Folds in the rectum 
The mucous membrane lining the interior is thrown into transverse folds and 
longitudinal folds.  
The circular and longitudinal muscle coats may extend into these folds.  
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RELATIONS OF THE RECTUM 
RELATION 
In Male Anteriorly, the rectum is related to the Recto vesical Pouch, Base of the 
urinary bladder, Seminal vesicles, Amuplla Of the vas deference, Terminal Uterus part of 
the ureter, posterior surface of the prostate gland, Sacrum, Coccyx, Ano coccygeal raphe, 
Median sacral vessels, Sympathetic chains 
In Female Anteriorly, the rectum is related to the Recto uterine pouch, back of 
the upper part Vagina, Uterus, Sacrum, Coccyx, Ano coccygeal raphe, Median sacral 
vessels, Sympathetic chains 
 
Posteriorly, the rectum is related to the sacrum, coccyx, and pelvic diaphragm. 
 
LATERAL RELATIONS  
Upper 1/3 of the rectum  -  para rectal fossa 
Middle 1/3 of the rectum  -  Pelvic rectal space  
   Levator ani muscle 
Lower 1/3 of the rectum  -  Ischio rectal fossa 
 
PERITONEAL RELATIONS 
Upper 1/3 of rectum - The peritoneum covers the anterior and  
  lateral surface of the rectum 
Middle 1/3 of rectum  - The peritoneum covers only the surface of  
     the rectum 
Lower 1/3 of the rectum  - Non-peritoneal 
 
INTERIOR OF THE RECTUM  
The mucous membrane lining the interior is thrown into transverse and 
longitudinal folds. When the rectum distends the longitudinal folds disappear. The 
transverse folds are three in number. They are permanent folds and are known as valves 
of Houston. They are arranged as upper, middle and lower folds.  
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BLOOD SUPPLY 
 
ARTERIAL SUPPLY 
 Superior rectal artery from inferior mesenteric artery 
 Middle recta artery from the internal iliac artery 
 Inferior rectal artery from internal pudendal artery 
 
VENOUS DRAINAGE 
 Inferior mesenteric vein drains blood from the rectum, sigmoidcolon,descending 
coon and splenic flexure 
 It begins as the sup.rectal vein and ascends, receiving tributaries from the 
sigmoid veins and the left colic veins. 
 
Lymphatic drainage 
 Upper 1/3 of the rectum is drained along the superior rectal vessels into inferior 
mesenteric lymph node.  
 Middle 1/3 of the rectum is drained along the middle rectal vessel into internal 
iliac nodes.  
 Lower 1/3 of the rectum is also drained into internal iliac nodes  
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NERVE SUPPLY 
Sympathetic supply  
Superior hypogastric plexus from L1, L2 segments of the spinal cord.  
 
Para sympathetic supply 
Pelvic splanchnic nerves and Inferior hypogastric plexses (S2, S3, S4). 
 
ANATOMY OF ANAL CANAL 
The anal canal is the terminal portion of the alimentary system. 
 
LENGTH 
The anal canal is about 4 cms long.  
 
EXTENT 
It commences as the downward continuation of the rectum at ano rectal junction 
and it ends by opening into the exterior at anal opening.  
 
COURSE 
It passes downwards and backwards to the anal opening.  
 
RELATIONS OF ANALCANAL 
ANTERIORLY 
MALE- Perineal body                    FEMALE-Back of the lower part of the vagina 
Bulb of the penis 
Membranous urethra 
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POSTERIORLY- Ano coccygeal raphe 
Lateral relations  
 Sphincters of the anal canal 
 Levator ani 
 Ischio rectal fossa 
 
MUSCULATURE OF ANAL CANAL 
The anal canal is surrounded by internal and external anal sphincters, which play 
a crucial role in the maintenance of faecal continence: 
Internal anal sphincter – surrounds the upper 2/3 of the anal canal. It is formed from a 
thickening of the involuntary circular smooth muscle in the bowel wall. 
External anal sphincter – voluntary muscle that surrounds the lower 2/3 of the anal 
canal (and so overlaps with the internal sphincter). It blends superiorly with the 
puborectalis muscle of the pelvic floor.This sphincter made up of striated muscle. It has 
3 parts 
The subcutaneous part 
It encircles the lower end of the anal canal. It has no bony coccyx. It encircles the anal 
canal.  
The deeper part  
It encircles upper part of the anal canal. It has no bony attachment 
The puborectalis Muscle 
Puborectalis, Part of the funnel – shaped muscular pelvic diaphragm, maintains the angle 
between the anal canal and rectum and hence is an important component. 
THE ANORECTAL RING 
At the junction of the rectum and the anal canal, there is a muscular ring – known as the 
anorectal ring. It is formed by the fusion of the internal anal sphincter, external anal 
sphincter and puborectalis muscle, and is palpable on digital rectal examination. 
THE PECTINATE LINE 
 The pectinate line is wave like line  
 This line is situated along the anal canal 
 This line is an important land mark morphologically and surgically.  
 
 
` 
32 
 
ARTERIAL SUPPLY 
 The part of the anal canal above the pectinate line is supplied by superior rectal 
arteries 
 The part below the pectinate line is supplied by inferior rectal arteries.  
 
VENOUS DRINAGE 
The upper half of the anal canal is drained by the superior rectal veins; tributaries 
of the inferior mesenteric vein thus the portal mesenteric venous system,  
The middle rectal veins, which drain into the internal iliac veins.  
The inferior rectal veins drain the lower half of the anal canal and the 
subcutaneous perianal plexus of veins. They eventually join the internal iliac vein on 
each ride.  
LYMPHATIC DRAINAGE 
Lymph from the upper half of the anal canal flows upwards to drain into the post 
rectal lymph nodes and from there goes to the para – aortic nodes via the inferior 
mesenteric chain.  
Lymph from the lower half of the anal canal drains on each side first into the 
superficial and then into the inguinal group of lymph glands.  
 
DEFECATION 
This is the reflex phenomenon with a voluntary control.Thus, it has both 
reflexive(automatic) and voluntary components.The center for defecation is present in 
the sacral portion of the spinal cord, which is influenced by higher center. 
Efferent pathway involves cholinergic para sympathetic fibers in the pelvic 
nerves 
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DEFECATION REFLEX 
 
 Response to distension of the rectal wall 
 Receptor send sensory nerve impulse to the sacral spinal cord 
 Motor impulses from the cord travel along parasympathetic nerves back to the 
descending colon, rectum, anus 
 Contraction of the longitudinal recta muscles shortens the rectum (increased 
pressure within it) 
 Pressure along with voluntary contractions of the diaphragm and abdominal 
muscles 
 Parasympathetic stimulation opens the internal anal sphincter 
 Constriction of external anal sphincter 
 Constriction of external anal sphincter 
 Initiation of defecation reflex  
 External anal sphincter opens 
 The person defecates (the amount of the bowel movements that a person has over 
a given period of time depends on various factors such as diet,health and stress) 
Normal range of bowel activity varies 2 or 3 bowel movement per day,3 or 4 
bowel per day. 
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A VIEW ON HAEMORRHOIDS 
 
SYNONYM 
Meaning of Haemorrhoids in Greek: haima = blood, rhoos = flowing 
Piles is a Latin word, In Latin Pila means a ball.  
 
EPIDEMIOLOGY 
Many individuals experience this condition without seeking medical consultation; 
patients are often reluctant to seek medical help because of embarrassment or the fear, 
discomfort, and pain associated with the treatment, so the exact incidence of this disease 
cannot be estimated.In India approximately 40,723,288 people are reported to have 
hemorrhoids. 1 million new cases are reported annually, it is estimated that 50-85% 0f 
people around the world have hemorrhoids and in India 75% of the population is 
estimated. Current statistics suggest that almost half of people in their fifties have piles. 
In both genders, a peak in before the age of 20 is unusual, and Caucasians are affected 
more frequently than African Americans.  
DEFINITION 
Haemorrhoids are varicosities or swelling and inflammation of veins in the 
rectum and anal canal.  
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CLASSIFICATION 
 Haemorrhoids may be external or internal to the orifice.  
 Internal haemorrhoids arise from the superior venous plexus, above the Hilton‟s 
line are covered by columnar epithelium.  
 External haemorrhoids arise from the inferior venous plexus, above the Hilton‟s 
line and are covered by squamous epithelium.  
 
PATHOGENESIS  
The anal canal has a lumen lined by three fibrovascular cushions of submucosal 
tissue. The cushions are suspended in the canal by a connective tissue framework derived 
from the internal anal sphincter and longitudinal muscle. Within each cushion is venous 
plexus that is fed by arterio venous communications. These specialized vascular 
structures allow for enlargement of the cushion to maintain fine continence. In health as 
in disease the anal cushion appears in the right anterior, right posterior, and left lateral 
positions.  
The anchoring and supporting connective tissue system deteriorates withaging. 
Fragmentation of the connective tissue supporting the cushion leads to their descent. 
Straining produces an increase in venous pressure and engorgement. The veins become 
distended as they lose their support. The descended loose lining becomes more sensitive 
to pressure from straining and to trauma from the stool.The prolapsed cushion has an 
impaired venous return, which results in cushion‟s epithelium, resulting in bleeding.  
 
INTERNAL HAEMORRHOIDS 
The term internal Haemorrhoids are varices of the tributaries of the superior 
haemorrhoidal veins which drain into the inferior mesenteric vein.  
 
AETIOLOGY 
Hereditary 
This condition iscongenital weakness of walls of the veins or an abnormally large 
arterial supply to the haemorrhoidal plexus seen in members of the same family that 
there must be a predisposing factor. 
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Anatomical 
 The collecting radicals of the superior haemorrhoidal vein lie unsupported in the 
very loose submucous connective tissue of the rectum 
 These veins pass through musculature tissue and are liable to be constricted by its 
contraction during defecation  
 The superior haemorrhoidal veins being tributaries of the portal vein, have no 
valves 
 
Occupational  
 Heavy manual labors like porters  
 Prolonged standing workers like train drivers, traffic policemen, bus conductors, 
tea masters etc. 
 Prolonged sitting workers like tailors. They are more prone to develop piles. 
 
Chronic constipation 
This causes straining while passing stools which in turn cause pressure effect in 
the rectum. Therefore, the veins are obstructed.  
 
Frequent purgation 
Frequent occurrences of dysentery and diarrohea all cause congestion of the 
rectal veins and favor the development of piles.  
 Straining at micturition 
 Presence of tumors 
 Loss of sphinctertone  
 Habitual over eating 
 High blood pressure 
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CLASSIFICATION 
 First degree  –   Bleed only, prolapse 
 Second degree –   Prolapse but reduce spontaneously 
 Third degree  –    Prolapse and have to be manually reduced  
 Fourth degree  –    Permanently prolapsed 
 
 
POSITION OF HAEMORRHOIDS 
Haemorrhoids are usually situated in,  
 3‟o clock position that is left lateral 
 7‟o clock position that is right posterior  
 11‟o clock position that right anterior 
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CLINICAL FEATURES 
Bleeding  
Bleeding, as the name haemorrhoid implies is the principal and earliest symptom. 
The bleeding is characteristically separate from the motion and is seen either on the 
paperon wiping or as a fresh splash in the pan 
 
 
 
 
 
 
 
 
 
 
Prolapse 
Prolapse is a much later symptom. In first – degree haemorrhoids, the 
haemorrhoidal tissue protrudes into the lumen of the anal canal, but does not prolapse 
outside the anal canal. The veins of the anal canal are increased in size and number and 
may bleed at the time of evacuation.  
Second – degree haemorrhoids may prolapse beyond the external sphincter and 
be visible during evacuation but spontaneously return to lie within the anal canal.  
Third – degree haemorrhoids protrude outside the anal canal and require manual 
reduction.  
Fourth – degree haemorrhoids are irreducible and are constantly prolapsed. It is 
important to document the grade of the haemorrhoids ot determine appropriate treatment 
and to evaluate the efficacy of a particular treatment modality.  
 
Discharge 
Soiling may occur in third and fourth degree haemorrhoids as a result of impaired 
continence or production of mucus discharge. Discharge can cause perianal irritation and 
itching.  
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Anal pain 
Pain is absent unless complications supervene, Fourth degree haemorrhoids may 
become “Strangulated” and present with acute severe pain. Progressive venous 
engorgement of the acutely inflamed haemorrhoids leads to thrombosis.  
 
Anaemia  
Anaemia can be caused very rarely by profuse bleeding from haemorrhoids.  
 
Constipation 
Haemorrhoids are associated with chronic straining secondary to constipation, 
diarrhea, tenesmus, or long periods trying to defecate.  
 
EXAMINATION 
Inspection  
On inspection there may be no evidence of internal haemorrhoids, In more 
advanced cases, redundant folds or tags of skin can be seen in the posterior of one or 
more of the primary haemorrhoids. When the patient strains, internal haemorrhoids may 
come into view transiently, or if they are of the fourth degree, and remain, prolapsed.  
 
Palpation 
Before digital examination palpation of the perianal region should be performed. 
A swelling or ulcer present in this region, an indurated tender swelling with brawny 
oedema on side of the anus is usually due to ano rectal abscess.  
External opening of fistula – in ano can be seen in this region. This has to be 
differentiated from prolapsed of the rectum.  
The patient lies in the left lateral position with the right buttock raised for the area 
to be inspected. Polyp tags and hematomas can be seen immediately Associated rashes 
and scratch marks are noted. Prolapsed internal haemorrhoids are distinguished by the 
covering of mucosa and by the lack of sensation. Strangulated haemorrhoids are grossly 
edematous 
  
` 
40 
 
DIGITAL EXAMINATION 
Internal haemorrhoids can befelt unless they are thrombosed. Possibly very large 
uncomplicated internal haemorrhoids are palpable. . 
By introduction of gloved finger into the anal canal and rectum the following 
structures can be felt. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anteriorly  
Male Female 
Recto vesicalPouch 
Base of bladder 
Seminal vesicles 
Vas deferens 
Prostate 
Bulb of penis 
Pouch of Douglas 
Vagina 
Cervix 
Urogenital diaphragm 
Diaphragm 
Perineal body 
 
Posteriorly  
Sacrum, coccyx and anococcygeal body 
Laterally 
Ischiorectal tissues and ischial spines 
 
` 
41 
 
Proctoscopy  
With the patient in the left lateral or knee elbow position, the lubricated and 
warmed instrument is gently inserted into the rectum. The instrument is introduced at 
first in the direction of the axis of the anal canal i. e. upwards towards the patient‟s 
umbilicus, until the anal canal is passed, then instrument is directed posteriorly to enter 
into the rectum proper. Now the obturator is withdrawn and the interior of rectum and 
anal canal is seen with prolapse into the proctoscope as the instrument is being 
withdrawn. Note the position of the piles as determined by the disposition of the 
branches of the superior haemorrhoidal artery.  
 
            LITHOTOMY POSITION                       KNEE-ELBOW POSITION 
 
 
 
 
 
 
 
 
 
 
There is one branch on the left side and two on the right side. Thus there are three 
primary piles via left lateral, right posterior and right anterior situated at 3, 7, and 11‟o 
clock positions respectively.  
The patient being in the lithotomy position a few (4 to 5) secondary piles may 
frequently develop in between the primary 
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PROCTOSCOPE 
 
 
 
 
 
 
 
 
 
Sigmoidoscopy 
The patient must be in the knee elbow position which allows coils of the intestine 
to fall forward and leads to natural distension of the rectum with air. By this instrument 
whole of the rectum and a large part of the sigmoid colon can be examined. The 
instrument is gently passed under vision by distending the rectum with few light battles 
of the abashed pillars.  
 
 
 
 
 
 
 
 
 
 
 
Sigmoidoscopy is useful in the younger age group (Under 35 years) who has 
bleeding haemorrhoids and no other symptom or risk factors.  
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Rubber band ligation 
Most internal haemorrhoids can be treated by this method. With a proctoscope in 
place the haemorrhoids can be grasped with forceps,then passed through a banding tool 
with which It is possible to apply a rubber band. \ 
 
Examination of the abdomen 
The examination of the abdomen to exclude palpable lesions of the colon or 
aggravated factors for haemorrhoids.  E. g. an enlarged liver.  
 
Barium enema X- ray 
The importance of this examination in a case bleeding per rectum and in 
pathologies of rectum and anal canal cannot be over emphasized. In any case of internal 
haemorrhoid barium enema X- ray must be performed to exclude any carcinoma above 
the rectum to be cause of this condition.  
 
Blood for Bleeding time and clotting time 
To rule out bleeding diathesis 
 
Motion for occult blood  
To rule out upper gastro intestinal disorders, carcinoma of colon and rectum.  
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DIFFERENTIAL DIAGNOSIS 
External haemorrhoids 
A thrombosed external haemorrhoids relates anatomically to the veins of the 
superficial or external haemorrhoids plexus and is commonly termed a perianal 
haematoma. It presents as a sudden onset, olive – shaped, painful blue subcutaneous 
swelling at the anal margin and is usually consequent upon straining at stool, coughing or 
lifting a heavy weight. The thrombosis is usually situated in a lateral region of the 
analmargin.  
 
 
 
 
 
 
 
 
Fistula in ano 
This is a track lined by granulation tissue which opens deeply in the anal canal or 
rectum and superficially on the skin around the anus. Sometimes the track does not open 
into the anal canal or rectum, when it should be called a sinus.  
An anal fistula may occur with or without symptoms. A history of intermittent 
swelling with pain. Discomfort and discharge in the perianal region can often be 
obtained. Inspection and palpation usually delineate the course and nature of the fistula.  
 
 
 
 
 
 
 
 
Anal Fistula -External opening 6‟0 clock and Internal opening is 6‟o clock position 
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Fissure in ano 
An anal fissure is a longitudinal split in the anoderm of the distal anal canal, 
which extends from the anal verge proximally towards, but not beyond, the dentate line.  
Acute anal fissures are, characterized by severe anal pain associated with 
defaecation, as well as the passage of fresh blood, normally noticed on the tissue after 
wiping. Chronic fissures are characterized by a hypertrophied anal papilla internally and 
a sentinel tag externally. When chronic, patients may also complain of itching secondary 
to irritation from the sentinel tag, discharge from the ulcer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fissure in ano- 6‟o clock position 
Rectal prolapse 
The mucous membrane and submucosa of the rectum protrude outside. The anus 
for approximately 1-4cm. When the prolapsed mucosa is palpated between the finger and 
thumb, it is evident that it is composed of no more than a double layer of mucous 
membrane(cf. full- thickness prolapse) 
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The condition in adults is often associated with third – degree haemorrhoids. 
Prolapsed mucous membrane is pink; prolapsed internal haemorrhoids are plum coloured 
and more pedunculated. In rectal prolapse faecal incontinence is an important feature.  
 
Rectal prolapse 
 
 
 
 
 
 
 
 
 
 
                                 
 
Condylomata Accuminata (Anal Warts) 
There is increasing evidence that sexually transmitted infection with human 
papilomavirus (HPV) forms the aetiological basis of anal and perianal warts, anal 
intraepithelial neoplasia (AIN) and squamous cell carcinoma of the anus.  
Condylomata accuminata is the most common sexually; transmitted disease 
encountered by colorectal surgeons and is most frequently observed in homosexual men. 
Associated warts on the penis and along the female genital tract are common.  
Many are asymptomatic, but pruritus, discharge, bleeding and pain are usual 
presenting complaints.  
 
Proctitis 
Inflammation of the rectal mucosa. The inflammation can be acute or chronic. 
The symptoms are tenesmus and the passage of blood and mucus and, in severe cases, of 
pus also. Although the patient has a frequent intense desire to defaecate, the amount of 
faeces passed at time is small. Acute proctitis is usually accompanied by malaise and 
pyrexia. On rectal examination, the mucosa feels swollen and is often tender.  
  
` 
47 
 
Polyp  
This is bright – red glistening pedunculated sphere („cherry tumor‟), which is 
found in infants and children. Occasionally, it persists into adult life. It can cause 
bleeding or pain if it prolapses during defecation 
 
Carcinoma of rectum 
The rectum is the most frequent site for cancer. Early symptoms of rectal cancer 
are bleeding per rectum, Tenesmus, Early morning diarrhea, colicky pain.  
 
COMPLICATIONS  
Profuse haemorrhage 
Profuse haemorrhage is not rare. The bleeding mainly occurs externally but it 
may continue internally after the bleeding haemorrhoid has retracted or has been 
returned. In these circumstances, the rectum is found to contain blood.  
 
Anaemia 
Repeated loss of small amounts of blood over a period of years can giverise to 
severe secondary anaemia and it is not unusual for a patient attending for treatment of 
piles to be found to have a haemoglobin concentration is below 50%. Prompt efficient 
treatment of the haemorrhoids results in rapid correction of the anaemia.  
 
Strangulation 
One or more of the haemorrhoids prolapsed and become gripped by the external 
sphincter. Further congestion follows because the venous return is impeding. Second 
degree haemorrhoids are most often complicated in this way. Strangulation is 
piles.Unless the internal haemorrhoids can be reduced within 1 or 2 hours. Strangulations 
is followed by thrombosis. 
 
Thrombosis 
The affected haemorrhoids or haemorrhoids become dark purple or block and feel 
solid. Considerable oedema of the anal margin accompanies thrombosis. Once the 
thrombosis has occurred, the pain of strangulation largely passes off, but tenderness 
persists.  
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Ulceration 
Superficial ulceration of the exposed mucous membrane often accompanies 
strangulation with thrombosis.  
 
Gangrene  
Gangrene occurs when strangulations is sufficiently tight to constrict the arterial 
supply of the haemorrhoid. The sloughing is usually superficial and localized. 
Occasionally a whole haemorrhoid sloughs off, leaving an ulcer which heals gradually.  
 
Fibrosis 
After thrombosis, internal haemorrhoids sometimes become converted into 
fibrous tissue. The fibrosed haemorrhoid is at first sessile, but by repeated traction during 
prolapsed at defecation, it becomes pedunculated and constituted a fibrous polyp that is 
readily distinguished by its white colour from an adenoma, which is bright red. Fibrosis 
is an external haemorrhoid favors prolapsed of an associated internal haemorrhoid.  
 
Suppuration  
Suppuration is uncommon. It occurs as a result of a thrombosed haemorrhoid. 
Throbbing pain is followed by perianal swelling or submucous abscess results.  
 
Pylephlebitis (portal pyaemia)  
Theoretically, infected haemorrhoids should be a potent cause of portal pyaemia 
and liver abscesses.  
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MATERIALS AND METHODS 
 A clinical study on siddha herbal formulation “Kukkilathy Chooranam” in 
“Ratha Moolam” (Bleeding Piles) 
 
STUDY DESIGN AND CONDUCT OF STUDY: 
 
Study type  : An open clinical trial 
Study place  : OPD of Ayothidoss Pandithar Hospital,  
   National Institute of Siddha,  
   Tambaram sanatorium, Chennai-47.  
Study period  : 12 months.  
Sample size  : 30 patients 
Randomization   :  Patients will be randomly assigned To Treatment.  
 
TREATMENT: 
 
Medicine Name   : KUKKILATHY CHOORANAM (Internal)  
Dosage   :  4g (twice/day) after food 
Adjuvant   :  Cow‟s Ghee 
Duration   : 45 days.  
 
STANDARD OPERATING PROCEDURE FOR “KUKKILATHY 
CHOORANAM”: 
Required raw drugs: 
 
 Purified Kukkil (Shorea robusta)         - 134.4g 
 
 Purified Parangipattai (Smilax china)   - 67.2g 
 
 Purified Gandhagam (Sulfur)                - 33.6g 
 
  Arisithippili (Fruit of Piper longam)    - 8.4g 
 
 Kandathippili (Root of Piper longam)  - 8.4g 
 
 Vetpalaiarisi (Wrightia tinctoria)         - 8.4g 
 
 Vaividangam (Embelia ribes)               - 8.4g 
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SOURCE OF RAW DRUGS: 
The above said raw drugs will be purchased from a well reputed country shop at 
Chennai. The raw drugs will be authenticated by Botanist and Pharmaegonist NIS, 
Chennai. The raw drugs will be purified, and the medicine will be prepared as per SOP 
as in the Gunapadam  Laboratory of NIS, Chennai.  
Purification of the ingredients: 
 
All the drugs mentioned here were purified as per the Siddha literature. 
 Shorea robusta: 
 Resin of Shorea robusta was boiled with tender coconut and then dried. 
 Sulphur: 
 The kalkamof Lowsonia inermis was mixed in cow's curd and placed in a 
mud pot. The mouth of the pot was covered with a cloth. Sulphur was placed 
over the cloth. The pot was covered with another suitable pot and buried in the 
ground. The entire setup was subjected topudam with five dung cakes.The 
sulphur which melts and settles down was collected. This procedure was 
repeated for 7 times.  
 
 Wrightia tinctoria: 
 Seeds of Wrightia tinctoria were cleaned well from dust and impurities. 
Then it was fried well. 
 Embelia ribes: 
 Seeds of Embelia ribes were cleaned well from dust and impurities. Then 
it was fried well. 
 Piper longum fruit: 
 Fruit of Piper longum was soaked in lemon juice and it was dried in 
sunlight until the juice gets evaporated. Then it was fried well. 
 Smilax china: 
 Rhizome of Smilax china was boiled with milk and then dried. 
 Piper longum root: 
 Root of Piper longum was soaked in lemon juice and it was dried in 
sunlight until the juice gets evaporated. Then it was fried well. 
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Method of Preparation: 
 The purified herbal ingredients were made into fine powder separately. Then the 
purified sulphur was grinded by using kalvam, after made into powder the above herbal 
powder were added and grinded. It was finely powdered and purified by Pittavial murai 
then kept in an air tight container. 
DISPENSING:  
 The prepared drug will be dispensed in sachets (4g) once in 7days for 45 days. At 
each visit the patients will be advised to return the unconsumed drug if any. 
SUBJECT SELECTION: 
When patients reporting at OPD NO 1, Dept of Maruthuvam, Ayothidoss 
Pandithar Hospital, NIS with symptoms of inclusion criteria will be subjected to 
screening test and documentation will be done by using screening proforma. 
 
11.0   SELECTION CRITERIA:  
INCLUSION CRITERIA: 
Patients who are having the following, will be included in the study: 
 Age: 20- 60Yrs 
 Sex – Both male and female 
 Patients who are having the following symptoms of bleeding piles (1st degree 
haemorrhoids) confirmed by Proctoscopy, constipation, bleeding per anus, 
itching in the perianal region, pain in all limbs. 
 Willing to give blood samples for the investigation when required. 
 
EXCLUSION CRITERIA: 
The patients one who have the following criteria will be excluded from  this study: 
 Patient having  2nd ,3rd degree internal haemorrhoids 
 Pregnancy & lactation 
 External haemorrhoids 
 Fissure in ano 
 Fistula in ano 
 Hypertension  
 Rectal polyp 
 Rectal cancer  
` 
52 
 
WITHDRAWAL CRITERIA: 
a. Development of any serious adverse reactions during the trial period. 
b. Increase in severity of symptoms. 
c. Patient will not take medication regularly 
d. The Patient one who not willing to continue the course of clinical trial. 
 
ASSESSMENTS AND INVESTIGATIONS: 
a)  Clinical assessment 
 b) Siddha assessment 
 c) Routine investigations: 
1.  Modern parameters 
2. Siddha parameters 
 d) Specific investigations 
 
a) CLINICAL ASSESSMENT: 
Bleeding after defecation 
               Anal pain 
               Rectal bleeding 
               Anemia 
               Constipation 
               Discharge of pus and mucous 
               Pruritus ani 
               Pain in all limbs 
               Irritation and soreness after defecation    
 
SIDDHA ASSESSMENT: 
Thinai (Living Place): 
1. Kurinchi (Hill areas) 
2. Mullai (Forest) 
3. Marutham (Fertile land) 
4. Neithal (Costal area) 
5. Paalai (Desert) 
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Paruva Kalam (season ) 
1. Kaarkaalam (Aug 18 – Oct 17) 
2. Koothir kaalm (Oct 18 – Dec 16) 
3. Munpanikaalm (Dec 17 – Feb 12) 
4. Pinpani kaalam (Feb 13 – April 13) 
5. Ilavenil kaalam (April 14 – June 14) 
6. Muthuvenil kaalam (June 15 – Aug 17) 
 
Iymporikal: 
1. Mei (Skin) 
2. Vaai (Tongue) 
3. Kan (Eye) 
4. Mooku (Nose) 
5. Sevi (Ear) 
 
UYIRTHATHUKKAL: 
Vatham: 
1. Praanan 
2. Abaanan 
3. Samaanan 
4. Udhaanan 
5. Viyaanan 
6. Naagan 
7. Koorman 
8. Kirukaran 
9. Dhananjeyan 
10. Devathathan  
Pitham: 
1. Anarpitham 
2. Prasakam 
3. Saathakam 
4. Aalosakam 
5. Ranjakam 
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Kabam: 
1. Avalambagam 
2. Kilethagam 
3. Santhigam 
4. Tharpagam 
5. Pothagam 
 
Enn Vagai Thervu (Eight types of Examination): 
1. Naadi (Pulse perception) 
2. Naa (Tongue) 
3. Niram (Complexion) 
4.  Mozhi (Voice) 
5. Vizhi (Eyes) 
6. Sparisam (Palpatory perception) 
7. Malam (Bowel habits) 
8. Moothiram (Urine){Neerkuri& Neikuri} 
 
ROUTINE INVESTIGATION 
HAEMATOLOGY 
 Hb (gms%) 
 Total WBC Count(cells/cumm) 
 DC 
 Polymorphs(%) 
 Lymphocytes (%) 
 Eosinophils (%) 
 Monocytes (%) 
 Basophils (%) 
 Total RBC count (cells/cu.mm) 
 ESR(mm/hr) 
 
BLOOD BIOCHEMISTRY 
 Fasting and postprandial Blood sugar  
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CLINICAL BIOCHEMISTRY 
 
RENAL FUNCTION TEST 
 Blood urea (mg/dl) 
 S. total creatinine (mg/dl) 
 Uric acid (mg/dl) 
 
LIPID PROFILE 
 S. Total cholesterol (mg/dl) 
 HDL (mg/dl) 
 LDL  (mg/dl) 
 VLDL (mg/dl) 
 TGL (mg/dl) 
 
LIVER FUNCTION TEST 
 S. Total bilirubin (mg/dl) 
 S. Direct bilirubin (mg/dl) 
 S. Indirect bilirubin (mg/dl)  
 SGOT (U/dl) 
 SGPT (U/dl) 
 S. Alkaline phosphatase (U/dl)  
 S. Total protein (g/dl) 
 S. Albumin (g/dl) 
 S. Globulin (g/dl) 
 
OTHER TEST 
 S. Calcium (mg/dl) 
 
URINE EXAMINATION  
 Neerkuri and Neikuri 
 Albumin  
 Sugar (Fasting & postprandial) 
 Deposits  
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MOTION  
 Ova  
 Cyst  
 SPUTUM  
 AFB 
 
SPECIAL INVESTIGATIONS: 
Proctoscopy  
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PATIENT SCREENING 
 
INCLUSION / EXCLUSION 
INCLUSION CRITERIA 
EXCLUSION CRITERIA 
EXCLUDED FROM TRIAL 
13.0 METHODOLOGY 
STUDY NUMBER 
HISTORY TAKING 
  LAB INVESTIGATION 
              TRIAL DRUG  
 GENERAL      
            TREATMENT 
CLINICAL ASSESSMENT 
 
OUTCOME 
     IF ANY ADVERSE EVENT 
REACTION 
TREATED IN OPD/REFERRED TO 
NEARBY GH 
INFORM ABOUT STUDY AND 
TRIAL DRUG 
  INFORMED CONSENT FORM 
REFERRED TO 
PHARMACOVIGILANCEDEPT OF    NIS 
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STUDY ENROLLMENT: 
 In this clinical trial, patients reporting at OPD 1 Maruthuvam, Ayothidoss 
Pandithar Hospital, NIS with the clinical symptoms of bleeding after defecation, 
anal pain with rectal bleeding, anemia, constipation, irritation and soreness after 
defecation, pruritis ani, pain present in all limbs will be examined clinically will 
be enrolled in the study based on the inclusion and exclusion criteria.  
 The patients enrolled in this study will be informed about the objective of the 
study, trial drug, possible outcomes in their own language and terms 
understandable to them. 
 After ascertaining the patient‟s willingness, informed consent will be obtained in 
the consent form. 
 All these patients will be given unique registration card which will contains 
information regarding patients‟ Registration number, Address, Phone number and 
Doctors phonenumber etc. It can help to report easily if any adverse reactions 
arise. 
 Complete clinical history, complaints and duration, examination findings-- all 
will be recorded in the prescribed case record form. Screening Form- I will be 
filled up; Form II will be used for recording the patients‟ history, clinical 
examination of signs and symptoms and laboratory investigations respectively. 
 Patients will be advised to take the trial drug with an appropriate dietary advice 
would be given according to the patients‟  perfect understanding. 
 
14.0 CONDUCT OF THE STUDY: 
 Patients who comes under Inclusion and Exclusion Criteria will be recruited for 
the Study. Then the trial drug “KUKKILATHY CHOORANAM” will be given at a 
dose of 4gm twice a day continuously for 45 days. For OPD patients, they should visit 
the hospital once in 7days. At each visit clinical assessment will be done and prognosis 
will be noted.   
 Laboratory investigations and proctoscopy will be done on 0
th
 day and 46
th
 day of 
the trial.During the treatment, patients will be advised not to take tamarind, tea, coffee, 
non-vegetarian, and advised to take the diet as given in Form VIII.  If any of the trial 
patients who fail to collect the trial drug on the prescribed day but wants to continue in 
the trial, from the next day or two, he/ she will be allowed, but defaulters of more than 
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one week will not be allowed to continue and be withdrawn from the study with fresh 
case being included.   
Follow-up: After the end of the treatment, the patient will be advised to visit the OPD 
for another 2 months for follow-up. In the follow-up period the patient‟s improvement 
will be documented. Trial medicines will not be given in this period.  
 
15.0 DATA MANAGEMENT:  
 After enrolling the patient in the study, a separate file for each patient will be 
opened and all forms will be filed in the file. Study No. and OPD/ IPD No. will 
be entered on the top of file for easy identification. Whenever the study patient 
visits OPD during the study period, the respective patient file will be taken and 
necessary recordings will be made at the CRF or other suitable forms. 
 The screening forms will be separately. 
 The Data recordings will be monitored for completion by Guide (HOD, Dept. of 
Maruthuvam), SRO (statistics) and the adverse event will be monitored by the 
members of the reactions Pharmacovigilance department of NIS. All forms will 
be further scrutinized in presence of investigator by Sr. Research Officer 
(statistics) for logical errors and incompleteness of data to avoid any bias. No 
modification in the results is permitted for unbiased reports. 
 
16.0 OUT COME OF TREATMENT: 
Primary out come:  
 Protoscopic examination,  
 Improvement of clinical symptoms with Questionnaire and Haemorrhoid 
Symptoms Severity  Score  (HSS Score). 
Secondary out come:  
 Relieving of other clinical symptoms such as anemia, Pruritis ani, constipation, 
General body weakness.Influence of other co factors related to the disease such 
as Age, Sex etc. 
 17.0 ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT:  
 If the trial patient develops any adverse reaction, he/she will be referred to the 
pharmacovigilance department of NIS. The members of this department will assess the 
adverse event and recorded in the prescribed adverse reaction form. For any AE the 
patients will be treated with proper management at NIS, OPD. 
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18.0 STATISTICAL ANALYSIS: 
 All the data will be entered into computer using MS Access software with macro 
for logical errors and manually cross checked for data entry error. Then the data will be 
exported to STATA/SPSS Software for univariate /multivariate analysis. Student„t‟ test  
and Paired „t‟ test and will be performed  for  determining the significance of a particular  
effect variable. 
 
19.0 ETHICAL ISSUES: 
1.To prevent any infection, while collecting blood sample from the patient, only  
disposable syringes, disposable gloves, with proper sterilization of lab equipments  
will be used.  
2. No other external or internal medicines will be used. There will be no infringement on  
the rights of patient for this particular indication. 
3. The data collected from the patient will be kept confidentially. The patientwill be  
informed about the diagnosis, treatment and follow-up. 
4. After the consent of the patient (through consent form) they will be enrolled in the  
study. 
5.  Informed consent will be obtained from the patient explaining in the understandable  
language to the patient. 
6. Treatment would be provided free of cost. 
7. In conditions of treatment failure, adverse reactions, patients will be given alternative  
treatment at the National Institute of Siddha with full care throughout the end. 
 8. The patients who are excluded [as per the exclusion criteria] will be given proper  
treatment at NIS. 
ASSESSMENT FORMS: 
Form - I              Screening and Selection Proforma 
Form - II             Case record form 
Form - III            Laboratory investigation form 
Form – IV   Treatment Compliance form 
Form - V                    Information sheet 
Form - VI                        Consent form 
Form -VII                       Withdrawal form/ Adverse drug reaction form/  
    Pharmacovigilance form 
Form -VIII   Dietary Advice form 
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OBSERVATION AND RESULTS 
For the clinical study 30 patients was selected and treated in PG Maruthuvam 
Department, Ayothidoss Pandithar Hospital, National Institute of Siddha, Chennai – 47 
Results were observed with respect to the following criteria.  
1. Gender Distribution 
2. Age Distribution 
3. Occupation 
4. Food Habits 
5. Socio Economic Status 
6. Seasons Distribution 
7. Land Distribution 
8. Yaakai Distribution 
9. Gunam Distribution 
10. Envagai Therguval  
11. Udal Kattukal 
12. Kosangal 
13. Naadi Nadai 
14. Uyir Thathukkal 
15. Pitham 
16. Kabam 
17. Neikuri 
18. Chronicity of Illeness 
19. Clinical Features 
20. Improvement of Clinical Features 
21. Health Assessment Questionarie 
22. Haemoglobin level 
23. Grade of result 
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PREPARATION AND PROPERTIES OF TRIAL DRUGS 
  
STANDARD OPERATING PROCEDURE FOR “KUKKILATHY 
CHOORANAM”: 
 
Required raw drugs: 
Purified Kukkil (Shorea robusta)     - 134.4g 
Purified Parangipattai (Smilax china)    - 67.2g 
 Purified Gandhagam (Sulfur)     - 33.6g 
Arisithippili (Fruit of Piper longam)    - 8.4g 
 Kandathippili (Root of Piper longam)   - 8.4g 
Vetpalaiarisi (Wrightia tinctoria)     - 8.4g 
Vaividangam (Embelia ribes)     - 8.4g 
 
Purification of the ingredients: 
 
All the drugs mentioned here were purified as per the Siddha literature. 
 Shorea robusta: 
 Resin of Shorea robusta was boiled with tender coconut and then dried. 
 Sulphur: 
 The kalkamof Lowsonia inermis was mixed in cow's curd and placed in a 
mud pot. The mouth of the pot was covered with a cloth. Sulphur was placed 
over the cloth. The pot was covered with another suitable pot and buried in the 
ground. The entire setup was subjected topudam with five dung cakes.The 
sulphur which melts and settles down was collected. This procedure was 
repeated for 7 times.  
 
 Wrightia tinctoria: 
 Seeds of Wrightia tinctoria were cleaned well from dust and impurities. 
Then it was fried well. 
 Embelia ribes: 
 Seeds of Embelia ribes were cleaned well from dust and impurities. Then 
it was fried well. 
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 Piper longum fruit: 
 Fruit of Piper longum was soaked in lemon juice and it was dried in 
sunlight until the juice gets evaporated. Then it was fried well. 
 Smilax china: 
 Rhizome of Smilax china was boiled with milk and then dried. 
 Piper longum root: 
 Root of Piper longum was soaked in lemon juice and it was dried in 
sunlight until the juice gets evaporated. Then it was fried well. 
 
METHOD OF PREPARATION: 
Make a fine powder of Gandhagam separately and powdered other drugs then 
finally mixed both. 
 
DRUG STORAGE: 
The trial drug will be stored in a clean and dry wide mouthed container.  
 
DISPENSING:  
The prepared drug will be dispensed in sachets (4g) once in 7days for 45 days.  
At each visit the patients will be advised to return the unconsumed drugs and return to 
the research scholar.  
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DRUGS PHOTOS 
 
               KUKKIL                                                               PARANGIPATTAI 
 
 
 
 
 
 
 
 
GANDHAGAM 
 
 BEFORE PURIFICATION   AFTER PURIFICATION 
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ARISI THIPPILI                                                    KANDA THIPPILI 
 
      VETPAALAI ARISI                                              VAAI VIDANGAM 
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                                            KUKKILATHY CHOORANAM 
 
AS PER SIDDHA LITERATURE-GUNAPADAM REVIEW 
KUKKIL – Shorea robusta 
Synonym: 
 Kungiliyam 
 Sarauvarasam 
 Gugglu 
 
Parts Used: 
 Resin 
 
Organoleptic Characters: 
 Taste          : Bitter 
 Character  : Heat 
 Division    : Acrid 
Action: 
 Stimulant 
 Expectorant 
 Diuretic 
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General Characteristics of Kukkil: 
¦ÀÕõÀ¡Î §Á¸õ§À¡õ §ÀÃ¡ Ð¼Ä¢ø 
   «ÕõÀ¢Â Òñ ½¡ÚÁ¢¨Å ÂøÄ¡ø-ÌÕõÀ¡õ 
 ±ÖõÒÕì¸¢ Òñ º¢Øõ ²Ìõ ¯Ä¸¢ø 
                 ºÄõÀÕÌí Ìí¸¢Ä¢Âò ¾¡ø.  
- «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Resin is used to cure disease like leucorrhoea, menorrhagia, ulcers, pustules, 
deep wounds. 
Medicinal Uses: 
 The powdered resin is mixed with sugar and given for diarrhoea in children. 
 The powdered resin along with milk is taken as an alterative. 
 It is used for fumigating the rooms of ill people. 
 It is used as an ointment for wound. 
 
PARANGIPATTAI – Smilax china 
Synonym: 
 Mathusmigam 
 Mathusmigi  
 Seenapattai 
 Parangichakkai 
Parts Used: 
 Root tuber. 
Organoleptic Characters: 
 Taste        : Sweet 
 Character :  Coolant 
 Division    :  sweet 
Action: 
 Alterative 
 Antisyphilitic 
 Aphrodisiac 
 Depurative 
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General characteristics of Parangi Pattai: 
  ¾¡¸õ ÀÄÅ¡¾ó ¾¡Ð¿ð¼õ ÒñÀ¢Ç¨Å 
  §Á¸í ¸Ê¸¢Ãó¾¢ Å£úãÄó-§¾¸Ó¼ý 
  Ýð¨¼ À¸ó¾§Áü ¦¸¡ûÅÁÉõ §À¡õÀÈí¸¢ô 
  Àð¨¼Â£¨É ÔîºÃ¢òÐô À¡÷.  
- §¾¨ÃÂ÷ Ì½Å¡¸¼õ 
 
 It cures thirst, Vatha disease, ulcer, diabetes, carbuncle,  haemorrhoid , leprosy 
and scabies. 
 
Medicinal Uses: 
 The decoction of the powder is given for above mentioned ailments. 
 The powdered root is used for ulcer, eczema, leucorrhoea, indigestion, diarrhoea, 
and belching. 
 
THIPPILI – Piper longum 
Synonyms: 
 Aargathi 
 Unrasam 
 Ulavainesi 
 Kaman 
 Kudari 
 Kolagam 
 Koli 
 Saram 
 Kanai 
 Aathi marunthu 
 
Parts used: 
 Fruit 
 
Organoleptic characters: 
 Taste           : Acrid 
Character : Heat 
Division     : Sweet 
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Action: 
 Stimulant 
 Carminative 
 
General characteristics of Thippili: 
  ¾¢ôÀ¢Ä¢Â¢ý ÈñÎÄï º¢§ÄòÁò¨¾ô §À¡ì¸¢Å¢Îõ 
  ¯ôÀ¢ºò¨¾ §Á¸ò¨¾ µðÎí¸¡ñ-¾ôÀ¡Áø 
  Å¡¾ ÍÃó¾½¢ìÌõ Á¡¸À§Ã¡ ¸ó¦¾¡¨ÄìÌõ 
  ¾¡Ð¨Å ÅÇ÷ôÀ¢ìÌí º¡üÚ. 
- «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
 It cures cough, ulcer, bronchial asthma, kapha diseases, anaemia, headache, 
delirium, sinusitis and throat pain. 
 
Medicinal uses: 
 The fruit powder along with Terminalia chebula is given for tuberculosis. 
 The fruit powder mixed with honey and bettle leaf juice is given for cough and 
fever. 
 The fruit powder mixed with milk is given for delirium. 
 The fruit powder mixed with honey cures tenia infection. 
 
KANDATHIPPILI – Piper longum 
Synonyms: 
 Kiranthigam 
 Thanmoolam  
 Thippili Kattai 
 Nathikaranthai 
 Narukkuver 
 Narukku Thippili  
 Modiver 
 
Parts Used: 
 Root 
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Organoleptic charaters: 
 Taste         : Acrid 
 Character  : Heat 
 Division  : Acrid 
 
Action: 
 Stomachic 
 
General characteristics of Kandathippili: 
 ¾¡¸À¢ò¾ï §º¡¸ó ¾½¢Â¡î ÍÃÁ¢ÕÁø 
§Á¸í ÌÃü¸õÁø ¦Áöì¸ÎôÒõ- ²Ìí¸¡ñ 
 ¾¢ôÀ¢Ä¢ã Äí¸ñ¼ò ¾¢ôÀ¢Ä¢Â ¾¡õ¿ÚìÌò 
¾¢ôÀ¢Ä¢¦Âý §È§Â¡Õì¸¡ü ¦ºôÒ. 
                                     - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
  
 It cures thirst, pitha disease, cough, diabetes, fever, delirium, cough, diarrhoea 
and body pain. 
 
Medicinal uses: 
 The Root powder mixed with milk is given for lumbago, thirst and vatha 
diseases. 
 The Root powder is used as snuff is in care of delirium, giddiness and heart 
attack. 
VAIVIDANGAM – Embeliaribes 
Synonym: 
 Vaivilangam 
 Varnanai 
 Keralam 
Parts used: 
 Seed 
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Organoleptic charaters: 
 Taste          : Bitter 
 Character   : Heat 
 Division     : Acrid 
 
Action: 
 Anthelmintic 
 Carminative 
 Stomachic 
 Stimulant 
 
General characteristics of Vaividangam:   
  À¡ñÎÌð¼õ ÌýÁõ ÀÕóàÄ §¿¡öÅ¡¾ó 
  ¿£ñÎ ¾¢Ã¢Å¢¼ï º¢ÃóÐñ¼õ-âñ¼ÁÊ 
  §¿¡öÅ¢Çí¸ì ¸¡ð¼¡¾ Ññ¸¢ÕÁ¢ Â¡ºÉôÒñ 
  Å¡öÅ¢Çí¸í¸¡ð¼ Å¢ÕÁ¡÷. 
                                     -  «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
It cures anaemia, peptic ulcer, obesity, snake bite and ano-rectal ulcer. 
 
Medicinal uses: 
 For anthelmintic action it is given along with honey. 
 The seed powder mixed with milk is given for indigestion, blotting and 
abdominal pain in children. 
 It is externally used for scorpion bite. 
 The seeds are grinded with butter and applied for headache. 
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VETPALAI ARISI – Wrightia tinctoria 
Synonym: 
 Girimalligai 
 Kudasam 
 Varsam 
 
Parts Used: 
 Leaves bark and seed. 
 
Organoleptic charaters: 
 Taste          : sweet 
 Character  : Coolant 
 Division    : Sweet 
 
Action: 
 
Leaves, bark    
 Aphrodisiac 
 Astringent 
 
Seed        
 Tonic 
 
General Characteristics of Vetpalai arisi: 
  ¦ÅðÀ¡¨Ä ¾ýÉÃ¢º¢ Å£ÚÀ¢ò¾ Å¡¾¦Á¡Î  
  ¦¸¡ðÀ¡÷ ¸ÃôÀ¡ý Ì¼øÅ¡¾-¯ôÀ¢ºò¨¾ì 
  ¸¡½¡Á §Ä¿¡Ùí ¸ñÊìÌí ¸¡º¢É¢Â¢ü 
  â½¡÷ Ó¨ÄÂ¡ Ò¸ø. 
  - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
   It cures vatha pitha disease, skin disease, blotting and diarrhoea. 
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Medicinal Uses: 
 The seed powder cures abdominal discomfort and blotting. 
 The leaf has the property to cure tooth ache. 
 Bark decoction is given for fever. 
 
GANDHAGAM - Sulphur 
 There are 64 kinds of Paashaanas which are classified into two types 
 Natural (32) 
 Synthetic (32) 
Sulphur is one of the natural Paashaanas which is bitter and astringent in taste. 
 
Other Names: 
 Natham  
 Paraiveeriyam 
 Athitha Prakasam 
 Beejam 
 Shakthi 
 Chendurathathi 
 Deviuram 
 Ponvarni 
 
Types: 
Based on the color the Gandhagam has been divided into four types. They are, 
 White  
 Red   
 Golden Yellow  
 Black  
 
Action: 
 Laxative. 
 Tonic. 
 Antiseptic. 
 It also increases the bile fluids. 
 It increases various body secretions. 
 When used in high doses it causes diarrhoea. 
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General characters of Gandhagam: 
  ¦¿øÄ¢ì¸¡öì ¸ó¾¢ìÌ ¿£ûÀ¾¢¦Éñ Ìð¼Áó¾õ 
Åø¨Ä ¸Å¢¨ºÌýÁ Å¡Ô¸ñ§½¡ö-¦À¡øÄ¡ 
Å¢¼ì¸ÊÅý §Á¸§¿¡ö Å£ÚÍÃõ §À¾¢  
¾¢¼ì¸¢Ã¸ ½£¸Àõ§À¡ó §¾÷. 
This is considered to useful in the treatment of 18 types of skin disease. 
 
Medicinal uses: 
 Liver Enlargement 
 Abdominal distension 
 Eye diseases 
 Chronic venereal diseases 
 Chronic diarrhoea 
 Gastric ulcer 
 Poisonous bites 
 Fever  
 Chronic dysentery 
 
BOTANICAL REVIEW 
SHOREA ROBUSTA 
Synonyms: 
 Sanskrit  : Sala, Sarja, Guggilam 
 Bengali  :  Sal,Salwa 
 Gujrati   : Ral 
 Hindi   :  Damar, Dhuna 
 Telgu             :  Guggilamu  
 Punjabi  :  Sal, Seral 
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Taxonomical classification: 
 Kingdom :  Plantae 
 Phylum :  Angiosperms 
 Order  :  Malvales 
 Family  : Dipterocarpaceae 
 Genus   : Shorea 
 Species : Shorea robusta 
 
Parts used-Resin 
Actions: 
 Stimulant 
 Expectorant, 
 Diuretic 
 Anti-Vatha 
 Styptic. 
 
Phytochemical constituents: 
 S. robusta resin has been reported to contain several mono-, sesqui- and tri-
terpenoids includes ursolic acid, tri and tetrahydroxy ursenoic acid, asiatic acid, α and β-
amyrin, α –amyrenone, mangiferonic acid, benthamic acid and uvaol. 
The phytochemical analysis of the extract showed the presence of triterpenoids, sterols 
and resin. 
 
Medicinal uses: 
 As an ingredient of ointments for skin diseases and in ear troubles. 
 The resin obtained from the plant is considered as an astringent and is used in 
dysentery and bleeding piles. 
 It is also given in gonorrhoea and for delayed digestion.  
 Mixed with boiled milk it is a useful remedy in cough, bronchitis, and 
leucorrhoea. 
 The resin is used for treating menorrhogea, enlargement of the spleen and for 
relieving eye irritations. 
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Scientific review: 
Wound healing activity: 
             The ethanolic extract of S.robusta resin(10% and 30% w/w applied locally in 
excised and incised wounds) produced a dose-dependent acceleration in wound 
contraction and incr4eased hydroxyproline content and tensile strength of wounds in 
rats.the result demonstrate wound healing activity of ethanolic extract of S.robusta resin. 
Analgesic activity 
The extract produced significant central and peripheral analgesic effects, as is 
evident from increase in reaction time in hot plate and tail flick tests, inhibition in 
writhing counts in acetic acid-induced writhing test, inhibition of licking time in 
formalin-induced hind paw licking, increased pain threshold in paw withdrawal latency 
in carrageenan-induced hyperalgesia and increased paw withdrawal threshold in post-
surgical pain. 
 
SMILAX CHINA 
Synonyms: 
 Sanskrit :  Madusnuhi 
 Telgu         :  Pirangi-chekka 
 Hindi   :  Chobchini 
 Malayalam :  Pavu 
 
Taxonomical classification: 
 
 Kingdom  :  Plantae 
 Phylum :  Angiosperms 
 Order  :  Coronarieae 
 Family  :  Lilliaceae 
 Genus   :  Smilax 
 Species : Smilax china  
 
Parts used: 
 Root tuber  
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Actions: 
 Alterative 
 Carminative 
 Depurative 
 Diaphoretic 
 Diuretic  
 Tonic  
 
Phytochemical constituents: 
 The root is known for its steroidal saponins. Pro-sapogenin-A of dioscin, 
gracillin. Me-protogracillin, me-protodioscin and its 22-hydroxy-analog. 
 
Scientific review: 
Anti inflammatory property: 
 A marked anti inflammatory activity of a Smilax china extract has been reported 
using carrageenin - induced rat oedema 
 
EMBELIA RIBES 
Synonyms: 
 Sanskrit :  Jantughna, Krmighna, Vella, Krmihara, Krmiripu 
 Bengali  :  Vidang 
 Gujarati  :  Vavding, Vavading, Vayavadang 
 Hindi   :  Vayavidanga, Bhabhiranga, Baberang 
 Malayalam  :  Vizhalari, Vizalari 
 Punjabi  :  Babrung, Vavaring 
 
Taxonomical classification: 
 
 Kingdom  : Plantae 
 Phylum  :  Angiosperms 
 Order   :  Ericales 
 Family  : Myrsinaceae 
 Genus   : Embelia 
 Species  :  Embeliaribes 
` 
78 
 
Parts used: 
Seeds 
Actions: 
 Anthelmintic  
 Astringent 
 Carminative 
 Alterative 
 Stimulant. 
 
Phytochemical constituents: 
 Embelia ribes berries contain several chemical constituents like embelic acid, 
volatile oil, fixed oil, resin, tannin,christembine (alkaloid). 
 Phenolic acids like caffeic acid, vanillic acid, chrorogenic acid, cinnamic acid, 
ocumaricacid16. 4.33% of the embelin content is observed in the berries of 
Embelia ribes. 
 Phytochemical investigation of the seeds revealed 3 new compounds identified as 
3 – (4-hydroxyoctadecanyloxy)–p-quinonyl-5-methylene-8-(10-pentanyloxy) -p-
quinine (embelinol), n-pentacosanyl-nnonadeca-71-en-91–alpha–ol-11-oate 
(embeliaribyl ester), 1,2,4,5-tetrahydroxy 3-undecanyl benzene (embeliol) and a 
known compound embelin. 
 
Scientific review: 
Anthelmintic activity 
              The ethanolic extract of the seeds of Embeliaribes was evaluated for its 
anthelmintic efficacy in vitro.Graded doses of the extract (10,50,100,200mg/mL) showed 
significant anthelmintic activity, with their sensitivity when compared with the standard. 
Anti oxidant property: 
Free radical scavenging reactions and antioxidant activity of embelin has been 
studied and found that embelin scavenge DPPH radical and inhibit hydroxyl radical 
induced deoxyribose degradation, lipid peroxidation and restore impaired superoxide 
dismutase in rat liver mitochondria 
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Medicinal uses: 
 Used in decoction for fevers and for diseases of the chest and skin. 
 Aquous extract of the fruit show anti bacterial activity against Stap.aureus and 
E.coli. 
 The plant is also useful and known for its blood purifying properties. 
 Aqueous extract of the fruit shows anthelmintic against tapeworms. 
 
PIPER LONGUM 
Synonyms: 
 Sanskrit  : Krishnapippali 
 Bengali  :  Pipul 
 Gujrati  : Lindi pepper 
 Hindi   :  Pippal 
 Malayalam :  Pippali 
 Punjabi  : Maghan 
 
Taxonomical classification: 
 Kingdom  : Plantae 
 Phylum :  Angiosperms 
 Order  :  Microembryeae 
 Family  :  Piperaceae 
 Genus   :  Piper  
 Species   : Piperlongum 
 
Parts used: 
 Root , Fruit 
Actions: 
Root: 
 Thermogenic, tonic, stomachic, digestive, anthelmintic, expectorant. 
 
Fruit: 
Acrid, stomachic, carminative, aphrodisiac, expectorant, digestive, emollient, 
antiseptic. 
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Phytochemical constituents: 
 The root of piper longum contains Piperine, piplartine, piperlongumine, 
piperlonguminine, triazontane, dihydro stigmasterol, reducing sugars and glycosides. 
The fruit contains, 
 Piperine (4-5%), piplartine. 
 Piperlongumine, piperlonguminine, methyl 3, 4, 5-trimehoxycinnamate. 
 Volatile oil, starch, protein, carbohydrates, saponin and amygdalins. 
 
Scientific review: 
Anti inflammatory property: 
      Piper extracts and piperine possess inhibitory activities on prostaglandin and 
leukotrienes COX-1 inhibitory effect and thus exhibit anti-inflammatory 
activity32. 
Fruit: 
Anti hyperlipidemic property: 
Methyl piperine significantly inhibited the elevation of total serum cholesterol, 
and the total cholesterol to HDL-cholesterol ratio, in rats fed with a high cholesterol diet. 
The unsaponifiable fraction of the oil of Piper longum also significantly decreased total 
serum cholesterol and hepatic cholesterol in hypercholesterolaemic mice39. 
 
Anti inflammatory property: 
A marked anti inflammatory activity of a decoction of P.longum fruits has been 
reported using carrageenin - induced rat oedema40. 
 
Medicinal uses: 
Root: 
 Used for the diseases of respiratory tract viz. cough, bronchitis, asthma. 
 Counter irritant and analgesic when applied locally for muscular pain and 
inflammation. 
 Sedative in insomnia and epilepsy. 
 General tonic and haematinic. 
 As cholagogue in obstruction of bile duct and gall bladder. 
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Fruit: 
 Fruit is used in palsy, gout and lumbago. 
 Fruit is a valuable alternative tonic in paraplegia, chronic cough and enlargement 
of spleen. 
 The roasted fruits are beaten up with honey and given to treat rheumatism. 
Fruit decoction is extensively used in acute and chronic bronchitis.
 
 It is reported as good remedy for treating gonorrhea, menstrual pain, tuberculosis, 
 Sleep disturbances, respiratory tract infections, chronic gut-related pain and 
arthritic conditions. 
WRIGHTIA TINCTORIA 
Synonyms: 
 Sanskrit : Hyamaraka 
 Bengali :  Indrajav 
 Gujrati  :  Mitha Indrajava 
 Hindi   :  Mitha Indrajava 
 Malayalam :  Bhanthappala 
 
Taxonomical classification: 
 Kingdom  :  Plantae 
 Phylum  :  Angiosperms 
 Order   :  Gentianales 
 Family  :  Apocyanaceae 
 Genus   :  Wrightia 
 Species :         Wrightia tinctoria 
 
Parts used: 
            Seeds 
 
Actions: 
 Anthelmintic  
 Astringent 
 Carminative 
 Alterative 
 Stimulant. 
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Phytochemical constituents: 
 Methanolic extract revealed the presence of Steroids, Flavonoids and Phenolics.  
 Ethyl acetate extract revealed the presence of Tannins, Steroids, Flavonoids and 
Phenolics. whereas chloroform extract revealed the presence of Alkaloids, 
Saponins and Steroids.  
 
Scientific review: 
Anthelmintic activity 
Methanolic extract of Wrightia tinctoria  have better anthelmintic activity  
 
Wound-healing activity 
The ethanol extract promotes better wound-healing by increasing the percentage 
wound closure.The pro healing action seems to be due to the increased synthesis of 
collagen, it's cross-linking as well as better alignment and maturation 
 
Medicinal uses: 
 The germinated seed is used to traditionally cure jaundice. 
 Bark and seeds are used in bilious infections 
 The bark and seeds are effective against psoriasis and non-specific dermatitis. It 
has anti-dandruff properties and hence is used in hair oil preparations.
 
 
MINERALOGICAL ASPECT
 
SULPHUR 
Sulphur is occurs in combination with many metals such as copper, iron etc.The 
chemical properties of sulphur and its compounds including the reaction with mercury, 
Hg to form a red solid, mercuric sulphide (H2S).  
 
Synonyms: 
Sulfur, Brime stone, colloidal sulphur, floor of sulphur, corosal D&F 
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General uses of sulphur 
Sulphur is commercially important in manufacture of chemical such as sulphuric 
acid the chemicals is also used for manufacture of sulfa drugs. In agriculture, the sulphur 
is the fore most important crop nutritive element & it is also used as a fertilizer it is also 
used to manufacture poultry feeds. Sulphur is used in medicines only after it is refined 
well.   
 
Medicinal uses: 
Sulphur is used in scabies. The fumes of burning sulphur are said to cures gout 
and rheumatic affections.  In organic sulphur reduces the motility and invasion of MDA-
MB-231 human breast cancer cells. It is also used as the following purposes in medical 
uses such as, 
 Ring worm 
 Indigestion 
 Diarrhoea 
 Vomiting 
 Belching 
 Hemorrhoids and anal fissures 
 Insomnia 
 Pre-menstrualsyndrome 
 Headache  
 Dizziness 
 Mental tension 
 Lack of memory 
 Cataract 
 Bronchitis 
 Migraine 
 Fever and Conjunctivitis. 
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GHEE (Adjuvant) 
Synonyms 
 Aavin nei 
  Ko nei 
  Thuppu 
 
When ghee taken in required quantities along with usual diet, it helps in proper 
digestion and utilization of the diet and gives strength and vigor to the body.  
 
General Character 
“jhf KoiyRl;fQ; rh;j;jp gpj;jk; thA gpu 
Nkfk; tapw;nwhpT tpf;fyoy; - khfhrq; 
Fd;kk; twl;rp Flw;Gul;l y];jpRl;fQ; 
nrhd;%yk; Nghf;F epiwj; Jg;G” 
- gjhh;j;;j Fz tpsf;fk; jhJ rPt tuf;;fk; 
Indication: 
  It controls thirst, vomiting, excessive pitha, burning sensation of the stomach, 
hiccup, abdominal pain, dryness, heat, cough, hypermotility of the gut, weakness of 
bones, piles etc.  
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93.3%
6.70%
0
CASE DISTRIBUTION BY GENDER
MALE
FEMALE
CASE DISTRIBUTION BY GENDER  
 
TABLE 1 
 
 
 
 
 
 
 
 
Inference: 
 30 patients of both sex were selected for this study, among them 28 (93.3%) were 
male and 2 (6.7%) were female 
 
 
 
 
 
GENDER NO OF CASES PERCENTAGE 
MALE 28 93.3% 
FEMALE 2 6.7% 
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CASE DISTRIBUTION BYAGE: 
TABLE 2: 
AGE NO OF CASES PERCENTAGE 
20-30 years 7 23.33% 
31-40 years 13 43.33% 
41-50 years 6 20% 
51-60 years   4 13.33% 
 
 
Inference: 
 Out of 30 cases age 20-30 years cases 7 (23.33%) were found ,age 31-40 years 13 
cases (43.33%) were found ,age 41-50 years 6 cases (20%) were found and age 51-60 
years 4 cases (13.3%) were found. 
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3.3%
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10%
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Case distribution by OCCUPATION
DRIVER
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COOLIE
BUSSINESS
CASE DISTRIBUTION BY OCCUPATION 
TABLE 3: 
WORK NO OF CASES PERCENTAGE 
DRIVER 8 26.7% 
HOUSEWIFE 1 3.3% 
STUDENT 1 3.3% 
ENGINEER 11 36.7% 
TAILOR 3 10% 
COOLIE   3 10% 
BUSINESSMEN 3 10% 
 
 
Inference: 
 Out of 30 cases 8 patients (26.7%) were driver, 1 patient (3.3%) is housewife, 1 
patient (3.3%) is student,11 patients (36.7%) were Engineers,3 patients (10%)were 
Tailors, 3 patients (10%)were coolie,3 patients (10%)were Businessman. 
  
` 
88 
 
100%
0
0 10 20 30 40 50 60 70 80 90 100
NON VEGETARIAN
VEGETARIAN
Case distribution by diet habits
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CASE DISTRIBUTION BY DIET HABIT  
TABLE4: 
DIET HABIT NO OF CASES PERCENTAGE 
NON-VEG 30 100% 
VEG 0 0% 
 
 
Inference: 
 Non-vegetarian 30 patients (100%) are more prone to Ratha moolam. 
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CASE DISTRIBUTION BY PARUVA KAALAM
KAAR KAALAM KOOTHIR KAALAM MUNPANI KAALAM
PINPANI KAALAM ILAVENIL KAALAM MUTHUVENIL KAALAM
CASE DISTRIBUTION BY PARUVA KAALAM (SEASON)  
Table 5: 
Paruva Kaalam (Season) No of cases Percentage 
Kaar Kaalam (Aug 15 - Oct 14) 0 0% 
Koothir Kaalam (Oct 15 - Dec 14) 0 0% 
Munpani Kaalam (Dec 15 - Feb 14) 21 70% 
Pinpani Kaalam (Feb 15 - Apr 14) 9 30% 
Ilavenil Kaalam (Apr 15 - Jun 14) 0 0% 
Muthuvenil Kaalam (Jun 15 - Aug 14) 0 0% 
 
 
Inference: 
 Among the 30 cases 21 cases (70%) were admitted in Munpani Kaalam (Dec 15-
Feb14) and 9 cases were (30%) admitted in Pinpani Kaalam (Feb 15-April 14) . 
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KURINJI MULLAI MARUTHAM NEITHAL PAALAI
CASE DISTRIBUTION BY THINAI (LAND)  
Table :6 
 
Thinai (Land) No of cases Percentage 
Kurinji (Hill) 0 0% 
Mullai (Forest) 0 0% 
Marutham (Fertile) 11 36.7% 
Neithal (Coastal) 19 63.3% 
Paalai (Desert) 0 0% 
 
 
 
Inference: 
 Among the 30 cases 19 cases (63.3%) were from Neithal thinai and 
11 cases (36.7%) were from Marutham thinai. 
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CASE DISTRIBUTION BY THEGI 
Table 7: 
Yaakai No of cases Percentage 
Vatham 14 46.7% 
Pitham 4 13.3% 
Kapham 2 6.7% 
Thondham 10 33.3% 
 
 
Inference: 
 Among the 30 cases 14 cases (46.7%) were Vatha thegi, 4 cases (13.3%) were 
Pithathegi, 2 cases (6.7%) were Kaba thegi and 10 cases (33.33%)were Thondha thegi. 
 
  
46.7%
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CASE DISTRIBUTION BY THEGI
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CASE DISTRIBUTION BY GUNAM
SATHUVA GUNAM RASATHA GUNAM THAMOGUNAM
CASE DISTRIBUTION BY GUNAM 
Table 8: 
 
Gunam No of cases PERCENTAGE 
Sathuvagunam 6 20% 
Rasatha Gunam 17 56.7% 
Thamo Gunam 7 23.3% 
 
 
Inference: 
 Out of 30 cases 17 cases (56.7%) were found to posses rasathagunam, 6 cases 
(20%) were found to possess sathuvagunam and 7 cases (23.3%) werefound to posses 
thamogunam 
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CASE DISTRIBUTION BY ENVAGAI THERVUGAL 
Table 9: 
Envagai Thervugal No of cases PERCENTAGE 
Naa 17 57% 
Niram 8 27% 
Mozhi 0 0% 
Vizhi 8 27% 
Sparisam 0 0% 
Malam 30 100% 
Moothiram 0 0% 
Naadi   
a) Vatha Pitham 16 53% 
b) Pitha Vatham 7 23% 
c) Vatha Kabam 4 14% 
d) Pitha Kabam 3 10% 
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Inference: 
 In Envagai Thervugal Malam was found to be affected in all 30 cases (100%) 
,Naa(Coated tongue)was affected in 17 cases (57%), Niram (Pallor) was affected in 8 
cases (27%), Vizhi (Pallor in palpabrel conjuctiva) was affected in 8 cases (27%). The 
Naadinadai seen in Rathamoolam were vathapitham in 16 cases (53%) , Pithavatham in 7 
cases (23%) vathakapham in 4 cases(14%) and pithakabam in 3 cases  (10%)  
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CASE DISTRIBUTION BY UDAL KATTUGAL  
Table 10: 
Udal Kattukal No of cases PERCENTAGE 
Saaram 30 100% 
Senneer 30 100% 
Oon 0 0% 
Kozhuppu 0 0% 
Enbu 15 50% 
Moolai 0 0% 
Sukkilam / Suronitham 0 0% 
 
Inference: 
 Among 30 cases saram was affected in 30 cases (100%) , Senneer was affected in 
30 cases (100%) and Enbu was affected in 15 cases (50%) . 
  
100% 100%
0% 0%
50%
0% 0%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
CASE DISTRIBUTION BY UDAL KATTUGAL
SAARAM SENEER OON KOZHUPPU ENBU MOOLAI SUKKILAM/SURONITHAM
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CASE DISTRIBUTION BY KOSANGAL 
Table 11: 
Kosam No of cases PERCENTAGE 
Annamaya Kosam 17 56.7% 
Pranamaya Kosam 0 0% 
Manomaya Kosam 0 0% 
Vignanamaya Kosam 15 50% 
Anandamaya Kosam 0 0% 
 
Inference: 
 Among with 30 cases Annamaya Kosam was affected in 17 cases (56.7%) and 
Vignanamaya kosam was affected in 15 cases (50%) 
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CASE DISTRIBUTION BY UYIR THATHUKKAL - VATHAM: 
Table 12: 
Uyir Thathukkal No of cases PERCENTAGE 
Pranan 0 0% 
Abaanan 30 100% 
Viyanan 30 100% 
Udhaanan 0 0% 
Samanan 30 100% 
Naagan 0 0% 
Koorman 0 0% 
Kiru karan 17 56.7% 
Devathathan 30 100% 
Dananjayan 0 0% 
 
Inference: 
 Among the 30 cases Abanan, Samaanan and Viyanan were affected in all 30 
cases (100%) Kirukaran was affected in 17 cases (56.7%) and Devathathan was affected 
in 30 cases (100%). 
  
` 
98 
 
percentage
0%
20%
40%
60%
80%
100%
57%
27%
100%
27%
CASE DISTRIBUTION BY PITHAM
ANARPITHAM RANJAGAPITHAM SATHAGAM ALOSAKAM PRASAGAM
CASE DISTRIBUTION BY PITHAM  
Table 13: 
Pitham No of cases PERCENTAGE 
Anarpitham 17 57% 
Ranjagapitham 8 27% 
Sathakam 30 100% 
Alosakam 0 0% 
Prasakam 8 27% 
 
 
 
 
 
 
 
 
 
Inference: 
 Sathagapitham was affected (Unable to perform their routine activities) in all the 
30 cases (100%) Anarpitham was affected in 17 cases (57%), Ranjagapitham was 
affected in 8 cases (27%) and prasaka pitham was affected (Itching present around the 
anus) in 8 cases (27%). 
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CASE DISTRIBUTION BY KABAM 
Table 14: 
Kabam No of cases PERCENTAGE 
Avalambasam 0 0% 
Kilethagam 17 57% 
Pothagam 0 0% 
Tharpagam 6 20% 
Santhigam 15 50% 
 
Inference: 
 Kilethagam was affected in 17 cases (57%) tharpagam was affected in 6 cases 
(20%) Santhigam was affected in 15 cases (50%) . 
 
  
  
` 
100 
 
CASE DISTRIBUTION BY NEIKURI  
Table 15: 
NEIKURI No of cases PERCENTAGE 
Serpentine Fashion 9 30% 
Annular Fashion (Ring) 6 20% 
Pearl Shape 10 33% 
Thontham 5 17% 
 
 
Inference: 
Among 30 cases in 9 cases (30%) nei kuri was observed as serpentine like, in 6 
cases (20%) the neikuri was observed as annular like, in 10 cases (33%) the neikuri was 
observed as Pearl shape, in 5 cases (17%) the neikuri was observed as thontham type.
SERPENTINE 
FASHION
30%
ANNULAR 
FASHION(RING)
20%
PEARL SHAPE
33%
THONTHAM
17%
CASE DISTRIBUTION BY NEIKURI
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CASE DISTRIBUTION BY CHRONICITY OF ILLNESS  
Table 16: 
CHRONICITY OF ILLNESS NO OF CASES PERCENTAGE 
0-3 Months 8 26.6% 
4-6 Months 5 16.7% 
7-9 Months 2 6.7% 
Above 9 months 15 50% 
 
 
Inference: 
 Among 30 cases 0-3 months chronicity of illness was found in 8 cases (26.6%) 4-
6 months chronicity of illness in 5 cases (16.7%), 7-9 months chronicty of illness in 2 
cases (6.7%) and above 9 months chronicity of illness in 15 case (50%) . 
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Series 1
CASE DISTRIBUTION BY CLINICAL FEATURES  
TABLE 17: 
CLINICAL FEATURES No of cases PERCENTAGE 
Bleeding during defecation 30 100% 
Constipation 30 100% 
Pain in all limbs 15 50% 
Tiredness 10 33.33% 
Anemia 8 27% 
Headache 4 13.33% 
Giddiness 0 0% 
Pruritus in ani 8 27% 
Discharge of pus and mucous 0 0% 
 
Inference: 
 In Clinical features all 30 cases (100%) had bleeding during defecation and 
constipation, 10 cases (33.33%) had tiredness,15 cases (50%) had pain in all limbs, 4 
cases(13.3%) had headache,8 cases(27%) had pruritic ani and Anemia 8 cases (27%).  
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PROCTOSCOPY EXAMINATION: BEFORE AND AFTER TREATMENT 
OP NO-J78540 
AGE/SEX-35/M 
 BEFORE TREATMENT                            AFTER TREATMENT   
 
RESULT-11‟o clock pile mass size reduced after the treatment 
OP NO-J28368 
AGE/SEX-24/M 
BEFORE TREATMENT                                   AFTER TREATMENT 
RESULT:3‟o clock pile mass size reduced afterthe treatment.  
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OP NO:J53599 
AGE/SEX-34/M 
BEFORE TREATMENT                                AFTER TREATMENT 
 
RESULT:3‟o clock pile mass size reduced after the treatment. 
OP NO: J19200 
AGE/SEX:49/M 
 
RESULT:3‟o clock.7‟o clock,11‟o clock pile mass size reduced well after treatment. 
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OP NO:J84439 
AGE/SEX: 30/M 
                BEFORE TREATMENT        AFTER TREATMENT 
 
RESULT-3 „o clock,7‟0 clock and 11‟o clock pile mass size reduced  
after the treatment 
OP NO:J94089 
AGE/SEX-35/M 
BEFORE TREATMENT                                   AFTER TREATMENT 
RESULT- 11‟O Clock pile mass size reduced after treatment. 
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OP NO-J38498 
AGE/SEX-58/M 
BEFORE TREATMENT                                   AFTER TREATMENT 
RESULT:3‟o clock and 11‟o clock Pile mass completely  
reduced well after the treatment 
POSITION OF PILE MASS: 
TABLE 18: 
S. NO POSITION OF PILE MASS NO OF CASES PERCENTAGE (%)  
1 3‟o Clock 6 20% 
2 7‟oClock 10 33.33% 
3 11‟oClock 7 23.33% 
4 
More than one pile mass 
in various clock position  (3,7,11) 
7 23.33% 
 
Inference: 
 Among 30 cases 6 cases (20%) were in 3‟oClock position, 10 cases (33.33%) 
were in 7‟oClock position ,7cases (23.33%) were in 11‟oClock and 7 (23.33%) cases 
were in more than one pile mass in various clock position. 
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Table 19: 
 
Inference: 
 Among 30 cases before treatment 2 cases (7%) were in below 10 gm/dl, 4 cases 
(13%) were 10-12 gm/dl, 5 cases (17%) were in 12-14 gm/dl and 19 cases (63%) were in 
above 14 gm/dl. 
 After treatment 2 cases (7%) were in below 10 gm/dl, 3 cases (10%) were in 10-
12, 6 cases (20%) were in 12-14 gm/dl, and 19 cases (63%) were in above 14 gm/dl.. 
  
LEVELS BEFORE TREATMENT AFTER TREATMENT 
Haemoglobin (mg %) No. of cases Percentage No. of cases Percentage 
Below 10 2 7% 2 7% 
10 – 12 4 13% 3 10% 
12 – 14 5 17% 6 20% 
Above 14 19 63% 19 63% 
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ASSESSMENT OF RESTRICATION OF MOVEMENTS 
 
HEALTH ASSESSME`NT QUESTIONNAIRE: 
 
Patients marks scored out of HAQ questionnaire is graded in level as follows in 
which increased score represent severity of the disease. (Annexure) 
(Perform activities without any difficlty) LEVEL I – Marks scored between 0 – 10 
(Perform activities with some difficulty) LEVEL II – Marks scored between 11 – 20 
(Perform activity with much difficulty) LEVEL III – Marks scored between 21 – 30 
(Unable to do)     LEVEL IV – Marks scored between 31 – 40
  
 
LEVELS 
HAQ SCORE BEFORE 
TREATMENT 
HAQ SCORE AFTER 
TREATMENT 
Scores No. of cases Percentage No. of cases Percentage 
1 (0 - 10) 0 0% 18 60% 
2 (11-20) 17 57% 12 40% 
3 (21-30) 13 43% 0 0% 
4 (31-40) 0 0% 0 0% 
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Observations : 
 
 Among 30 cases before treatment 17 cases (57%) were in level II and 13 cases 
(43%) were in level III according to their mark scores.  
 After treatment 18 cases (60%) were in level I and 12 cases (40%) were in level 
II according to their mark scores. 
 
Results: 
 Hence according to the HAQ score improvements  
Good Improvement   – 60% 
Moderate Improvement  – 40% 
Poor Improvement   – 0% 
 
STATISTICAL ANALYSIS: 
HEALTH ASSESSMENT QUESTIONAAIRE: 
HAQ 
Score 
Sample Mean 
Std. 
Deviation 
Std. Error 
Mean 
t VALUE p VALUE 
Before 
Treatment 
30 17.46 4.80 0. 88 
13.77 P<0.0001 
After 
Treatment 
30 9.7 2.71 0.49 
 
OBSERVATION: 
Statistical analysis reveals that there has been a significant reduction in HAQ 
score after treatment indicating the improvement in patient doing their daily activities.  
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MEAN AND STANDARD DEVIATION OF CLINICAL SYMPTOMS BY 
HAEMORRHOIDS SYMPTOMS SEVERITY SCORE(HSS SCORE) AT 
BEFORE AND AFTER TREATMENT: 
HSS Score Sample Mean 
Std. 
Deviation 
Std. Error 
Mean 
t VALUE p VALUE 
Before 
Treatment 
30 6.93 1.31 0. 24 
31.81 p <0.0001 
After 
Treatment 
30 0.766 0.678 0.12 
 
OBSERVATION: 
Statistical analysis reveals that there has been a highly significant reduction in 
HSS score after treatment indicating the improvement. 
HAEMOGLOBIN: 
HAEMOGLOBIN Sample Mean ± SD 
Std. Error 
Mean 
t VALUE p VALUE 
Before Treatment 30 13.8 ± 1.8 0.33 
0.46 p = 0.64 
After Treatment 30 13.9 ± 1.74 0.29 
 
OBSERVATION: 
 There was no significant increase after the treatment 
 
 
 
 
` 
111 
 
PROGNOSIS CHART 
CLINICAL SEVERITY SYMPTOMS BY HAEMORRHOIDS SYMPTOMS SEVERITY 
SCORE (HSS SCORE) AT BEFORE AND AFTER TREATMENTS (Annexure) [Score:0-
Never, 1-Less than once/week, 2-1-6 times /week, 3-Always]  
SEVERE SYMPTOMATIC CASES BY HSS SCORE: 
 
*Reduction in scores -Moving forward from high levels to low levels                      
From the above HSS scoring measure it can be concluded that 4 cases symptoms are 
completely relieved and for 15 cases symptoms were reduced well, those patients were improved 
severe to Mild level. 
Symptoms completely relieved  
 
 
 
 
BEFORE TREATMENT AFTER TREATMENT 
 
 
S.NO 
 
OP NO 
Freq. 
of 
pain 
in the 
anal 
region 
Freq. of 
itching or 
discomfort 
in anal 
region 
Freq. of 
bleeding 
at stools 
Freq. 
of 
soiling 
of 
under 
clothes 
Freq.of 
prolapsed 
pile mass 
Total 
Score 
Freq. 
of 
pain 
in the 
anal 
region 
Freq. of 
itching or 
discomfort 
in anal 
region 
Freq. of 
bleeding 
at stools 
Freq. 
of 
soiling 
of 
under 
clothes 
Freq. of 
prolapsed 
pile mass 
Total 
score 
1 J38498 
3 2 3 1 - 
9 
1 0 1 0 - 
2 
2 J68904 3 3 3 0 - 9 0 0 0 0 - 0 
3 K18601 
3 3 3 0 - 
9 
1 1 0 0 - 
2 
4 J97362 
2 3 3 1 - 
9 
1 0 1 0        - 
1 
5 J78540 
3 2 3 1 - 
9 
0 1 0 0 - 
1 
6 K12746 
3 2 3 1 - 
9 
1 0 0 0 - 
      1 
7 J91103 
3 3 2 0 - 
8 
0 1 0 0 - 
1 
8 K00069 
3 2 3 0 - 
8 
0 1 0 0 - 
1 
9 J81833 
3 2 3 0 - 
8 
0 1 0 0 - 
1 
10 J81620 
3 3 2 0 - 
8 
0 1 0 0 - 
1 
11 J28368 
2 3 3 0 - 
8 
0 0 0 0 - 
0 
12 J84175 
3 2 3 0 - 
8 
1 0 0 0  
1 
13 I70669 
2 3 2 0 - 
7 
1 0 0 0 - 
1 
14 G19200 
2 2 2 1 - 
7 
0 0 0 0 - 
0 
15 J75058 
2 2 3 0 - 
7 
1 0 0 0 - 
0 
16 J94089 
2 3 2 0 - 
7 
1 0 0 0 - 
1 
17 J52425 
2 2 3 0 - 
7 
1 0 0 0 - 
1 
18 I86147 
2 2 2 0 - 
6 
0 1 0 0 - 
1 
19 J84439 
2 2 2 0 - 
6 
0 0 0 0 - 
0 
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MODERATE SYMPTOMATIC CASES BY HSS SCORE: 
  BEFORE TEATMENT AFTER TREATMENT  
S.NO OP NO 
Freq. 
of 
pain 
in the 
anal 
region 
Freq. of 
itching or 
discomfort 
in anal 
region 
 
Freq. of 
bleeding 
at stools 
Freq.of 
soiling 
of 
under 
clothes 
Freq. of 
prolapsed 
pile mass 
Total 
score 
Freq.of 
pain in 
the 
anal 
region 
Freq. of 
itching or 
discomfort 
in anal 
region 
 
Freq. of 
bleeding 
at stools 
Freq. 
of 
soiling 
of 
under 
clothes 
Freq. 
of 
prolapsed 
pile mass 
Total 
score 
1 
E008475 3 1 3 1 - 
8 
0 0 0 0 - 
0 
2 
J92730 3 1 3 0 - 
7 
1 0 0 0 - 
0 
3 
J90246 3 1 3 0 - 
7 
1 0 0 0 - 
0 
4 
J74703 3 0 3 0 - 
6 
1 0 0 0 - 
1 
5 
J53599 3 1 2 0 - 
6 
0 0 0 0 - 
0 
6 
G88614 3 1 2 0 - 
6 
1 0 0 0 - 
1 
7 
J57261 3 1 2 0 - 
6 
0 0 0 0 - 
0 
8 
J86157 2 1 3 0 - 
6 
0 0 0 0 - 
0 
9 
J80311 2 0 2 1 - 
5 
0 0 0 0 - 
0 
10 
J81185 2 2 1 0 - 
5 
0 0 0 0 - 
0 
11 
J94085 2 0 2 0 - 
4 
0 0 0 0 - 
0 
 
*Reduction in scores -Moving forward from high levels to low levels 
From the above HSS scoring measure it can be concluded that 7 cases symptoms 
are completely relieved and for 11 cases symptoms were reduced well, those patients 
were  improved  Moderate to Mild level. 
Symptoms completely relieved 
From this HSS Score finally it is concluded that 11 cases (37%) symptoms  
were completely relieved and 19 cases ( 64%) symptoms were reduced well, those 
patients were improved Moderate to mild. 
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IMPROVEMENT OF CLINICAL FEATURES -HEALTH ASSESSMENT 
QUESTIONAAIRE(HAQ): 
TABLE 20 
GOOD CONTROL      MODERATE CONTROL 
 
 
  
S. 
NO 
OP NO A/S 
HAQ SCORE 
BEFORE 
TREAT 
MENT 
AFTER  
TREAT 
MENT 
1 J81185 37/M 14 8 
2 J28368 24/M 12 7 
3 I70669 36/M 20 8 
4 J74703 48/M 12 8 
5 J94085 32/M 11 6 
6 I86147 50/M 12 7 
7 J53599 34/M 13 5 
8 J80311 58/M 11 6 
9 G19200 47/M 15 10 
10 J81833 30/M 22 10 
11 G88614 29/M 12 8 
12 J75058 35/M 13 8 
13 J84439 30/M 11 7 
14 J94089 35/M 20 10 
15 J68904 58/M 19 9 
16 J57261 52/M 11 9 
17 J86157 37/M 13 8 
18 E08475 49/M 22 8 
S. NO OP NO A/S 
HAQ SCORE 
BEFORE  
TREAT 
MENT 
AFTER  
TREAT 
MENT 
1 J84175 21/F 21 11 
2 J38498 58/M 22 12 
3 K18601 34/M 24 17 
4 J97362 26/M 22 12 
5 J91103 32/M 22 14 
6 K00069 34/M 21 12 
7 J74540 33/M 23 13 
8 K12746 41/M 24 11 
9 J81620 49/M 21 12 
10 J52425 21/M 22 13 
11 J92750 40/M 21 11 
12 J90246 34/M 18 11 
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LABORATORY REPORTS 
OBSERVATION OF CLINICAL LABORATORY EXAMINATIONS 
At the time of admission to the trial, in all the 30 patients following parameters 
observed,  
I. Routine blood investigations,  
1. Haemoglobin estimation 
2. Total WBC Count 
3. Total RBC Count 
4. Differential Count 
5. Erythrocyte sedimentation rate 
6. Bleeding Time 
7. Cloting Time 
II. Blood Sugar  
1. Fasting 
2. Post Prandial 
III. Liver Function Test 
IV. Renal Function Test 
V. Serum Lipid Profile 
VI. Urine Examination 
1. Albumin 
2. Sugar 
3. Deposit 
VII. Motion    
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S NO OP NO 
Hb 
(gm/dl) 
TOTAL 
WBC 
DC-
P(cel
ls/µl) 
DC -
L(cells/µl
) 
DC-
E(cells/µl) 
TOTAL 
RBC(million/
µl) 
ESR ½ 
hour(mm/Hr) 
ESR 1 
hr(mm/H
r) 
Bleeding time Clotting time 
Sugar 
fasting(m
g/dl) 
Suga
r 
PP(
mg/d
l) 
urea 
mg/d
l 
creat
inine
mg/d
l 
uric 
acid 
mg/d
l 
1 J81185 14.4 9100 79 19 2 4.6 8 10 2mins20sec 4mins20sec 91 86 25 1.1 6.7 
2 J28368 11.1 8900 56 41 3 3.6 12 24 1min50sec 3min50sec 100 115 12 0.7 2.5 
3 J84175 9.6 8100 52 44 4 3.5 34 70 2mins20sec 3 min 20sec 86 110 18 0.7 4 
4 J38498 14.9 7800 73 25 2 4.9 4 8 1min30sec 4min15sec 107 115 18 0.9 4.3 
5 K18601 13 8500 54 38 8 4.3 3 6 1min10sec 2min20sec 88 128 23 0.7 4.3 
6 I70669 15.5 6900 65 30 3 5.9 10 22 2min20sec 3min50sec 93 108 13 1 7.2 
7 J97362 15 8500 78 20 2 5.2 2 4 2min20sec 3min15sec 86 125 17 0.9 6.2 
8 J74703 16.6 8100 59 34 7 4.6 10 20 2min20sec 3min15sec 103 110 21 1.1 6.9 
9 J94085 15.1 7500 68 28 4 4.8 4 8 2min15sec 4min50sec 94 113 15 1 5.3 
10 I86147 14.1 5900 70 27 3 4.4 10 8 2min20sec 3mins15sec 95 120 14 1.2 6.7 
11 J53599 14.7 8900 56 35 8 5.2 10 22 2min20sec 3min15sec 94 112 13 0.9 5.2 
12 J91103 14.7 5400 58 40 2 5.5 4 10 3min15sec 4min55sec 93 108 13 1 3.7 
13 J80311 11.8 6900 61 36 3 5.5 2 4 1min20sec 2min40sec 110 128 10 1 4.7 
14 G19200 15.5 4800 65 30 5 5.6 4 10 2min20sec 3min50sec 95 121 15 0.9 5.5 
15 K00069 15.1 7400 72 24 4 5.1 2 4 1min20sec 2min15sec 85 122 15 1 4.6 
16 J74540 14.5 6500 64 34 2 5.4 10 20 2min15sec 2min20sec 102 118 17 1 5.5 
17 J81833 11.5 8800 60 35 5 4.6 10 6 1min50sec 1min20sec 90 120 15 0.9 5.5 
18 K12746 10 6800 64 30 6 4.5 12 26 2min30sec 5min10sec 83 103 18 0.7 4.2 
19 G88614 12.6 9100 69 27 4 5.3 2 4 1min20sec 2min20sec 88 117 16 1.1 6.4 
20 J75058 14 5300 67 31 2 6.8 2 6 2min20sec 3min20sec 93 126 12 0.9 3 
21 J84439 15.2 6200 57 38 5 4.8 2 4 2min25sec 4min10sec 89 130 13 0.9 7.7 
22 J81620 12.6 9900 59 38 3 4.6 36 72 1min20sec 3min15sec 86 112 15 1.1 5.4 
23 J94089 15.3 7900 64 34 2 5 2 10 2min15sec 3min20sec 110 149 20 1 6.3 
24 J68904 15.7 7200 65 32 3 5.8 10 20 2min20sec 3min50sec 194 138 18 1.4 4.9 
25 J57261 14.4 7700 65 32 3 4.8 2 4 2min15sec 3min20sec 82 110 16 1.1 5.6 
26 J52425 12.3 5800 58 40 2 5.2 2 6 2min40sec 3min15sec 84 128 11 0.9 4.5 
27 J86157 13.7 8000 63 32 5 4.8 8 10 2min50sec 3min20sec 93 125 23 0.8 4.2 
28 J92730 15.2 7800 67 31 2 4.9 2 4 2min50sec 2min20sec 96 132 16 1.1 5 
29 J90246 14.5 5800 61 30 9 4.8 4 10 1min15sec 4min10sec 78 95 12 1 6 
30 E08475 11 5600 58 40 2 5.1 20 42 1min55sec 3min50sec 96 102 38 1.2 6.9 
KUKKILATHY CHOORANAM-BEFORE TREATMENT 
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S 
NO 
 
OP NO 
 
Tot  
cho 
mg/d
l 
HDL 
mg/dl 
LDL 
mg/dl 
VLDL 
mg/dl 
TGL 
mg/dl 
T.bili 
mg/dl 
D.Bili 
mg/dl 
ID 
bili  
mg/dl 
Calcium 
mg/dl 
SGO
T IU/l 
SGPT 
IU/l 
Alk.pho
s IU/l 
Urine 
Albu
min 
Urine 
sugar  Urine depoist  
bile 
salt 
bile 
pigm
ent  ova  cyst 
occlt 
blood  
 J81185 
138 60 81 18 88 0.8 0.3 0.5 9.4 22 15 70 nil nil 
3-5pus/3-6 epi 
cells nil neg nil nil absent 
2 J28368 200 58 100 14 74 1 0.4 0.6 9.6 13 9 81 nil nil 2-4pus/2-5epi nil neg nil nil absent 
3 J84175 121 50 73 13 65 0.4 0.2 0.2 9.2 15 16 65 nil nil 6-8pus/6-8epi nil neg nil nil absent 
4 J38498 256 62 157 23 112 0.6 0.2 0.4 11.1 17 18 88 nil nil 1-2pus/1-2epi nil neg nil nil absent 
5   K18601 158 48 95 15.2 158 0.3 0.4 0.3 9 20 89 89 nil nil 2-3epi/3-6pus nil neg nil nil absent 
6 I70699 183 56 116 18 93 1 0.4 0.6 9.4 20 22 73 nil nil 2-4pus/2-4epi nil neg nil nil absent 
7 J97362 147 45 75 11 55 1.43 0.51 0.92 9.7 17 21 73 nil nil 1-2pus/1-3epi nil neg nil nil absent 
8 J74703 146 44 91 58 289 0.8 0.3 0.5 9 21 30 62 nil nil 3-5pus/1-6epi nil neg nil nil absent 
9 J94085 110 38 64 17 87 1.2 0.5 0.8 9.3 18 13 51 nil nil 2-4pus/1-2epi nil neg nil nil absent 
10 I86147 106 43 56 17 85 0.4 0.1 0.2 8.1 17 18 81 nil nil 2-4pus/2-4epi nil neg nil nil absent 
11 J53599 191 45 119 51 256 0.5 0.2 0.3 9.3 23 19 86 nil nil 3-5pus/3-5epi nil neg nil nil absent 
12 J91103 195 48 117 31 156 0.3 0.1 0.2 9.6 17 21 139 nil nil 3-5pus/1-2epi nil neg nil nil absent 
13 J80311 190 45 116 60 299 1.1 0.4 0.7 9.7 36 47 90 nil nil 2-4pus/2-4epi nil neg nil nil absent 
14 G19200 207 54 107 23 115 1 0.3 0.5 9 18 19 80 nil nil 4-6pus/1-2epi nil neg nil nil absent 
15 K00069 166 40 78 22 109 0.5 0.2 0.3 8.1 17 11 67 nil nil 2-4pus/1-2epi nil neg nil nil absent 
16 J74540 226 56 142 27 136 0.9 0.3 0.6 9.3 19 24 51 nil nil 1-2pus/1-2epi nil neg nil nil absent 
17 J81833 200 50 105 20 120 1 0.5 0.4 8.5 20 18 50 nil nil 1-2pus/2-6epi nil neg nil nil absent 
18 K12746 160 38 99 20 101 0.4 0.2 0.2 10.2 22 27 89 nil nil 3-5pus/4-5epi nil neg nil nil absent 
19 G88614 145 45 75 18 90 1.1 0.4 0.7 10.1 22 31 32 nil nil 2-4pus/3-4epi nil neg nil nil absent 
20 J75058 145 52 80 21 108 0.7 0.2 0.4 10.2 19 14 57 nil nil 4-6pus/1-2epi nil neg nil nil absent 
21 J84439 209 51 130 44 220 0.6 0.2 0.4 9.6 35 50 86 nil nil 1-2pus/1-2epi nil neg nil nil absent 
22 J81602 140 35 90 30 150 0.3 0.1 0.2 8.8 14 23 108 nil nil 3-5pus/3-6epi nil neg nil nil absent 
23 J94089 140 41 84 22 108 0.8 0.3 0.5 10.3 18 25 78 nil nil 1-2pus/2-5epi nil neg nil nil absent 
24 J68904 186 44 117 45 225 0.3 0.1 0.2 9.2 19 26 77 nil nil 2-4pus/2-4epi nil neg nil nil absent 
25 J57261 190 56 116 28 141 0.4 0.2 0.2 9.4 20 29 99 nil nil 2-4pus/2-4epi nil neg nil nil absent 
26 J52425 114 46 68 20 100 0.9 0.4 0.5 9.6 16 12 75 nil nil 1-2pus/1-2epi nil neg nil nil absent 
27 J36157 133 40 83 24 122 0.3 0.1 0.2 10.5 16 19 69 nil nil 2-4pus/2-4epi nil neg nil nil absent 
28 J92730 141 48 83 15 74 1 0.4 0.7 9.9 15 9 69 nil nil 1-3pus/1-3epi nil neg nil nil absent 
29 J90246 140 41 83 24 11 0.8 0.3 0.5 9.1 23 36 43 nil nil 2-4pus/2-4epi nil neg nil nil absent 
30 E08475 191 37 103 65 227 0.5 0.2 0.3 4.3 20 25 84 nil nil 1-3pus/3-4epi nil neg nil nil absent 
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KUKKILATHY CHOORANAM-AFTER TREATMENT 
S 
NO 
OP NO 
Hb g/dl 
WBC 
cells/µl 
DC -P 
cells/µl 
DC-L 
cells/µl 
DC - E 
cells/µl 
Total 
RBC 
ESR 
½ hr 
ESR 1 
hr BT CT  
Sugar  
Fasting 
gm/dl 
Sugar 
PP 
gm/dl 
urea 
gm/dl 
Creatinine 
gm/dl 
uric acd 
gm/dl 
Calcium 
gm/dl 
1 J81185 14.8 8000 72 26 2 4.5 16 14 2mins30sec 4mins20sec 122 120 17 1 6.4 9.1 
2 J28368 11.2 9200 55 40 5 3.8 8 10 1min20sec 3 min 20sec 90 110 16 0.6 2.6 9.4 
3 J84175 9.8 8200 56 39 5 3.6 15 30 2mins10sec 3 min 30sec 84 108 8 0.7 3.3 9.6 
4 J38498 15.2 7300 67 31 2 5 4 9 1min20sec 2min30sec 112 120 16 1 4 9.2 
5 K18601 13.1 8600 52 37 9 4.1 3 7 1min30sec 2min30sec 85 125 20 0.8 4.4 9.1 
6 I70669 16.2 6600 57 41 2 5.6 8 20 1min45sec 3mins56sec 90 105 20 1 9.2 9.2 
7 J97362 15.2 6600 52 44 4 4.9 2 3 2min10sec 3min10sec 90 120 18 0.8 6.5 9.3 
8 J74703 16.7 6200 62 30 8 4.2 9 12 2min25sec 3min10sec 105 112 22 1 6.5 9.2 
9 J94085 15.3 9800 65 30 5 4.6 4 6 2min20sec 4min20sec 90 115 16 1 5.4 9.2 
10 I86147 14.5 5800 72 25 3 4.6 22 6 2min3osec 3min20sec 90 118 16 1 6.8 8.6 
11 J53599 14.9 7200 54 37 9 5.3 8 20 2min20sec 3min10sec 90 110 12 1 5.4 9 
12 J91103 14.3 6100 55 43 2 5.4 2 10 3min10sec 4min50sec 90 105 14 1 3.5 9.8 
13 J80311 12.1 7200 60 37 3 5.7 3 6 1min20sec 2min35sec 105 120 10 1.1 4.2 7.7 
14 G19200 15.4 4480 67 31 2 5.8 4 6 2min3osec 3min20sec 90 120 16 0.8 5.2 9.2 
15 K00069 15 7200 70 25 6 5.2 2 6 1min30sec 2min3osec 80 126 12 1 4.3 8.2 
16 J74540 14.8 6800 64 32 4 5.6 2 6 3min50sec 3min50sec 98 110 18 1 5.2 9.8 
17 J81833 11.9 8200 65 30 5 4.7 8 4 2min20sec 2min50sec 91 110 16 0.4 5.8 8.4 
18 K12746 10.4 6000 61 33 6 4.6 2 4 2min20sec 4min10sec 90 100 16 0.9 4.6 9.8 
19 G88614 12.4 8900 65 29 6 5.2 2 4 1min20sec 2min25sec 89 120 1.2 6.1 6.1 9.4 
20 J75058 13.8 5800 60 38 2 5.4 2 7 2min20sec 3min25sec 104 110 11 1.1 3.7 10.3 
21 J84439 15.3 6800 58 39 3 4.6 2 10 2min10sec 4min40sec 113 118 21 1 8.1 10.2 
22 J81620 14.3 8200 52 45 3 5.4 4 8 1min20sec 3min15 98 110 19 1.2 7.2 8.6 
23 J94089 15.1 8300 61 35 4 4.8 2 8 2min45sec 3min50sec 114 128 20 1.1 6.4 8.4 
24 J68904 15.2 8100 64 33 3 5.5 14 30 2min15sec 3min20sec 120 130 17 1.2 4.7 7.1 
25 J57261 14.6 5800 58 40 2 4.6 2 10 2min10sec 4min5sec 80 102 18 0.9 4.6 8.2 
26 J52425 12.8 5700 55 42 3 5.1 2 4 2min40sec 3min20sec 78 120 12 0.8 4.8 9.8 
27 J36157 13.5 7800 60 33 7 4.9 8 9 2min5sec 4min50sec 112 120 17 1 5.9 9.5 
28 J92730 15.3 7400 65 33 2 4.8 2 5 1min30sec 2min50sec 90 120 20 1.2 5.9 9.1 
29 J90246 14.8 8800 60 36 4 4.9 3 8 1min40sec 3min50sec 88 132 12 1.1 6.4 9.4 
30 E008475 11.2 7200 55 43 3 5.2 18 20 1min50sec 3min40sec 90 103 35 1 6.2 4.6 
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S 
NO OP NO 
Total 
Chol. HDL  LDL  VLDL  TGL T.Bilirubin D.Bili 
ID 
Bili SGOT  
SGPT 
AT 
Urine 
Albumin 
Urine 
Sugar Deposits 
Bile 
salt 
Bile 
pigment 
Motion-
Ova Cyst 
Occult 
bloodt 
1 
J81185 140 47 86 11 58 0.7 0.3 0.4 20 12 nil nil 
3-5 pus /2-4 
epi nil neg nil nil absent 
2 J28368 190 56 102 16 72 1.1 0.3 0.5 12 8 nil nil 2-4pus/2-6epi nil neg nil nil absent 
3 J84175 120 40 75 19 98 0.3 0.1 0.2 13 12 nil nil 2-4pus/1-2epi nil neg nil nil absent 
4 J38498 230 52 135 26 132 0.7 0.3 0.4 19 21 nil nil 2-4pus/1-2epi nil neg nil nil absent 
5 K18601 155 45 90 15.1 150 0.4 0.3 0.2 22 80 nil nil 2-4epi/3-8pus nil neg nil nil absent 
6 I70669 187 48 107 29 147 1.2 0.4 0.8 20 22 nil nil 3-5pus/2-4epi nil neg nil nil absent 
7 J97362 140 40 72 12 50 1 0.2 0.3 19 20 nil nil 1-2pus/1-3epi nil neg nil nil absent 
8 J74703 140 42 82 59 250 0.6 0.3 0.5 16 28 nil nil 2-3pus/3-4epi nil neg nil nil absent 
9 J94085 108 39 65 14 82 1 0.5 0.6 15 13 nil nil 2-5pus/1-2epi nil neg nil nil absent 
10 I86147 102 40 52 18 86 0.3 0.2 0.1 20 21 nil nil 2-5pus/3-4epi nil neg nil nil absent 
11 J53599 190 40 110 40 196 0.5 0.3 0.3 25 18 nil nil 3-5pus/3-6epi nil neg nil nil absent 
12 J91103 196 45 120 30 158 0.2 0.1 0.3 16 22 nil nil 3-4pus/1-2epi nil neg nil nil absent 
13 J80311 179 41 103 30 148 0.9 0.3 0.6 15 14 nil nil 1-3pus/4-6epi nil neg nil nil absent 
14 G19200 200 52 106 24 110 1 0.2 0.3 15 24 nil nil 2-4pus/1-2epi nil neg nil nil absent 
15 K00069 165 42 76 20 104 0.4 0.1 0.2 12 13 nil nil 2-4pus/1-2epi nil neg nil nil absent 
16 J74540 210 50 140 26 130 0.3 0.2 0.7 22 28 nil nil 1-2pus/1-2epi nil neg nil nil absent 
17 J81833 198 51 101 19 110 0.5 0.4 0.3 22 19 nil nil 1-2pus/2-4epi nil neg nil nil absent 
18 K12746 141 35 82 24 122 0.3 0.1 0.2 20 25 nil nil 3-5pus/4-6epi nil neg nil nil absent 
19 G88614 43 78 19 94 18 1 0.3 0.6 25 28 nil nil 2-6pus/2-4epi nil neg nil nil absent 
20 J75058 152 52 82 17 83 0.5 0.2 0.3 29 38 nil nil 2-3pus/2-4epi nil neg nil nil absent 
21 J84439 210 46 125 55 218 0.6 0.2 0.4 21 18 nil nil 1-2pus/1-4epi nil neg nil nil absent 
22 J81620 174 41 99 27 137 0.5 0.2 0.2 17 30 nil nil 3-5pus/2-5epi nil neg nil nil absent 
23 J94089 153 42 87 15 75 0.9 0.3 0.6 14 17 nil nil 1-3pus/1-3epi nil neg nil nil absent 
24 J68904 202 38 118 34 172 0.4 0.1 0.3 13 11 nil nil 2-3pus/2-4epi nil neg nil nil absent 
25 J57261 188 46 104 37 187 0.4 0.1 0.3 16 20 nil nil 2-4pus/2-3epi nil neg nil nil absent 
26 J52425 116 40 62 22 98 0.6 0.5 0.6 18 17 nil nil 1-2pus/1-2epi nil neg nil nil absent 
27 J86157 154 43 88 40 153 0.5 0.2 0.3 21 25 nil nil 2-3pus/2-3epi nil neg nil nil absent 
28 J92730 125 42 96 17 88 1.1 0.4 1 13 12 nil nil 2-3pus/2-3epi nil neg nil nil absent 
29 J90246 136 40 82 20 102 0.8 0.3 0.6 15 16 nil nil 2-3pus/3-4epi nil neg nil nil absent 
30 E008475 198 30 78 66 220 0.3 0.1 0.4 22 20 nil nil 1-5pus/3-6epi nil neg nil nil absent 
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QUALITATIVE ANALYSIS 
 
BIO CHEMICAL ANALYSIS 
 (Qualitative Analysis of “KUKKILATHY CHOORANAM”)  
Preparation of the Extract 
 5 gm of KUKKILATHY CHOORANAM was weighed accurately and placed in 
a 250 ml clean beaker. Then 50 ml distilled water was added and dissolved well. Then it 
is boiled well for about 10 minutes. It was cooled and filtered in a 100 ml volumetric 
flask and then it was made up to 100 ml with distilled water. This fluid was taken for 
analysis.  
SL. 
NO 
EXPERIMENT OBSERVATION INFERENCE 
1. Appearance of the sample 
Greyish white in 
colour 
 
2. 
Solubility:  
a. A little of the sample is 
shaken well with distilled 
water.  
b. A little of the sample is 
Shaken well with con. Hcl 
 Con. H2SO4.  
 
 
Sparingly soluble 
 
 
 
 
 
Presence of 
Silicate 
3. 
Action of Heat: 
A small amount of the sample 
is taken in a dry test tube and 
heated gently at first and then 
Strong.  
 
No colour fumes.  
 
Absence of 
Carbonate 
andNitrate.  
4. 
Flame  Test: 
A small amount of the sample 
is made into a paste with con. 
Hcl in a watch glass and 
introduced into non-luminous 
part of the Bunsen flame.  
 
No colour flames 
appeared.  
 
 
Absence of 
Copper.  
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5 
Ash Test: 
A filter paper is soaked into a 
mixture of sample and cobalt 
nitrate solution and introduced 
into the Bunsen flame and 
ignited.  
 
No Yellow colour 
flame.  
 
Absence of 
Sodium.  
 
 
SL. 
NO.  
EXPERIMENT OBSERVATION INFERENCE 
TEST FOR ACID RADICALS 
1. 
Test For Sulphate: 
a. 2 ml of the above prepared 
extract is taken in a test tube to 
this added 2ml of 4% ammonium 
oxalate solution.  
b. 2ml of the above prepared 
extract is added with 2 ml of dil-
Hcl is added until the 
effervescence ceases off. Then 
2ml of Barium chloride solution is 
added.  
No 
Cloudy 
appearance 
present 
 
 
 
 
Absence of 
sulphate 
 
 
 
2. 
Test For Chloride: 
2 ml of the above prepared 
Extract is added with dil. HNO3 
till the effervescence ceases. Then 
2 ml of silver nitrate solution is 
added.  
No Cloudy 
appearance. 
 
Absence of 
Chloride.  
3. 
Test For Phosphate: 
2 ml of the extract is treated with 
2ml of ammonium molybdate 
solution and 2 ml of con. HNO3 
Cloudy yellow 
appearance 
Presence of 
 Phosphate. 
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4. 
Test For Carbonate: 
2m1 of the extract is treated with 
2m1 magnesium sulphate solution 
No cloudy 
appearance 
Absence of 
Carbonate.  
 
5 
 
Test For Nitrate: 
1gm of the substance is heated 
with copper turnings and 
concentrated H2SO4and viewed 
the test tube vertically down.  
No characteristic 
changes.  
 
Absenceof 
Nitrate.  
 
 
 
 
6. 
Test For Sulphide 
1 gm of the substance is 
Treated with 2m1 of con. Hcl. 
No Rotten egg 
Smelling 
Absence of 
Sulphide 
 
7. 
 
 
 
 
Test for fluoride & oxalate 
 2 m1 of The Extract Is Added 
With 2m1of Acetic Acid and 2 m1 
calcium Chloride solution and 
heated.  
No Cloudy 
appearance.  
Absence 
ofFluoride & 
Oxalate 
 
8. 
 
 
 
Test for Nitrite: 
3drops of extract is placed on a 
filter paper, on that 2 drops of 
acetic Acid and 2 drops of 
benzidine solution is placed.  
No characteristic 
Changes.  
Absence of 
nitrite.  
 
9. 
 
 
 
 
 
Test For Borate: 
2 pinches of the substance is made 
into paste by using sulphuric acid 
and alcohol (95%) and introduced 
into the blue flame.  
No yellow 
precipitate is 
obtained.  
Absence of 
borate.  
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II. TEST FOR BASIC RADICALS 
1 
Test For Lead: 
2 m1of the extract is added with 
2m1of potassium iodide solution.  
 No Yellow 
precipitate 
is obtained 
Absence of 
Lead.  
2. 
Test for Copper: 
a. One pinch of substance is 
Made into paste with con. Hcl 
In a watch glass and introduced 
into the non-luminous part of the 
flame.  
b. 2 ml of extract is added with 
Excess of ammonia solution. 
No Blue colour 
flame  
precipitate 
 
 
 
No Blue colour 
precipitate  
Absence of 
Copper.  
 
 
 
 
Absence of 
Copper.  
3. 
Test For Aluminium: 
Take the 2m1of the extract 
sodium hydroxide is added in 
drops to excess.  
No characteristic 
changes 
 
Absence of 
Aluminium.  
 
4. 
TestForIron: (Ferrous)  
To the 2 ml of extract 2m1 
ammonium thiocyanate solution 
and 2m1of con. HNO3 is added.  
 
 
 
 
 
 
 
No Brown colour 
Appearance 
 
 
Absence of 
Iron.  
 
 
 
 
 5. 
Test For Zinc: 
To 2m1 of the extract sodium 
hydroxide solution is added in 
Drops to excess.  
No White 
precipitate  
Formed 
Absenceof 
Zinc. 
 
6. 
Test For Calcium: 
2m1 of the extract is added with 
2m1 of 4% ammonium oxalate 
Solution.  
No Cloudy 
appearance 
And white 
precipitate  is 
Present. 
Absenceof 
Calcium.  
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7. 
Test For Magnesium: 
To 2ml of extract sodium 
hydroxide solution is added in 
Drops to excess.  
 White precipitate 
is not 
Obtained.  
Absence of 
Magnesium.  
8. 
Test For Ammonium: 
To 2ml of extract few ml of 
Nessler's reagent and excess of 
sodium hydroxide solution are 
Added.  
Brown colour not 
Appeared.  
 
Absence of 
Ammonium.  
9. 
Test For Potassium: 
A pinch of substance is treated 
with 2ml of sodium nitrite 
solution and then treated with 
2m1 of cobalt nitrate in 30% 
glacial acetic acid.  
Yellowish 
precipitate is 
obtained 
 
 
Presence of 
Potassium. 
10. 
Test For Sodium: 
2 pinches of the substance is 
made into paste by using HCL 
And introduced into the blue 
flame of Bunsen burner. 
 No Yellow colour  
Flame appeared.  
 Absence of 
Sodium.  
 
11. 
Test For Mercury: 
2m1 of the extract is treated with 
2ml of sodium hydroxide solution. 
 
 
 
Yellow precipitate 
is Present 
 
 
Presence of 
Mercury.  
 
 
12. 
Test For Arsenic: 
2m1 of the extract is treated with 
2m1 of sodium hydroxide 
solution. 
No brownish red 
Precipitate is 
obtained 
Absence of 
Arsenic.  
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III. MISCELLANEOUS 
 
1. 
Test for Starch: 
2ml of extract is treated with weak 
iodine solution.  
No blue colour 
developed 
Absence of 
Strarch.  
 
2. 
Test For Reducing Sugar: 
5. ml of Benedict's qualitative 
Solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract 
and again boil it for2 minutes. The 
colour changes are noted.  
 No Brick red 
colour developed 
Absence of 
Reducing 
sugar.  
 
3. 
Test For The Alkaloids: 
a. 2m1 of the extract is treated 
with 2ml of potassium Iodide 
solution.       
Yellow colour 
developed 
Presence of 
Alkaloid.  
 
4. 
Test for Tannic Acid: 
2ml of extract is treated with  
2ml of ferric chloride solution.  
No Black 
precipitate is 
formed 
Absence of 
Tannic acid. 
 
5. 
Test for Unsaturated 
Compound: 
To the 2ml of extract 2ml of 
Potassium Permanganate solution 
is added.  
Potassium 
Permanganate is 
not decolourised 
Absence of 
Unsaturated 
Compound.  
 
6. 
Test For Amino Acid: 
2 drops of the extract is placed on 
a filter paper and dried well and 2 
ml of biuret reagent is added.  
 
No Violet colour 
developed 
Absence of 
Amino acids.  
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7. Test For type of Compound: 
2ml of the extract is treated with 2 
ml of ferric chloride solution. 
No Green colour 
developed 
 
 
 
 
No Red colour 
developed 
 
 
 
 
No Violet colour 
developed 
 
 
No blue colour 
Developed 
Absence of 
oxyquinole 
epinephrine 
and pyro 
catechol.  
 
Anti pyrine, 
Aliphaticamino 
acids and 
Meconic acid 
are absent.  
 
Salicylate and 
Resorcinol is 
absent.  
 
Morphine, 
Phenol 
cresol and 
hydro 
quinone are 
absent 
 
RESULT: 
 Silicate 
 Phosphate 
 Potassium 
Alkaloid are the chemical constituents present in KUKKILATHY CHOORANAM. 
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PHYSIOCHEMICAL ANALYSIS OF –KUKKILATHY CHOORANAM 
 
1. Loss On Drying: 
An accurately weighed 2g of Kukkilathy Chooranam formulation was taken in a 
tarred glass bottle. The crude drug was heated at 105
0
C for 6 hours in an oven till a 
constant weight. Percentage moisture content of the sample was calculated with 
reference to the shade dried material. 
2. Determination of total ash: 
Weighed accurately 2g of Kukkilathy Chooranam formulation was added in 
crucible at a temperature 600
0
C in a muffle furnace till carbon free ash was obtained. It 
was calculated with reference to the air dried drug.  
3. Determination of acid insoluble ash: 
Ash above obtained, was boiled for 5min with 25ml of 1M Hydrochloric acid and 
filtered using an ash less filter paper. Insoluble matter retained on filter paper was 
washed with hot water and filter paper was burnt to a constant weight in a muffler 
furnace. The percentage of acid insoluble as was calculated with reference to the air 
dried drug. 
4. Determination of water soluble ash: 
Total ash 1g was boiled for 5min with 25ml water and insoluble matter collected 
on an ash less filter paper was washed with hot water and ignited for 15 min at a 
temperature not exceeding 450
0
C in a muffle furnace. The amount of soluble ash is 
determined by drying the filtrate.  
5. Determination of water soluble Extractive: 
5gm of air dried drug, coarsely powered Kukkilathy Chooranam was macerated 
with 100ml of distilled water in a closed flask for twenty-four hours shaking frequently. 
Solution was filtered and 25 ml of filtrated was evaporated in a tarred flat bottom 
shallow dish, further dried at 100
0
 C and weighted. The percentage of water soluble 
extractive was calculated with reference to the air dried drugs.   
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6. Determination of alcohol soluble extractive: 
 
2.5gm. of air dried drugs, coarsely powdered Kukkilathy Chooranam was 
macerated with 50 ml. alcohol in closed flask for 24 hrs. With frequent shaking it was 
filtered rapidly taking precaution against loss of alcohol. 10ml of filtrate was then 
evaporated in a tarred flat bottom shallow dish, dried at 100
0
C and weighted. The 
percentage of alcohol soluble extractive was calculated with reference to air dried drug. 
 
S. No Parameters Percentage 
1 Loss on drying 2.64% 
2 Total ash value 2.02% 
3 Acid insoluble ash Less than 1% 
4 Water soluble ash 1.30% 
5 Water soluble extraction 4.57% 
6 Alcohol soluble extraction 53.46% 
 
The above stated physiochemical properties for the given sample certified to be 
present. 
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PRELIMINARY PHYTOCHEMICAL SCREENING 
KUKKILATHY CHOORANAM 
The preliminary phytochemical screening test was carried out for each extracts of 
Kukkilathy Chooranam as per the standard procedure. 
 
1. Detection of alkaloids: 
Extracts were dissolved individually in dilute Hydrochloric acid and filtered. 
a) Mayer’s Test: Filtrates were treated with Mayer’s reagent (Potassium Mercuric 
Iodide). Formation of a yellow colored precipitate indicates the presence of alkaloids.  
b) Wagner’s Test: Filtrates were treated with Wagner’s reagent (Iodine in Potassium 
Iodide). Formation of brown/reddish precipitate indicates the presence of alkaloids.  
c) Dragendroff’s Test: Filtrates were treated with Dragendroff’s reagent (solution of 
Potassium Bismuth Iodide). Formation of red precipitate indicates the presence of 
alkaloids. 
d) Hager’s Test: Filtrates were treated with Hager’s reagent (saturated picric acid 
solution). Presence of alkaloids confirmed by the formation of yellow colored 
precipitate.  
2. Detection of carbohydrates: 
Extracts were dissolved individually in 5 ml distilled water and filtered. The 
filtrates were used to test for the presence of carbohydrates. 
 
a) Molisch’s Test:  
To 2 ml of plant sample extract, two drops of alcoholic solution of α- naphthol 
are added. The mixture is shaken well and few drops of concentrated sulphuric acid is 
added slowly along the sides of test tube. A violet ring indicates the presence of 
carbohydrates.   
 
b) Benedict’s Test: 
Filtrates were treated with Benedict’s reagent and heated gently. Orange red 
precipitate indicates the presence of reducing sugars. 
 
3. Detection of glycosides: 
Extracts were hydrolyzed with dil. HCl, and then subjected to test for glycosides.  
a) Modified Borntrager’s Test: Extracts were treated with Ferric Chloride 
solution and immersed in boiling water for about 5 minutes. The mixture was cooled and 
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extracted with equal volumes of benzene. The benzene layer was separated and treated 
with ammonia solution. Formation of rose-pink color in the ammonical layer indicates 
the presence of anthranol glycosides.  
b) Cardiac glycoside (Keller-Killiani test):  Extract was shaken with distilled 
water (5 mL). To this, glacial acetic acid (2 mL) containing a few drops of ferric chloride 
was added, followed byH2SO4 (1 mL) along the side of the test tube. The formation of 
brown ring at the interface gives positive indication for cardiac glycoside and a violet 
ring may appear below the brown ring 
 
4. Detection of saponins 
a) Froth Test: Extracts were diluted with distilled water to 20ml and this was 
shaken in a graduated cylinder for 15 minutes. Formation of 1 cm layer of foam indicates 
the presence of saponins.  
b) Foam Test: 0.5 gm of extract was shaken with 2 ml of water. If foam 
produced persists for ten minutes it indicates the presence of saponins.  
 
5. Detection of phytosterols  
 
a) Salkowski’s Test: Extracts were treated with chloroform and filtered. The 
filtrates were treated with few drops of Conc. Sulphuric acid, shaken and allowed to 
stand. Appearance of golden yellow color indicates the presence of triterpenes. 
 
6. Detection of phenols Ferric Chloride Test: 
Extracts were treated with 3-4 drops of ferric chloride solution. Formation of 
bluish black color indicates the presence of phenols.  
 
7. Detection of tannins Gelatin Test: 
The extract is dissolved in 5 ml of distilled water and 2 ml of 1% solution of 
Gelatin containing 10% NaCl is added to it. White precipitate indicates the presence of 
phenolic compounds.  
 
8. Detection of Flavonoids  
a) Alkaline Reagent Test: Extracts were treated with few drops of sodium 
hydroxide solution. Formation of intense yellow color, which becomes colorless on 
addition of dilute acid, indicates the presence of flavonoids. 
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 b) Lead acetate Test: Extracts were treated with few drops of lead acetate 
solution. Formation of yellow color precipitate indicates the presence of flavonoids.  
 
9. Detection of proteins and aminoacids 
a) Xanthoproteic Test: The extracts were treated with few drops of conc. Nitric 
acid. Formation of yellow color indicates the presence of proteins. 
b) Ninhydrin Test: To the extract, 0.25% w/v ninhydrin reagent was added and 
boiled for few minutes. Formation of blue color indicates the presence of amino acid. 
 
10.Detection of diterpenes Copper Acetate Test: 
 Extracts were dissolved in water and treated with 3-4 drops of copper acetate 
solution. Formation of emerald green color indicates the presence of diterpenes   
 
11. Gum and Mucilage:  
To 1ml of extract add 2.5ml of absolute alcohol and stirring constantly. Then the 
precipitate was dried in air and examine for its swelling properties. Swelling was 
observed that will indicate presence of gum and mucilage. 
 
12. Test for Fixed oils and Fats  
a. Spot test  : A small quantity of extract is pressed between two filter papers. 
Oil stain on the paper indicates the presence of fixed oils.  
 
13. Test for Quinones 
Extract was treated with sodium hydroxide blue or red precipitate indicates the 
presence of Quinones. 
The Preliminary phytochemical studies of aqueous extract of Kukkilathy 
Chooranam were done using standard procedures. The results were presented in tables. 
The present study reveals that the bioactive compounds were present in all the extracts of  
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Kukkilathy Chooranam 
S.no Phytochemicals Test Name H2O Extract 
1.  Alkaloids 
Mayer’s Test -ve 
Wagner’s Test -ve 
Dragendroff’s Test -ve 
Hager’s Test -ve 
2.  Carbohydrates 
Molisch’s Test: +ve 
Benedict’s Test +ve 
3.  Glycoside 
Modified Borntrager’s Test +ve 
Keller Killiani -ve 
4.  Saponin 
Froth Test +ve 
Foam Test -ve 
5.  Phytosterol Salkowski’s Test -ve 
6.  Phenols Ferric Chloride Test -ve 
7.  Tannins Gelatin Test -ve 
8.  Flavonoids 
Alkaline Reagent Test -ve 
Lead acetate Test -ve 
9.  Proteins and amino acids Xanthoproteic Test -ve 
10.  Diterpenes Copper Acetate Test -ve 
11.  Gum & Mucilage Extract + Alcohol -ve 
12.  Fat & Fixed Oil Spot Test -ve 
13.  Quinones NAOH + Extract -ve 
 
+ve/-ve present or absent if component tested 
The above stated physiochemical properties for the given sample certified to be present. 
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TOXICITY STUDY 
Toxicity studies: 
The treated rats with 2000 mg/kg in the acute toxicity study did not show any 
mortality, any untoward clinical sign, any behavioral signs, alterations in body weight 
and necropsy findings at the end of the study. This indicates that the dosages 
administered were below toxic level and proves the safety of the drug. The acute toxicity 
helped to fix the doses for pharmacological activities. 
The 28 days Repeated dose oral toxicity (OECD - 407) and 90-days Repeated dose 
oral toxicity study (OECD – 408) of Kukkilathy chooranam in Wistar albino rats were 
studied. The treated animals survived throughout the study period of 28 days and 90 days 
respectively and did not reveal any treatment related major abnormal clinical signs at the 
test dose levels. The overall percentage of body weight gain in rats treated with the drug 
was found to be normal indicating that the test animals were in a healthy condition 
during the 90 days of observation period. 
TheP valuesof  haematological parameters and biochemical parameters of the 
tested rats were not significant indicating that the drug exerted nil impact on the 
parameters and they were within the reference range.In histopathological study on KC 
high dose treated rats no significant abnormalities  were seen. The necropsy studies 
showed no remarkable changes. 
This results strongly stress the fact of the drug having no toxic effect on the body 
metabolism.So, the trial drug Kukkilathy chooranam hope fully use for human trails. 
    Reference: Reg No-321412204,Dept. of Gunapadam,Oct-17, The Tamil Nadu 
Dr.M.G.R. Medical University, NIS Library book ref no-D342  
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DISCUSSION 
 Authentication of herbaland mineralraw drug, the ingredients of the trail drug 
Kukkilathy Chooranam were obtained from the Assistant Professor of medicinal 
botany and lecturer, Department  of Gunapadam of National institute of Siddha 
prior to the medicine preparation. 
 The pre clinical toxicity study for the trail drug Kukkilathy chooranam was 
already have been evaluated (Ref: Reg No-321412204, Dept.of Gunapadam,  
Oct-17,The Tamil Nadu Dr.M.G.R. Medical University, NIS  Library book ref 
no-D342). 
 The Phytochemical and physicochemical analysis of the trail drug were done in 
The Tamil Nadu Dr.M.G.R. Medical University, Dept. of Siddha, and the bio 
chemical qualitative analysis were done in the bio chemistry lab of National 
Institute of Siddha. It is reveled the presence of phytochemical Alkaloid, silicate, 
phosphate, potassium, carbohydrate, glycoside, Saponin. 
 
 The clinical study was conducted with a well defiened protocol and proper 
profoma after the approval of the Institutional Ethical Committee 
(NIS/IEC/2016/11-01/14.10.2016). 
 After the screening of 70 cases reporting at the OPD of Dept. of Maruthuvam and 
Dept. of Aruvai and thol maruthuvam 30 cases were recruited as per inclusion 
criteria(Form-I). Before enrollment to the trail the informed consent was obtained 
from all the patients. (Forum-IV) 
  
S.No Parameters Percentage 
1 Loss on drying 2.64% 
2 Total ash value 2.02% 
3 Acid insoluble ash Less than 1% 
4 Water soluble ash 1.30% 
5 Water soluble extraction 4.57% 
6 Alcohol soluble 
extraction 
53.46% 
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 All the patients were advised to have oil bath with Chitramutti oil on Day -1 and 
Day-2 they were given purgation with Agasthiyar kulambu 130mg with ginger 
juice, Day-3 advised to take rest,no medicine was given on that day. From Day-4 
onwards treatment started.  The patient were treated for a period of 45 days with 
Kukkilathy Chooranam (Internal)4g, twice a day with ghee (After food) 
 The trail drug was given for 7 days/visit and clinical assessment was done during 
each visit in OPD patients (7 days once) and the data were noted in the clinical 
assessment proforma (Form-II) 
 Routine clinical laboratory investigation and proctoscopy examination were done 
on day 0 ,46
th
 day of the trail for OPD patients. All the patients were put under 
observation for 2 months (Follow up period) without the trail drug treatment. 
 
DISCUSSION ON THE OBSERVATIONS of; Age, Gender, Place of living, Season, 
Occupation, Uyir thathukkal, Udal kattukal,  Kosam, Gunam, Thegi,En vagai thervu, 
Chronicity of illness, Clinical features, Proctoscopic examination, HAQ,HSS Score, 
Clinical laboratory parameters. 
Incidence with reference to gender distribution: 
30 patients of both sex were selected for this study, among them 28 (93.3%) were 
male and 2(6.7%) were female. The majority affected was male. 
Incidence with reference to with age distribution: 
Out of 30 cases age 20-30 years cases 7 (23.33%) were found ,age 31-40 years 13 
cases (43.33%) were found ,age 41-50 years 6 cases (20%) were found and age 51-60 
years 4 cases (13.3%) were found. This study showed that the highest incidence of Ratha 
moolam was between age group 31-40 years cases (43.33%%) were to be found. 
Incidence with reference occupation: 
Out of 30 cases,8 patients (26.7%) were driver, 1 patient (3.3%) was 
housewife, 1 patient (3.3%) was student, 11 patients (36.7%) were Engineers,3 patients 
(10%) were Tailor, 3 patients (10%) were coolie, 3 patients (10%) were Businessman. 
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This data showed the relationship of occupation towards the disease Ratha 
moolam. 
 (Drivers, Tailors-Prolonged sitting)  
 (Engineers, Housewives, Bussinessman, Student-Stress) 
Prolonged sitting and stressful occupation vitiates the vatham and pitham 
causes Moolam 
”mdpy gpj;j njhe;jkyhJ %yk; tuhJ”.  
- Njiuah; 
Incidence with reference to diet: 
All 30 patients (100%) were Non vegetarians, as per their dietic history (low 
fiber Intake) they were more prone to Ratha moolam. 
 
Incidence with reference to Paruva kaalam: 
 Among the 30 cases 21 cases (70%) were reported in Munpani Kaalam (Dec 
15-Feb14) and 9 cases were (30%) reported in Pinpani Kaalam (Feb 15-April 14) .  
 
Incidence with reference to Thinai: 
Among the 30 cases 19 cases (63.3%) were from Neithal thinai and11 cases 
(36.7%) were from Marutham thinai. 
Most of the cases were belong to Neithal land.  
 
“nea;jdpy NkYth;;g;ig ePq;fh JwpDkJ 
nta;jdpy Nkjq;F tPlhFk;. ” 
- Nehapy;yh newp. 
 
Incidence with reference to  body constitution : 
Among the 30 cases 14 cases (46.7%) were Vatha thegi, 4 cases (13.3%) were 
pithathegi , 2 cases (6.7%) were kaba thegi and 10 cases(33.33%) were thondha thegi. 
As per Saint Theraiyar,Vatha thegi were more prone to Moolam. 
”mdpy gpj;j njhe;jkyhJ %yk; tuhJ”.  
- Njiuah; 
Vatha thegi were more affected with the bleeding piles symptoms.  
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Incidence with reference to Gunam: 
Out of 30 cases 17 cases (56.7%) were found to possess rasathagunam, 6 cases 
(20%) were found to possess sathuvagunam and 7 cases (23.3%) found to possess 
thamogunam Majority of cases possessed Rasatha gunam. 
 
Incidence with reference to Envagai thervugal(Eight diagnostic tools) 
In Envagai Thervugal Malam was found to be affected in all 30 cases (100%) , 
Naa(Coated tongue) was affected 17 cases (57%) , Niram (Pallor) was affected in 8 cases 
(27%) ,Vizhi (Pallor in palpabrel conjunctiva) was affected in 8 cases (27%). The 
Naadinadai seen in Rathamoolam were Vathapitham in 16 cases (53%), Pithavatham in 
7 cases (23%) vathakapham in 4 cases (14%) and pithakabam in 3 cases (10%)  
 
Inference: 
“nghUshd thjj;jpy; gpj;jQ; Nrh;e;J 
 nghUe;J Fzq;fSl;z thA rf;jp 
 nrhpahik Gspj;Njg;gk; nghUky; ePhpw; 
 rptg;Gyk; gpbj;jy; cUj; jhJel;lk;”.  
       -rjf ehb 
Incidence with reference to Udal kattukal: 
Among 30 cases saram was affected (Unable to perform their routine activites) in 
30 cases (100%), Senneer was affected (Bleeding at stools) in 30 cases (100%) and Enbu 
(pain in all the limbs) was affected in 15 cases (50%) . 
 
Incidence with reference to kosangal: 
Among with 30 cases Annamaya Kosam was affected (loss of appetite) in 17 
cases (56.7%) and Vignanamaya kosam was affected(Pain in all the limbs) in 15 cases 
(50%)  
 
Incidence with reference to uyir thathukkal: 
Incidence with reference to Vatham: 
Among the 30 cases Abanan, Samaanan and Viyanan were affected in all 30 
cases (100%) which results in bleeding P/R during defecation,Pain in all the limbs, 
Constipation. Kirukaran was affected (loss of appetite) in 17 cases (56.7%). Devathathan 
was affected in 30 cases (100%) (Tiredness and constipation). 
  
137 
 
Incidence with reference to pitham: 
Sathagapitham was affected (Unable to perform their routine activities) in all the 
30 cases (100%) Anarpitham was affected (loss of appetite) in 17 cases (57%), 
Ranjagapitham was affected (Anaemia) in 8 cases (27%) and Prasaka pitham was 
affected (Itching present around the anus) in 8 cases (27%). 
 
Incidence with reference to kabam: 
Kilethagam was affected (loss of appetite) in 17 cases (57%) tharpagam was 
affected (burning sensation in the both eyes) in 6 cases (20%) Santhigam was affected 
(pain in all the limbs) in 15 cases (50%) .  
 
Incidence with reference to Neer kuri and Nei kuri: 
All 30 cases were observed straw coloured normal urine. Among 30 cases in 9 
cases (30%) nei kuri was observed as serpentine like, in 6 cases (20%) the neikuri was 
observed as annular ring  like , in 10 cases (33%) the neikuri was observed as Pearl 
shape, in 5 cases (17%) the neikuri was observed as thontham type. 
 
CHRONICITY OF ILLNESS:  
Among 30 cases 0-3 months chronicity of illness was found in 8 cases (26.6%) , 
4-6 months chronicity of illness in 5 cases (16.7%) , 7-9 month’s chronicity of illness in 
2 cases (6.7%) and above 9 months chronicity of illness in 15 cases (50%) .  
 
CLINICAL FEATURES: 
Among 30 cases (100%) had bleeding during defecation and constipation, 10 
cases (33.33%) had tiredness, 15 cases (50%) had pain in all limbs ,4 cases (13.3%) had 
headache, 8 cases (27%) had pruritic ani and Anemia in 8 cases (27%). 
 
PROCTOSCOPY EXAMINATION: 
Among 30 cases, the position of pile masses were as follows: 
In 6 cases (20%)        -3’o clock position 
In 10 cases (33.33%)  -7’o clock position 
In 7 cases ( 23.33%)  - 11’o clock position 
In 7 cases (23.33%) were in more than one pile mass in various clock position. (eg:3’o 
clock and 11’o clock). Pile mass size reduced well after the treatment. 
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HEALTH ASSESSMENT QUESTIONNAIRE: 
The health status of the patients is assessed before and after the treatment with 
the test drug to know whether the treatment has significant effect in improving the health 
status of the patient. Paired comparison test is used to find the effectiveness of the test 
drug.  
Among 30 cases before treatment 17 cases (57%) were in level II and 13 cases 
(43%) were in level III according to their mark scores.  
 After treatment 18 cases (60%) were in level I and 12 cases (40%) were in level 
II according to their mark scores.  
Statistical analysis done shows that the trail drug Kukkilathy chooranam is effective and 
significant (p<0. 0001). Thus it is effective in improving the health status of the patients 
through which they can able to perform their daily activities independently.  
 
Results arrived on the basis severity of clinical symptoms-HSS Score 
From the HSS Score, finally it is concluded that 11 cases (37%) symptoms were 
completely relieved and 19 cases (64%) symptoms were reduced well, those patients 
were improved Moderate to mild score. Statistical analysis done shows that the trail drug 
Kukkilathy chooranam is effective and significant (p<0. 0001). 
 
BLOOD PARAMETER: HEMOGLOBIN 
Among 30 cases before treatment the haemoglobin level in 2 cases (7%) were  below 
10gm/dl, 4 cases (13%) haemoglobin level were 10-12 gm/dl , in 5 cases (17%) the 
haemoglobin level were in 12-14gm/dl and 19 cases (63%) were in above 14.  
 After treatment 2 cases (7%) were in below 10, 3 cases (10%) were in 10-12, 6 
cases (20%) were in 12-14, and 19 cases (63%) were in above 14gm/dl.  
There was no significant difference in before and after treatment. 
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SUMMARY 
 The aim of the study was to evaluate the therapeutic efficacy of the Kukkilathy 
Chooranam (internal) in Ratha moolam.  
 Before initiating the clinical trial, approval was got from the Institutional Ethical 
committee of National Institute of Siddha (NIS/IEC/2016/11-01/14.10.2016) for 
conducting the clinical studies respectively by submitting the well defined 
protocol and proforma. It was registered prospectively in the Clinical Trail 
Registry of India (CTRI Reg No:CTRI/2017/07/009127) 
 The raw drugs were authenticated by the Assistant professor of medicinal botany 
and Investigator, Dept.of Gunapadam, NIS, and the trail drug was prepared by 
the investigator in the Gunapadam lab of National Institute of Siddha as per the 
standard operating procedure mentioned in the protocol. 
 As per Siddha Materia Medica the ingredients of the trial drug were found to 
possess astringent, anthelmintic, anti-inflammatory and styptic action.  
 The Phytochemical and physico chemical analysis of the trail drug were done in 
The Tamil Nadu Dr.M.G.R. Medical University, Dept. of Siddha and the bio 
chemical qualitative analysis were done in the bio chemistry lab of National 
Institute of Siddha. It is reveled the presence of phytochemicals Alkaloid, silicate, 
phosphate, potassium, carbohydrate, glycoside, Saponin.  
 For clinical study 70 cases were screened based on inclusion and exclusion 
criteria at the OPD of department of Maruthuvam, NIS. Out of 70 cases 30 cases 
were recruited for the clinical trial. Clinical diagnosis of Ratha moolam was made 
by both Siddha and modern methodology.  
 Before initiating the trial informed consent was obtained from all the                                              
patients. 
 Prognosis was assessed through proctoscopic examination done at initial day and 
at the end of 46
th
 day. Prognosis was recorded through HAQ and Haemorrhoids 
Symptoms Severity Score. 
 All the patients were advised to have oil bath with Chitramutti oil on Day -1 and 
Day-2 they were given purgation with Agasthiyar kulambu 130mg with ginger 
juice, Day-3 advised to take rest, no medicine was given on that day(to correct 
the elevated mukkutram) From Day-4 onwards treatment started.  The patient 
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were treated for a period of 45 days with Kukkilathy Chooranam (Internal) 
4g,twice a day with ghee (After food) 
 The patients were treated for a period of 45 days. The trial medicine selected for 
internal treatment was Kukkilathy Chooranam (internal medicine) at the dose of 4 
g twice a day with adjuvant of ghee as per Siddha literature Anuboga vaithiya 
navaneetham thirattu- Page no :1248-1249 
 Routine clinical laboratory investigation was carried out before and after 
treatment and the concerned data were recorded in the proforma.(Form-III) 
 Clinical assessment was done during each visit in OPD patients (7 days once) and 
the data were noted in the prescribed proforma. (Form-II) 
  During the study period there was no event of any adverse reactions were 
reported owing to the drug or disease.  
 Diet restriction was strictly followed during the period of drug administration as 
well as in re-dieting period as per noted in the dietary advice form .(Form-VII) 
 The HAQ questionnaire score showed good improvement in 60% and moderate 
improvement in 40%.Improvement in other clinical symptoms before and after 
treatment revealed the efficacy of the trail drug, in relieving constipation, 
bleeding at stools, anal itch, discomfort, dyschezia etc. Statistical analysis done 
for HAQ and it shows that the trail drug Kukkilathy chooranam is effective and  
significant (p<0. 0001). Thus it is effective in improving the health status of the 
patients through which they can able to perform their daily activities 
independently.   
 From the HSS Score, finally it is concluded that 11 cases (37%) symptoms were 
completely relieved and 19 cases ( 64%) symptoms were reduced well, those 
patients were improved Moderate to mild score. Statistical analysis done for HSS 
Score shows that the trail drug Kukkilathy chooranam is effective and significant 
(p<0. 0001). 
 In the case of Clinical laboratory parameters there was no significant 
improvement in hemoglobin level after treatment. 
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CONCLUSION 
 
 It is concluded by this study that Kukkilathy Chooranam (Internal) is  to be safe, 
efficacious and cost effective potent herbo mineral drug in the treatment of 
Haemorrhoids. 
 From the HSS Score, finally it is concluded that 11 cases (37%) symptoms were 
completely relieved and 19 cases ( 64%) symptoms were reduced well, those 
patients were improved Moderate to mild score. Statistical analysis done for HSS 
Score shows that the trail drug Kukkilathy chooranam is effective and  significant 
(p<0. 0001).On Proctoscopic examination showed significant reduction of  
internal pile mass  size in after treatment. 
 There was no adverse reaction was reported during the trial period. 
 Because of the encouraging clinical outcome, the study may be further carried out 
with the same drug “Kukkilathy Chooranam”in a larger clinical population. 
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AYOTHIDOSS PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
A CLINICAL STUDY  ON SIDDHA HERBAL FORMULATION “KUKKILATHY 
CHOORANAM” IN  “RATHA MOOLAM” (BLEEDING PILES). 
 
FORM I  -  SCREENING AND SELECTION PROFORMA 
 
1. O.P No   ________    2. S.No: ________    
 
4. Name: __________________     5. Age (years):                     6. Gender: Female/male 
 
7. Contact No:    ------------------------------------------ 
 
8.INCLUSION CRITERIA: 
 Age: 20- 60Yrs       Yes/No                                                                                            
 Sex- Both male and female      Yes/No 
 Patients who will be having classical symptoms of bleeding piles    Yes/No 
 Willing to give blood samples for the investigation required. Yes/No 
 Patient’s willing for consent to include in trail   Yes/No 
 
9.EXCLUSION CRITERIA: 
 
Patient having 2
nd
, 3
rd
 degree 
internal haemorrhoids. 
Yes No Fistula in ano Yes No 
Pregnancy and lactation Yes No Rectal tuberculosis Yes No 
Fissure in ano Yes No Cardiac disease Yes No 
External haemorrhoids Yes No 
History of taking treatment 
for any other ailments 
Yes No 
History of drug/alcohol abuse Yes No Hypertension Yes No 
 
10.ADMITTED TO TRAIL: YES             NO            If  Yes Serial No: 
Date:        Signature of the Lecturer:                                                               
Station:                                                                            
Signature of the Investigator:                                           Signature of the HOD: 
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AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
                             A CLINICAL STUDY ON SIDDHA HERBAL FORMULATION  
“KUKKILATHY CHOORANAM” IN  “RATHA MOOLAM” (BLEEDING PILES). 
 
FORM II-CLINICAL REPORT FORM 
 
1. Serial No:   _______________                          2. OP/IP No: ---------- 
 
3. Name: _______________________                  4. Gender:   Female/ Male 
 
5. Age (years): _________   DOB    
                                                                Date        Month          Year 
6. Address:     -------------------------------------- 
                      ------------------------------------- 
                      ------------------------------------- 
 
7. A) Occupation: -----------------------------             B) Nature of work ----------------- 
 
8. Educational Status:   A) Illiterate                  B) Literate  
 
9. Height:  --------- cms                10.Weight: ---------- kg 
 
Date of Trial Drug Initiation ________  Date of Trial Drug Cessation__________ 
11. COMPLAINTS AND DURATION:   
_______________________________________________________________________ 
 
______________________________________________________________________ 
 
________________________________________________________________________ 
 
________________________________________________________________________ 
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12. HABIT OF 
A) Smoking                  Yes         duration ________ years    Number-              
 B) Tobacco chewing     Yes        duration ________ years                                                                       
             C) Betel chewing          Yes         duration ________ years                                
             D) Alcoholism              Yes         duration ________ years; Quantity-      ml    
 
13. DIETARY STYLE: A. Pure vegetarian                                  B. Non-vegetarian             
 
     Less intake of water :     Yes                   No 
 
14. DRUG HISTORY:  
      Had the patient been treated before with allopathic drug       A) Yes              2) No 
 
15. MARITAL STATUS:    1.Married   2.Unmarried  
 
 
                                               No of children:             Male:          Female: 
16. FAMILY HISTORY: 
 
      Whether this problem runs in family?                                1. Yes                                  2.No   
 
       If yes, mention the relationship of affected person(s)        ------------------------- 
                                                                                                 ------------------------- 
17. MENSTRUAL HISTORY: 
 
18. BOWEL HABITS & MICTURITION:  Normal 
 
            Historyof habitual constipation    1.Yes                           2.No                                                       
 
            History of frequent diarrhoea        1.Yes                           2.No                 
 
MODE OF ONSET:       Gradual                             Sudden 
 
DURATION            :               ____________ weeks/Months/Years 
 
 PAIN IN ANAL REGION                                  Yes                               No                   
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If yes, whether there was pain in the beginning?  Yes                No 
 
TENDERNESS     :         At Beginning                        During the Course   
DISCHARGE /BLEEDING      Yes                    No                  
If Yes, its nature: Serous      Serosanguineous          pus         blood 
 
19.SLEEP: Sleep disturbance    -    Yes               No 
 
                    If yes: …………………………..                                
20. PSYCHOLOGICAL STATE: 
 
Normal                 Occupational stress                     Anxiety            Depression 
 
5. THEGI: [ TYPE OF BODY CONSTITUTION]  
  
Vatham predominant  Kabam predominant  
Pitham predominant  Thondha udal  
 
 
6.NILAM: [ LAND WHERE PATIENT LIVED MOST ] 
 
           Kurinji                 Mullai                  Marutham            Neithal              Paalai 
   (Hilly terrain)           (Forest range)          (Plains)             (Coastal belt)    (Arid regions)  
 
 
 7. KAALAM: [SEASON] 
 
Kaarkalam(Aug15-Oct14)                         Pinpanikalam(Feb15-Apr14)         
 
Koothirkalam(Oct15-Dec14)                     Ilavenil(Apr15-June14) 
 
Munpanikalam(Dec15-Feb14)         Muthuvenil(June15-Aug14) 
 
 
8. GUNAM:[CHARACTER] 
 
Sathuvam                        Rasatham                       Thamasam 
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SIDDHA SYSTEM OF EXAMINATION 
 
1. ENVAGAI THERVU: [EIGHT-FOLD EXAMINATION] 
I. NAADI: [PULSE PERCEPTION] 
*MAATHIRAI ALAVU:Vatham-1;  Pitham-1/2; Iyyam-3/4 
 
II. NAA:[TONGUE] 
 
 BEFORE TMT AFTER TMT 
Colour normal/Red pale/yellow normal/ Red pale/yellow 
Taste 
Sweet/Sour/ Pungent/ 
Bitter/None 
Sweet/Sour/ Pungent/Bitter/None 
Coating Present/Absent Present/Absent 
Fissure Present/Absent Present/Absent 
Saliva 
Normal/Increased/Decreas
ed 
Normal/Increased/Decreased 
Dryness Present/Absent Present/Absent 
Glossitis Present/Absent Present/Absent 
Baldness Present/Absent Present/Absent 
 
 
III.NIRAM: [COMPLEXION]   
 
BEFORE TMT AFTER TMT
 
Dark/Yellow tinted/Wheatish brown / 
Pale 
Dark/Yellow tinted  / Wheatish 
brown/ Pale 
 
 
 
 
  
  0
th
 day 7
th 
day 14
th 
day 21
th
 day     28
th
 day      35
th
 
day 
45
th
 
day 
 Date        
KAALAM Vatham        
 Pitham        
 Iyyam        
MAATHIRAI Vatham        
 Pitham        
 Iyyam        
NAADI         
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IV.MOZHI: [VOICE] 
 
BEFORE TMT AFTER TMT
 
Medium/High / Low pitched Medium/High/Low pitched 
 
V.VIZHI: [EYES] (Lower palpabrel conjunctiva) 
 
BEFORE TMT AFTER TMT
 
Yellow / Red/ Pale/Normal Yellow/  Red/ Pale/Normal 
 
VI. MALAM; [BOWEL HABITS / STOOLS] 
 
Malam BEFORE TMT AFTER TMT
 
Colour Dark/ Yellow/ 
Pale/Others 
Dark/ Yellow/ 
Pale 
Consistency Solid/Semisolid 
Watery 
Solid/Semisolid 
Watery 
Stool  bulk                          Normal/Reduced 
 
Normal/Reduced 
Constipation   Present/Absent 
 
Present/Absent 
 
Diarrhoea Present/Absent Present/Absent 
 
VII. URINE EXAMINATION: 
 
 
 
NEERKU
RI 
BEFORE TMT AFTER TMT
 
Niram 
[Colour] 
White/Yellowish/Straw 
coloured/Crystal clear 
White/Yellowish/ 
Straw coloured / Crystal 
clear 
Manam 
[Odour] 
Present 
Absent 
Present 
Absent 
Nurai 
[Froth] 
Nil 
Reduced/Increased 
Nil 
Reduced/Increased 
Edai 
[Sp.gra] 
Normal 
Increased/Reduced 
Normal 
Increased/Reduced 
Enjal 
[Deposits] 
Present/ Absent Present/ Absent 
Volume 
Normal 
Increased/Reduced 
Normal 
Increased/Reduced 
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*FS-Fast Spreading;  SS-Slow spreading;  NS-Not spread 
 
VIII. SPARISAM: [PALPATORY  PERCEPTION] 
 
BEFORE TMT AFTER TMT
 
Warmth/Cold/Normal 
Sweat 
Warmth/ Cold/Normal 
Sweat 
 
9. AIYMPORIGAL (SENSORY ORGANS) 
 
 
 
 
 
 
 
 
 
 
 
10.KANMENDRIYAM ( MOTOR ORGANS) 
 
 
NEIKURI 
BEFOR
E TMT 
AFTER TMT
 
Serpentine fashion(FS/SS/NS)   
Annular/Ringed fashion( FS/SS/NS)   
Pearl beaded fashion(FS/SS/NS)   
Mixed fashion(FS/SS/NS)   
Other fashion(FS/SS/NS)   
IYMPORIGAL BEFORE TMT AFTER TMT
 
Mei (Skin)   
Vai (Buccal Cavity)   
Kann (Eye)   
Mooku (Nose)   
Sevi  (Ear)   
KANMENDRIYAM BEFORE TMT AFTER TMT
 
Kai (upper limb)   
Kaal (lower limbs)   
Vai  (buccal cavity)   
Eruvai (excretory organs)   
Karuvai (reproductive organs)   
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11. KOSANGAL (Sheath)   
 
KOSANGAL BEFORE TMT AFTER TMT
 
Annamaya Kosam   
Pranamaya kosam   
Manomaya kosam   
Vignanamaya kosam   
Ananthamaya kosam   
 
 
12. MUKKUTRAM: [AFFECTION OF THREE HUMORS] 
 
A)VATHAM: 
 
VATHAM BEFORE TMT AFTER TMT
 
Praanan   
Abaanan   
Samaanan   
Udhaanan   
Viyaanan   
Naagan   
Koorman   
Kirukaran   
Devathathan   
Dhananjeyan   
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B) PITHAM: 
 
PITHAM BEFORE TMT AFTER TMT
 
Anarpitham   
 Prasakam   
Ranjakam   
Aalosakam   
Saathakam   
 
C) IYYAM: 
 
IYYAM BEFORE TMT AFTER TMT
 
Avalambagam 
  
Kilethagam 
  
Pothagam 
  
Tharpagam  
  
Santhigam 
  
 
13. SEVEN DHATHUS: (7 SOMATIC COMPONENTS) 
 
SEVEN DHATHUS BEFORE TMT AFTER TMT
 
Saaram [Chyme] 
  
Senneer [Blood]  
  
Oon [Muscle] 
  
Kozhuppu [Fat] 
  
Enbu [Bones] 
  
Moolai [Bonemarrow] 
  
Sukkilam/Suronitham [Genital  discharges] 
  
154 
 
 
GENERAL EXAMINATION 
Pallor                          Jaundice                       Cyanosis                 Clubbing       
 
BP_______ mm/Hg     Pulse  _____/mt      Oedema              Breathlessness 
 
CLINICAL SYMPTOMS: 
 
CLINICAL SYMPTOMS 
BEFORE 
TMT 
AFTER 
TMT 
Bright red bleeding occurs during 
defecation(splash in the pan) 
  
Constipation   
Loss of appetite   
Pain in all limbs   
Anaemia   
Headache   
Tiredness   
Giddiness   
    
PROCTOSCOPY: Position of haemorrhoids 
1.3’o clock                    2. 7’o clock                              3. 11’o clock 
 
Date: 
 
Station: 
Signature of the Investigator: 
 
 
 
Signature of the Lecturer:           Signature of the HOD: 
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“KUKKILATHY CHOORANAM” IN  “RATHA MOOLAM” (BLEEDING PILES). 
 
FORM III   LABORATORY PARAMETERS-CHART 
 
1. OP/IP No: ________                          2.S. No:                                   
 
3. Name: ________________                 4. Age:   _______ years      5. Gender: M/F 
BLOOD INVESTIGATION 
0
th
 DAY 
Date: 
45
th
 DAY 
Date 
NORMAL 
VALUES 
HB ( gms%)   M:14-18 ;W:11-15 
T.RBC(milli/cu.mm)   
M:4.5-6.5 ;W:3.5-
5.5 
 
ESR (mm) 
½ hr.    
1 hr.   M:0-10 ;W:0-20 
T.WBC (cu.mm) 
 
 
DIFFERENTIAL 
COUNT (%) 
   4000-11,000 
Polymorphs   40-75 
Lymphocytes   20-35 
Monocytes   2-10 
Eosinophils   1-6 
 Basophils   0-1 
BT (per min)   2-6 
Clotting time   3-8 
Blood 
glucose 
(mg/dl) 
Fasting   80-120 
PP   <130 
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Random   <140 
Lipid 
profile 
(mg/dl) 
Serum cholesterol   150-250 
HDL   30-60 
LDL   Upto 130 
VLDL   40 
TGL   Upto 160 
RFT 
(mg/dl) 
Blood urea   16-50 
Serum creatinine   0.6-1.2 
Serum Uric acid   M:3-9 ;W: 2.5-7.5 
LFT 
(mg/dl) 
Total bilirubin   0.3-1 
Direct bilirubin   0.1-0.3 
Indirect bilirubin   0.2-0.8 
Serum calcium   9-11 
 SGOT (IU/L)   6-18 
 SGPT (IU/L)   3-26 
 
Alkaline phosphatase 
(kingÅ units) 
  3-12 
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DATE: 
STATION: 
SIGNATURE OF THE INVESTIGATOR 
 
 
 
 
SIGNATURE OF LECTURER                                                  SIGNATURE OF THE HOD 
 
 
 
URINE 
INVESTIGATION 
Before TMT 
Date: 
After TMT 
Date: 
            Albumin   
Neerkkuri   
Niram   
Manam   
Nurai   
Edai   
Enjal   
Neikkuri   
Fasting sugar   
PP sugar   
Random Sugar   
Deposits   
Bile salts    
Bile Pigments   
MALAM   
Ova   
Cyst   
Occult blood   
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CHOORANAM” IN  “RATHA MOOLAM” (BLEEDING PILES). 
 
FORM IV  (DRUG COMPLIANCE FORM) 
 
S. NO: ---------   OPD/IPD NO : ---------------  NAME :-----------------------         
 
Name Of The Drug :, KUKKILATHY CHOORANAM 4g,twice a day with Ghee 
 
On 0
th
 day–Date              ;Drug issued:  (Nos)   /   Drug returned:  (Nos) 
On 7th day-Date:                ;Drug issued: (Nos)   /   Drug returned:    (Nos) 
On 14th day -Date:             ;Drug issued: (Nos)   /   Drug returned:    (Nos) 
On 21
th
 day-Date:               ;Drug issued:  (Nos)   /   Drug returned:    (Nos) 
On 28
th
 day-Date:               ;Drug issued:  (Nos)   /   Drug returned:    (Nos) 
On 35
th
 day-Date:               ;Drug issued:  (Nos)   /   Drug returned:    (Nos) 
On 45
th
 day-Date:               ;Drug issued:  (Nos)   /   Drug returned:    (Nos) 
 
Day  Date Morning (7-8 am) Evening (7-8 pm) 
Day 1    
Day2    
Day3    
Day4    
Day5    
Day6    
Day7    
Day8    
Day9    
Day10    
Day11    
Day12    
Day13    
Day14    
Day15    
Day16    
Day17    
159 
 
Day18    
Day19    
Day20    
Day 21    
Day22    
Day23    
Day24    
Day 25    
Day 26    
Day27    
Day 28    
Day29     
Day30    
Day31    
Day32    
Day33    
Day34    
Day35    
Day36    
Day37    
Day38    
Day39    
Day40    
Day41    
Day42    
Day43    
Day44    
Day45    
 
Date:                                      
Station: 
Signature of the Investigator: 
 
 
 
Signature of the Lecturer:       Signature of the HOD  
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§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ ¦ºý¨É 47 
«§Â¡ò¾¢¾¡º÷ ÀñÊ¾÷ ÁÕòÐÅÁ¨É 
þÃò¾ãÄõ §¿¡öì¸¡É º¢ò¾ ÁÕóÐ "Ìì¸¢Ä¡¾¢ ÝÃ½õ” 
ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø ÀÊÅõ. 
 
¾¸ÅøÀÊÅõ 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ¦ÀÂ÷ : ÁÕ.«.³ŠÅ÷Â¡ 
 
¿¢ÚÅÉò¾¢ý¦ÀÂ÷   :  §¾º¢Âº¢ò¾ÁÕòÐÅ¿¢ÚÅÉõ 
      ¾¡õÀÃõº¡É¼§¼¡Ã¢Âõ 
  ¦ºý¨É- 47 
ÁÕ.«.³ŠÅ÷Â¡ ¬¸¢Â ¿¡ý §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø Àð¼§ÁüÀÊôÒ 
ÀÂ¢ýÚÅÕ¸¢§Èý. ,Ãò¾ãÄõ ±Ýàð ¦¾¡ப்புளில் வலிகதிர்§À¡ல இÃத்தõ பீறிட்டு 
ஊற்றுõ மேனிவற்றி வவளுப்பு உண்டாகுõ கககால்கள் அச¾¢ §º¡¨Àயுண்டாகுõ. 
தகல §¿¡Ôண்டாகுõ. ேயக்கõ ¬¸¢Â ÌÈ¢Ì½í¸û¸¡Ïõ. þó§¿¡öìÌ §¾º¢Â 
º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø ÀÄ º¢ò¾ÁÕóÐ¸û ÀÂýÀÎò¾ôÀðÎ ÅÕ¸¢ýÈÐ. 
º¢ò¾Àð¼§ÁüÀÊôÀ¢ø ¬öÅ¢ý ´Õ ÀÌ¾¢Â¡¸ Ò¾¢Â ÁÕóÐ¸¨Ç ÀÂýÀÎòÐõ 
§¿¡ì¸¢ø "குக்க¢லாத¢ ÝÃ½õ” (¯û ÁÕóÐ) ÀÃ¢óÐ¨Ã ¦ºö¸¢§È¡õ. þó¾ 
ÁÕó¾¢ý ¦ºöÓ¨È, «Ç×, «ÛÀ¡Éõ ÁüÚõ ÁÕòÐÅ ÀÂý¸û «¨ÉòÐõ 
«í¸£¸Ã¢ì¸ôÀð¼ º¢ò¾ ÁÕòÐÅ áÄ¢ø ÜÈôÀðÎûÇÐ. ±ó¾Å¢¾ ¸ð¼½ÓÁ¢ýÈ¢ 
¾¡í¸û þó¾ ÁÕó¾¢¨É ¦ÀüÚì¦¸¡ûÇÄ¡õ. þó¾ ¬öÅ¢ø ÁÕóÐ 
¯ð¦¸¡ûÙõ ¸¡Äõ 45 ¿¡ð¸û ¬Ìõ. þõÓ¨ÈôÀÊ  ¦ÅÇ¢ §¿¡Â¡Ç÷¸û 7 
¿¡ð¸ÙìÌ ´Õ Ó¨È ÁÕòÐÅÁ¨ÉìÌ ÅÃ§ÅñÎõ. 45 ¿¡ð¸û ÁÕóÐ 
¯ð¦¸¡ûÙõ ¸¡Äõ ÓÊó¾ À¢ÈÌ §¿¡öì¸¡É ÌÈ¢Ì½í¸û ÁüÚõ ¬öÅ¸ 
ÀÃ¢§º¡¾¨É¸û þÅüÈ¢ý ÓÊ×¸Ç¢ý «ÊôÀ¨¼Â¢ø ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò¾¢Èý 
¸ñ¼È¢ÂôÀÎõ. 
 
þó¾ ¬ö× ºõÀó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Ç ¾í¸Ç¢¼õ §¸ð¸ þÕì¸¢§Èý. 
¾í¸Ç¢¼Á¢ÕóÐ ¦ÀÈôÀÎõ ¸ÕòÐì¸û ÁüÚõ ÌÈ¢ôÒ¸û «¨ÉòÐõ 
¿õÀ¢ì¨¸Â¡¸ À¾¢× ¦ºöÂôÀÎõ.þó¾ ¬öÅ¢ø ¾í¸¨Ç ¯ðÀÎò¾¢ì¦¸¡ûÅ¾¢ý 
ãÄõ ±ó¾ Å¨¸Â¢Öõ À¡¾¢ôÒìÌûÇ¡¸ Á¡ðË÷¸û ±É ¯Ú¾¢ «Ç¢ì¸¢§Èý. 
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±ó¾Å¢¾ ÅüÒÚò¾ÖÁ¢ýÈ¢, þó¾ ¬öÅ¢ø Àí§¸ü¸×õ, þó¾ ¬ö× 
ºõÀó¾Á¡¸ §¸ð¸ôÀÎõ §¸ûÅ¢¸ÙìÌ À¾¢ø ÜÈ×õ ¾í¸ÙìÌ ÓØ Í¾ó¾¢Ãõ 
«Ç¢ì¸ôÀÎ¸¢ÈÐ. þó¾ ¬öÅ¢ø Àí§¸üÀ¾üÌ ±ó¾ ºýÁ¡ÉÓõ 
ÅÆí¸ôÀ¼Á¡ð¼¡Ð. ¬É¡ø, ¬ö× ÓØÅÐõ ±ÉÐ §ÁüÀ¡÷¨ÅÂ¢Öõ, ¾í¸û 
¯¼ø¿Äý ÌÈ¢ò¾ ¾É¢ ¸ÅÉò¾¢Öõ ¬ö× §Áü¦¸¡ûÇôÀÎõ. þÃò¾ ãÄõ 
§¿¡öì¸¡É Ò¾¢Â ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò¾¢È¨É ºã¸ò¾¢üÌ ¯½÷òÐõ Å¨¸Â¢ø 
þó¾ ¬ö× §Áü¦¸¡ûÇôÀÎ¸¢ÈÐ, þó¾ ¬öÅ¢ø, ÁÕóÐ ¯ð¦¸¡ûÙõ 
¸¡Äò¾¢ø Á¡ÚÀð¼ ÌÈ¢Ì½í¸û ¦¾¡¼÷óÐ þÕìÌõ Àðºò¾¢ø, Ó¾ý¨Á 
¬Ã¡öîº¢Â¡ÇÃ¡É ±ýÉ¢¼õ ¦¾Ã¢Å¢ì¸ôÀðÎ, §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø 
«¾üì¸¡É ¾£÷× ÅÆí¸ôÀÎõ. þó¾ ¬öÅ¢¨Éò ¦¾¡¼Ã ¾í¸ÙìÌ Å¢ÕôÀõ 
þø¨Ä¦ÂÉ¢ø, ±ô¦À¡ØÐ §ÅñÎÁ¡ÉÖõ ¬öÅ¢ý þ¨¼Â¢ø 
Å¢Ä¸¢ì¦¸¡ûÇ×õ, ÁÕòÐÅÁ¨ÉÂ¢ø ÅÆí¸ôÀÎõ þó§¿¡öì¸¡É ÅÆì¸Á¡É 
ÁÕóÐ¸¨Ç ¦ÀüÚì¦¸¡ûÇ×õ «È¢×Úò¾ôÀÎ¸¢È£÷¸û. 
 
þó¾ ¬öÅ¢ø §º¸Ã¢ì¸ôÀÎõ Å¢ÀÃí¸û «¨ÉòÐõ ¾í¸ÙìÌõ Ó¾ý¨Á 
¬Ã¡öîº¢Â¡ÇÃ¡É ±ÉìÌõ þ¨¼Â¢ø þÃ¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ. §¸ûÅ¢ À¾¢ø 
ÅÊÅò¾¢ø ¾í¸Ç¢¼õ §¸ûÅ¢¸û §¸ð¸ôÀÎõ. அகைத்து ÀÊÅí¸Ç¢Öõ ¾í¸Ç¢ý 
¦ÀÂ÷ ¾Å¢÷ì¸ôÀðÎ ¬öÅ¡ÇÃ¡ø ¾í¸Ùì¦¸É ¾É¢ì ÌÈ¢Â£Î ÅÆí¸ôÀÎõ. 
«ó¾ì ÌÈ¢Â£Î ¬öÅ¡ÇÕìÌ ÁðÎ§Á ¦¾Ã¢ó¾¾¡¸ þÕìÌõ. ¿£í¸û þó¾ 
¬öÅ¢ø Àí§¸ü¸ Å¢ÕôÀôÀð¼¡ø, ¾¢ð¼ Å¨Ã× ¾¸Åø ÀÊ §¾÷× 
¦ºöÂôÀÎÅ£÷¸û.    
 
¿£í¸û þó¾ ¬öÅ¢ø Àí§¸üÌõ Óý, þó¾ ¬öÅ¢¨Éô ÀüÈ¢Â §ÁÖõ 
Å¢ÀÃí¸û ¦ÀÈ §ÅñÎ¦ÁÉ Å¢ÕôÀôÀð¼¡ø, þó¾ ¬öÅ¢ý Ó¾ý¨Á 
¬Ã¡öîº¢Â¡Ç÷ ÁüÚõ §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨É, Àð¼ §ÁüÀÊôÒòÐ¨È 
ÁÕ.«.³ŠÅ÷Â¡¬¸¢Â ±ý¨É 8526460100 ±ýÈ ±ñ½¢ø ¦¾¡¼÷Ò ¦¸¡ûÇÄ¡õ. 
§ÁÖõ, ¿£í¸û þó¾ ¬öÅ¢ø, ¯í¸ÇÐ Àí§¸üÒ ÁüÚõ ¯Ã¢¨Á ÀüÈ¢ ¦¾Ã¢óÐ 
¦¸¡ûÇ §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨É, ¾¨ÄÅ÷/¦ºÂüìÌØ ¯ÚôÀ¢É÷ 
«Å÷¸¨ÇÔõ 91-44-22411611 ±ýÈ ±ñ½¢ø ¦¾¡¼÷Ò ¦¸¡ûÇÄ¡õ.   
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AYOTHIDASAR PANDITHAR HOSPITAL 
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A clinical study on Siddha Herbal formulation “KUKKILATHY 
CHOORANAM” in  “RATHA MOOLAM” (bleeding piles)” 
FORM V – INFORMATION SHEET 
 
Name of the Principal Investigator  : Dr.A.Aishwarya 
Name of the Institution                 : National Institute of Siddha, Tambaram  
Sanatorium, Chennai-47. 
 
 I, Dr.A.Aishwarya  Studying M.D(S) in National Institute of Siddha, Chennai. 
The disease called “RATHA MOOLAM” (BLEEDING PILES), symptoms  like 
as pain around the umbilicus, splashing of blood during defecation, weakness in 
the limbs, giddiness
1
 can be correlated with Internal Haemorrhoids mentioned in 
Modern science.
 
 .. This condition is being treated is NIS with many siddha formulations. As a part 
of M.D(S) research programme and developing new efficacious medicine, we 
propose to study the “KUKKILATHY CHOORANAM” (Internal)  formulation 
for treating the condition. This formulation has been mentioned in siddha 
literature and empirical evidence with contemporary tools is required for 
documentation. You can receive medicines free of cost “KUKKILATHY 
CHOORANAM”(Internal) ( 4 gm bd ) twice for 7 days in a duration of 45 days 
The diagnosis tests will be carried out free of cost. We will assess the effect of 
treatment after completion of 45 days of treatment using clinical and lab 
parameters. 
 In this regard, we need to ask you few questions. We will maintain confidentiality 
of your comments and data obtained from you. There will be no risk of disclosing 
your identity and no physical, psychological or professional risk is involved by 
taking part in this study. 
 Taking part in this study is voluntary. No compensation will be paid to you for 
taking part in this study. You can choose not to answer any specific question. 
There is no specific benefit for you if you take part in the study, but you will be 
under our clinical monitoring and specific attention will be given for your health. 
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Taking part in the study may be of benefit to the community, as it may help us to 
develop medicine for “RATHA MOOLAM” (BLEEDING PILES), In case of 
any adverse symptoms which is expected for few patients during the treatment, 
shall be reported to PIs and care will be taken in NIS for relief. You can withdraw 
from the study at the midst of treatment period, if you are not interested to 
continue and you will receive our usual treatment without condition. 
 The information we will collect in this study, will remain between you and the 
principal investigator. We will ask you a few questions through questionnaire. 
We will not write your name on different forms which sent to other investigation 
forms investigating/analysis sections and we will use a code instead given by the 
principal investigator. Only the principal investigator will know the key to this 
code which will be kept in safe custody. If you agree to be a participant in this 
study, you will be screened as per the study protocol.  
 If you wish to find out more about this study before taking part, you can ask me 
all the questions you want or contact Dr.A.Aishwarya Studying M.D(S) scholar 
cum principal investigator of this study, attached to the National Institute of 
Siddha, Chennai (Mobile phone no:8526460100). You can also contact the 
Chairman/Member-secretary of Ethics committee, National Institute of Siddha, 
Chennai – 600047, Tel no: 91-44-22411611, for rights and participation in the 
study. 
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தேசி஬ சித்ே ஫ருத்துவ நிறுவனம், சசன்னன-47 
அத஬ோத்ேிேோசர் பண்டிேர் ஫ருத்துவ஫னன 
þÃò¾ ãÄõ §¿¡öì¸¡É º¢ò¾ ÁÕóÐ "குக்க¢லாத¢ ÝÃ½õ” 
ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ  ¬öÅ¢ü¸¡É ஒப்புேல் படிவம். 
 
FORM VI  
 ஒப்புேல் படிவம் 
 
நோன்  த஫ற்கூமி஬  ேகவல்  படிவத்னே  படித்து  அல்யது  படிக்க  தகட்டுக் 
சகோண்தேன். இது சேோேர்போன விரக்கங்கனரயும் தகட்டு சேரிந்து  
சகோண்தேன். எந்ேவிே வற்புறுத்ேயின்மி என் சசோந்ே விருப்பத்ேின் தபரில் 
என்னன இந்ே ஆ஭ோய்ச்சிக்கு உட்படுத்ே  என்  முழு஫னதேோடும்  
சு஬நினனதவோடும் சம்஫ேம் சேரிவிக்கின்தமன் . எனக்கு விருப்பம்  
இல்யோே பட்சத்ேில்  இந்ே  ஆ஭ோய்ச்சி஬ில்  இருந்து என்னன எப்தபோது 
தவண்டு஫ோனோலும் விடுவித்து சகோள்ளும் உரின஫ன஬ சபற்றுள்தரன் 
என்பனேயும் அமிதவன். 
இந்த ஆய்வின் ப ோது எடுக்கப் டும் புகக டங்கள் மருத்துவ  அறிவியலின் 
முன்பேற்றத்திற்கோக மட்டும் யன் டுத்தப் டும். 
 
 
தேேி  :      
 
இேம்  : 
 
 
 
னகச஬ோப்பம்      சோட்சிக்கோ஭ர் 
னகச஬ோப்பம் 
 
 
சப஬ர்       சப஬ர் 
 
       உமவுமுனம: 
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FORM – VICERTIFICATE OF CONSENT 
 
“I have read the foregoing information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions I have asked have been answered 
to my satisfaction.  
            I   consent voluntarily to participate as a participant in this study and understand 
that I have the   right to withdraw from the study at any time without in any way it 
affecting my further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date:  
 
Signature of the participant 
 
In case of illiterate participant, 
“I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm that the 
individual has given consent freely.”                                                   
The photographs taken in the study will be displayed only in scientific conference 
for the advancement of medical knowledge. 
 
Date: 
 
 
 Signature of a witness  
       Left thumb Impression of the Participant  
  
(Selected by the participant bearing no connection with the survey team) 
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FORM VII- WITHDRAWAL FORM/ADVERSE DRUG 
REACTION/PHARMACOVIGILANCE FORM 
 
Reg No: 
Serial No:      OP/IP No: 
Name:       Age:                                          Gender:  M/F 
DATE OF TRIAL COMMENCEMENT:  
 
DATE OF WITHDRAWAL FROM TRIAL:  
 
REASONS FOR WITHDRAWAL: 
 
 Long absence at reporting :                 Yes/ No 
 Irregular treatment:                           Yes/ No 
 Shift of locality :                                    Yes/No 
 Increase in severity of symptoms:   Yes/No 
 Development of severe adverse drug reactions:  Yes/No 
 
NATIONAL PHARMACOVIGILANCE PROGRAMME 
FOR SIDDHA DRUGS 
 
Date of trial commencement: 
 Please note:  i. All consumers / patients and reporters 
information will remain confidential. 
         ii. It is requested to report all suspected reactions to the concerned, even if  
             it does not have complete data, as soon as possible. 
PeripheralCenter code:     State:  
 
1. Patient / consumer identification (please complete or tick boxes below as 
appropriate) 
 
Name  Father name 
 
Patient / Record No. 
Ethnicity  Occupation 
Address  
Village / Town 
Date of Birth / Age: 
 
Reporting Form for Suspected Adverse Reactions to Siddha Drugs 
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Post / Via 
District / State    
Sex:     Male / 
Female  
Weight : 
Degam: 
 
2. Description of the suspected Adverse Reactions (please complete boxes 
below) 
 
Date and time  of 
initial observation 
 Season: 
Description of 
reaction   
 
 Geographical area: 
 
3. List of all medicines / Formulations including drugs of other systems used by 
the patient during the reporting period: 
 
Medicine Daily 
dose 
Route of 
administration 
& Vehicle - 
Adjuvant 
Date  Diagnosis for 
which medicine 
taken  
Starting Stopped 
Siddha 
 
 
 
 
     
Any other system 
of medicines 
 
 
     
 
 
4. Brief details of the Siddha Medicine which seems to be toxic : 
 
Details Drug – 1 Drug – 2 Drug – 3 
a) Name of the medicine    
b) Manufacturing unit and 
batch No. and date 
   
c) Expiry date    
d) Purchased and obtained 
from 
   
e) Composition of the 
formulation / Part of the drug 
used 
   
 
 
b) Dietary Restrictions if any 
c) Whether the drug is consumed under Institutionally qualified medical supervision or 
used as self medication.  
d) Any other relevant information. 
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5. Treatment provided for adverse reaction: 
 
6. The result of the adverse reaction / side effect / untoward effects (please 
complete the boxes below) 
 
Recovered:           Not 
recovered: 
 Unknown: Fatal: If Fatal 
Date of death: 
Severe:   Yes   /   No. Reaction abated after drug stopped or dose reduced: 
 
Reaction reappeared after re introduction: 
 
 
Was the patient admitted to hospital? If 
yes, give name and address of hospital 
 
 
7. Any laboratory investigations done to evaluate other possibilities?  If Yes 
specify:  
 
8. Whether the patient is suffering with any chronic disorders? 
Hepatic    Renal    Cardiac    Diabetes    Malnutrition  
 
Any Others  
 
9. H/O previous allergies / Drug reactions:  
 
10. Other illness (please describe): 
 
11. Identification of the reporter: 
 
Type (please tick):  Nurse / Doctor / Pharmacist / Health worker / Patient / Attendant / 
Manufacturer /                                                                      
                                Distributor / Supplier / Any others (please specify) 
Name: 
 
Address: 
 
Telephone / E – mail if any : 
 
 
Signature of the reporter:       Date: 
Please send the completed form to:  
    The Director 
            National Institute of Siddha, 
(Pharmacovigilance Regional Centre For Siddha Medicine), 
                                                           Tambaram Sanatorium, Chennai-600 047. 
 (O) 044-22381314  Fax : 044 – 22381314 
Website : www.nischennai.org 
        Email: nischennaisiddha@yahoo.co.in 
 
 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ** * * * *  
This filled-in ADR report may be sent within one month of observation 
/occurrence of ADR   
 
 
 
Date:                                                                              
Name & address of the RRC-
ASU/ PPC-ASU 
Who Can Report?     
 Any Health care professionals like Siddha Doctors /  Nurses / Siddha 
Pharmacists / Patients etc.  
What to Report?  
 All reactions,  Drug interactions,  
Confidentiality  
 The patient’s identity will be held in strict confidence and protected to the 
fullest extent.  
 Submission of report will be taken up for remedial measures only not for 
legal claim  
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FORM VIII-  DIETARY ADVICE FORM 
 
A CLINICAL STUDY  ON SIDDHA HERBAL FORMULATION “KUKKILATHY 
CHOORANAM” IN  “RATHA MOOLAM” (BLEEDING PILES). 
 
IEC NO: NIS/IEC 
 
DIET ADVICE: 
 
Do’s 
 Drink 3 to 4 litres of Water, a day. 
 Take more amount of  Tender coconut 
 Vegetables : Cow’s butter milk, Cow’s ghee,  Fresh vegetables,  Fiber 
content vegetables. 
 Fruits: Water melon, Cucumber. 
 Advice to do pranayamam, Yoga ,for mental stress.  
 Aria keerai, Thuthi keerai, Siru keerai 
 Asafetida 
 Castor oil 
 
Dont’s 
 
  Cauliflower, Coffee, Tea, Chocolate, Meat, Fish, Bitter ground, Brinjal, 
Tubers, Egg, Oil foods, Maize, Caustic soda, Tamarind, Tobacco, Liquor 
 Preserved beverages, Foods rich in salts,  Spicy and fried foods 
 Prolonged sitting ,Excessive sexual inter course. 
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Njrpa rpj;j kUj;Jt epWtdk;> nrd;id – 47 
mNahj;jpjhru; gz;bju; kUj;Jtkid 
nghJkUj;Jtj; Jiw 
 
þÃò¾ ãÄõ §¿¡öì¸¡É º¢ò¾ ÁÕóÐ "குக்க¢லாத¢ ÝÃ½õ” 
ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ  ¬öÅ¢ü¸¡É  
gbtk; VIII - czT gupe;Jiu gbtk; 
IEC NO: NIS/IEC 
Nru;f;fNtz;bait: 
 ehs; xd;Wf;F 2 Kjy; 3 ypl;lu; tiu jz;zPu; mUe;j Ntz;Lk;. 
 ,sePu; Nru;f;f Ntz;Lk;. 
 
fha;fs;: 
mtiu> ntz;il> fhWf;fUiz> fhwhf; fUiz> Nridf; fpoq;F> 
mj;jpf; fha;> Mfpait Nru;f;f Ntz;Lk;. 
fPiufs;: 
 rpWfPiu> jhspf;fPiu> griyf;fPiu> Rf;fhd; fPiu> Jj;jpf; fPiu> nte;jaf; 
fPiu Mfpait Nru;f;f Ntz;Lk;. 
 fhu; muprp> rt;tuprp> kzf;fj;ij> FWit Mpfait Nru;f;f Ntz;Lk;. 
1. jpahdk; kw;Wk; Nahfk; nra;a Ntz;Lk; 
2. cl;fhUk;Nghnjy;yhk; fPo;tha; cWj;jhjpUf;fg; gQ;R nkj;ijapy; 
mku;e;jpUg;gJ ed;ik. 
mirt czTfs;: 
 kPd; tiffsp;y tpyhq;F kPd; ed;W. 
 ej;ij cz;gJ ed;W. 
 
jtpu;f;f Ntz;bait: 
 fpoq;F tiffs; 
 fhuk; 
 Kl;ilf;Nfh]; 
 fhspgpstu; 
 fhgp/B 
 rhf;Nyl; 
 khkprk; 
 Kl;il 
 ];l;uhngu;up 
 rikay; Nrhlh 
 kpFGsp 
 Gifapiy 
 gjg;gLj;jg;gl;l Fspu; ghdq;fs; 
 cg;G epiwe;j czT kw;Wk; ePu; 
 nghupf;fg;gl;l kw;Wk; krhyh Nru;e;j czT tiffs;. 
  
171 
 
HEALTH  ASSESSMENT  QUESTIONNAIRE  FOR HEMORRHOIDS  
(HAQ – H) 
NATIONAL INSTITUTE OF SIDDHA -  CHENNAI 
 
1. DO YOU DEFAECATE                                 WITHOUT ANY DIFFICULTY (1) 
                     WITH SOME DIFFICULTY  (2) 
                                                                             WITH MUCH DIFFICULTY  (3) 
     WITH TOO MUCH DIFFICULTY     
     POSTPONE   DEFECATION ITSELF.      
     (4)                    
2. TIME TAKEN FOR DEFAECATION:          1 - 5  MINUTES                             (1) 
           6 – 10 MINUTES                            (2) 
                                                                             11– 15 MINUTES                           (3) 
                                                                             MORE THAN 15 MINUTES         (4) 
 
3. HOW DO YOU FEEL AFTER                 FREE (COMPLETELY EVACUATED) (1) 
DEFAECATION                MILD DISCOMFORT  (THAT IT  
                         DISAPPEARS QUICKLY)   (2) 
                             MODERATE DISCOMFORT (IT   
                             LASTS FOR SOME TIME)  (3) 
MORE DISCOMFORT, TRY TO         
 DEFAECATE AGAIN  (4) 
.4. FREQUENCY OF PASSING                    ONCE DAILY/TWICE DAILY          (1)   
STOOLS                                                          TWO DAYS ONCE                             (2) 
                                                                 THREE DAYS ONCE                          (3) 
                   FOUR DAYS ONCE                           (4) 
  
172 
 
5. DO YOU PASS BLOOD DURING  
      DEFAECATION.                              NO                                   (1) 
                     FEW DROPS                   (2) 
                                                                            MORE DROPS                (3) 
                                                                            SEVERE BLEEDING     (4) 
6. DO YOU FEEL PAIN  
    DURING DEFAECATION                             NO  (1) 
      MILD PAIN (HOWEVER I  
       DEFAECATE)              (2) 
       SEVERE PAIN (HOWEVER I     
       DEFAECATE)         (3) 
                                                                              EXCRUCIATING PAIN  
                                                                               (I POSTPONE DEFAECATION) (4) 
7. DO YOU FEEL PAIN                                      NO                                           (1) 
    AFTER DEFAECATION                                 5 – 10 MINUTES                    (2) 
                                                                               11 – 15 MINUTES                 (3) 
                                                                               MORE THAN 15 MINUTES (4) 
8. DO YOU FEEL PAIN/ DISCOMFORT             NO                             (1) 
     WHILE DOING LONG TIME SITTING,         SOMETIMES           (2) 
     RIDING, ETC                                                     OFTEN                      (3) 
                                                                                 ALWAYS                  (4) 
9. DO YOU THINK OF THIS PROBLEM            NO                           (1) 
      WHILE AT WORK                                          SOMETIMES           (2) 
                                                                                OFTEN              (3) 
                                                                                    ALWAYS       (4) 
10. DO YOU WHEEL EMBRASSED WHILE        NO                                (1) 
    MOVING OUT WITH OTHERS                          SOMETIMES               (2) 
                                                                                    OFTEN                         (3) 
                                                                                    I AVOID OUTING       (4) 
 
BEFORE TREATMENT TOTAL MARKS 
 
AFTER TREATMENT TOTAL MARKS  
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WEEKLY ASSESSMENTS 
Date of Initiation _______Date of Trial Cessation__________ 
Haemorrhoids Symptom  Severity  Score* 
 
 
*Haemorrhoids grading and Symptoms Severity Scoring Published by Karolinska 
University Hospital Huddinge Stockholm 
 
Answers       
→  
1
ST
 WEEK 
    
Never 
Less 
than   
once/we
ek 
     1–6 
times/We
ek 
Everyda
y 
/Always 
2
ND
 
WEEK  
3
RD
 
WEEK 
4
TH
 
WEEK 
5
TH
 
WEEK  
6
TH
 
WEEK  
7
TH
 
WEEK  
Questions        
↓ 
          
Frequency 
of Pain in 
the anal 
region 
 
 [ 0 ] 
 
[ 1 ] 
 
[ 2 ] 
 
[ 3 ] 
      
Frequency 
of Itching or 
discomfort 
in the anal 
region 
 
[ 0 ] 
 
[ 1 ] 
 
[ 2 ] 
 
[ 3 ] 
      
Frequency 
of bleeding 
at stools 
 
[ 0 ] 
 
[ 1 ] 
 
[ 2 ] 
 
[ 3 ] 
      
Frequency 
of soiling of 
underclothes 
 
[ 0 ] 
 
[ 1 ] 
 
[ 2 ] 
 
[ 3 ] 
      
Frequency 
of prolapsed  
pile mass 
 
[ 0 ] 
 
[ 1 ] 
 
[ 2 ] 
 
[ 3 ] 
      
Adding 
answer 
scores 
 
_____  +    ________  +     _________     +     
____ 
      
HSS Score /15       










ISSN: 2322 - 0902 (P) 
ISSN: 2322 - 0910 (O) 
     IJAPR | March 2018 | Vol 6 | Issue 3  37 
International Journal of Ayurveda  
and Pharma Research 
 
Review Article 
 
A SCIENTIFIC REVIEW OF MOOLAM (ANO RECTAL DISEASES)-YUGI’S VERSION  
A.Aishwarya1*, T.Lakshmi Kantham2, K.Manikavasakam3, V.Banumathi4 
*1PG Scholar, 2 Lecturer, 3Head of the Department, Department of Maruthuvam, National Institute of Siddha, 
Tambaram Sanatoruim, Chennai, Tamil Nadu 
4Director, National Institute of Siddha, Tambaram Sanatoruim, Chennai, Tamil Nadu 
ABSTRACT 
Worldwide, the overall prevalence of an ano rectal disease in the general population is estimated 
to be 4.4%. The faulty dietary pattern and life style , hereditary factors are important etiological 
factors of this disease. As per saint Yugi  Moolam is classified as 21 types based on clinical 
symptoms and size, shape, colour of the pile mass which includes some of the ano-rectal diseases. 
The diet and deeds which influences the vital humors Vatham  (Intestinal peristaltic movement) 
and Pitham (metabolism and absorption) of food stuffs are said to be major causative factors of 
this disease. As per Yugi’s version the following ano rectal diseases under Moola noi have been 
categorized as, Neer moolam (Inflammatory bowel disease), Aazhi moolam (strangulated 
haemorrhoids), Sittru moolam (adenomatous colorectal polyps), Varal moolam (colorectal non- 
neoplastic polyps), Seezh moolam (kaposis sarcoma), Silaethuma moolam (anal warts condyloma), 
Thondha moolam (rectal cancer), Vinai moolam (irritable bowel syndrome), Powthira moolam 
(anal fistula), Kutha moolam (rectal prolapse), Ratha moolam (internal haemorrhoids 1st degree -
bleeding piles), Mega moolam (gonococcal proctitis), Vaatha moolam (interno-external 
hemorrhoids), Pitha moolam (prolapsed haemorrhoids), Surukku moolam (anal stenosis), Mulai 
moolam (sentinel pile), Savvu moolam (perianal tuberclosis). This paper focuses the scientific 
basis of etiology and classification of Moolam by saint Yugi. 
KEYWORDS: Ano rectal disease, Haemorrhoids, Moolam, Siddha, Yugi. 
INTRODUCTION
 Siddha system is well founded under the 
basic principles of nature and its elements. 
prevention and treatment are the basic aim of the 
Siddha system  of medicine. Siddha insists to lead a 
healthy life both physically and mentally. They 
classified the disease on the basis of Thiridhosa 
theory. Saint Agasthiyar identified 4448 diseases and 
one among them is Eruvai Mulainoi. Saint Yugi 
classified Moolanoi into 21 types. Moolam in Siddha 
means the area Moolathram or root. Moolatharam 
has been given maximum important in Siddha system 
as it is energy producing centre of the body 
(Kundalini). If the early stage is not being taken care 
of it may lead to complications and need to be 
corrected with surgery. “Anilapithathondhamalathu- 
moolamvaraathu” (Anilam-vaatham, Pitha-pitham)- 
As per saint Theraiyar derangement of Vatham and 
Pitha humor due to lifestyle changes diet and deeds 
resulting Moolam.  
 
 
 
 
The main Vatha humor and Pitha humor get affected 
cause in Moolanoi (Haemorrhoids). In Moolanoi, 
increased Keelvaikanal stimulates Vatha humor these 
totally stimulate Pithahumor, constipation develops 
due to effects of Keevaikanal. So the symptoms like 
loss of appetite, emaciation, mental depression, 
decreased body fluids and blood volume are 
developed. 
METHODOLOGY 
     The literature cited here principally extracted from 
the Yugivaithyasidhamani. For the understanding and 
validation of the correlated information reputed 
journals and databases were referred. After the 
methodological collection of the above information 
data were correlated with the current scenario and 
conclusions were arrived. Then a comprehensive 
review was made. 
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OBSERVATION   
ETIOLOGY-According to Yugivathiya chindhamai1  
Thathaiyang mathiga maang kuliri naalum 
Thariyatha thavazhchiyaar kirandhi yaalum 
Puthayaam porunthaa ushnathaalum 
Punarchi yaayi kobathaar salippinaau 
Kaththayaam vegukaamam vendalaalum 
Kadinamam mupplaum kaarathaalum 
Mothayaam veguthanagal ponathalum 
Moolam vanthu munaiyum thaanay. 
The  poem  describes the etiology of Moolam, these are 
1. Exposure to excessive heat and excessive cold 
2. Anger and frustration 
3. Anxiety and depression increased sexual desire 
4. Heavy intake of salt and pungent food 
These are all Vitiates Abanavayu (Vatha humor) 
Sanippana mooaththin peyaray thennil 
Samarasamam neermoolang sendu mooam 
Munipana mulaimoolang sittru moolam 
Moorkkamamvaralmoolamrathamoolam 
Thinipana seemoola maazhi moolam 
Thiniyana thamaraga mamoolath thodu 
Vanipana vathamodu pithamoolam 
Vagaiyaana setumathin moola mae. 
Vagaiyagundh thondhamaa moolathodu 
Valarkindra vinaimoolam mega moolam 
Pagaiyaagum powthira mamoolamodu kuthaya moolam 
Pugaiyaagum puramoolang surukku moolam 
Porugundra savvagu moolathodu 
Thugaiyaagu moolandhaani rubath thondrum 
Sootchamaa yithinudaiya surubang kaelay. 
Above poem as per saint Yugi moolam is classified as 21 types based on clinical symptoms and pile mass size, 
shape colour which includes some of the ano-rectal diseases. They are  
1. Neer moolam 
2. Sendu moolam 
3. Mulai moolam 
4. Sittru moolam 
5. Varal moolam 
6. Seezh moolam 
7. Ratha moolam 
8. Aazhi moolam 
9. Thamaraga moolam 
10. Vatha moolam 
11. Pitha moolam 
12. Kaba moolam 
13. Thondha moolam 
14. Vinai moolam 
15. Mega moolam 
16. Powthira moolam 
17. Kiraandhi moolam 
18. Kudha moolam 
19. Pura moolam 
20. Surukku moolam 
21. Savvu moolam 
Interpretation 
1.Neer Moolam    (Figure 1) 
Surupangkael thoppulilay miga valithu 
Surundumay keezhvayitrai porumi kondu 
Varupangkael maamvarandu vaai neeruroom 
Vaayvuthaan pirigaiyilay nuraipor kaanum 
Thurungkael pidavaithanir roivu maagum 
Surukkaga malamvaruthal polirukum 
Nirupangkael adikadikku neerai pogum 
Nilaiyaana neermoolam ninaivaaip paaray 
 Abdominal pain 
 Abdominal distension 
 The stools will dry up 
 Excessive salivary secretion 
 Frothy discharge during flatus 
Inflammatory Bowel Disease 
 
 Abdominal pain 
 Abdominal discomfort 
 Tenesmes, pellety stools 
 Diahrrhoea with mucus 
 Oral ulceration2 
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2. Sendu Moolam (Figure 2) 
Ninaivaaga karunaiyida mulaiyay pola 
Nimirnth ezhunthu naalmondru nirpamaagi 
Kanavaagak kandriyay miga vaikkum 
Kaarandhaan pottavudan kalaiyaayi veezhum 
Inavaaga raththamodu thaneer kaanum 
Irugiyay maanththee yumirai chaaagum 
Thinavaaga vasanaththai surukki koollum 
Seya sendu mooolathin riramai thaanay. 
 Pile mass is like base scape of elephant foot 
yam 
 There will be pain on three days from 
occurrence of pile mass 
 Patient will get rid of the mass after 
application of Kaaram 
 Bloody and watery discharge 
 Constipation, Anal stricture 
Thrombosed External Hemorrhoids 
 
 Patients present with acute pain. 
 Surgical excision is indicated for symptomatic 
thrombosed external hemorrhoids within 48 
to 72 hours of pain onset3 
 Constipation 
 the clot may erode through the skin and 
discharge itself. 4 
 
3. Mulai Moolam (Figure 3) 
Thiramaga vaasanathir kaduppu mundaam 
Thiratchiyaai thaditherivu seyalung kaanum 
Aramaga vadivayir ukallu poam 
Aasanadhaan migasurungi thinavu mundam 
Kuramaga kuthikolla raththapee rirangum 
Koosatha iraichalmiga veppa mundaam 
Maramaaga manjalmulai polaezhumbum 
Malandheeyu mulaimoola vanmai thaanay 
• Anal pain 
• The anus get hardened and burning 
sensation occurs 
• Bleeding 
• Belching  
• Constipation 
• Pile mass may look like turmeric buds 
Sentinel Pile 
 
 Chronic anal fissures are also often accompanied 
by an external skin tag (sentinel pile) at the distal 
end of the fissure and a hypertrophied anal papilla 
at the proximal end. 
 Severe tearing pain with the passage of  faeces 
often with a small amount of bright red blood with 
the stool. 
  Constipation.5 
4. Sittru Moolam (Figure 4) 
Vanmaiyaa udamberiyum mayakka maagum 
Vayiruthaan palapalannum valuvaai kuttrum 
Inmayaai kurukurendaray iraichalaagum 
Isivudanay porumalaayi laippu maagum 
Thinmayaai siththumoolai pala vundaagum 
Thegamengum veluppaagum seyalung kaanum 
Venmaiyaai veuthumay pasiyirathau 
Meni kannunj sittru mulai midukkundha thaanay 
• Giddiness 
• The skin of the abdomen look shining, 
tender and borborygmi. 
• Abdominal distension 
• Weight loss 
• Pallor of the body 
• Small masses will appears 
• Loss of appetite 
• General weakness 
Adenomatous Colorectal Polyps 
 
 Polyps are usually asymptomatic but may 
ulcerate and bleed, cause abdominal pain, 
and, when very large, produce intestinal 
obstruction. 
 Adenomatous polyps are common 
 colorectal cancers arise from adenomas.6 
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6. Ratha Moolam (Figure 6) 
Sethiyaai thopputhanil valiththu nondhu 
Sirukathir porpeerittu ratham veezhum 
Maethiyaai menivattri veluththu pogum 
Miga kaikaalsanthumay sobaiyaagum 
Maathiyaai marpiakkundh thalaini vundaam 
Mayakkndhaan miguthiyaai thali podum 
Naathiyaai kannirandu manjal polaam 
Naliyum ratha moolaththin nanbuthaanay. 
 Pain in umbilical region 
 Pallor of the body 
 Edema of both upper limb and lower limbs 
 Chest pain 
 Headache 
 Giddiness 
 Yellowish discoloration of eyes 
Internal Haemorrhoids 1st Degree (Bleeding Piles) 
 
 The most common presentation of internal 
hemorrhoids is rectal bleeding during defecation. 
 Patients with acutely thrombosed or strangulated 
internal hemorrhoids usually present with 
severely painful.7 
 
7. Seezh Moolam (Figure 7) 
Nanbaaga kuthangkaduththu erippu thondrum 
Naatriyay seeyodu thaneer kaanum 
Manpaaga maamisangal karaindhu kondu 
Vadivamellam veluthunmay manjaalagum 
Menbaaga mevumvaa neera thaagum 
Midukkana nadaikuraiyu melivu maagum 
Thinbaaga siruneer thaan manjlikkum 
Seemoola thannudaiya saethi yaamay. 
 Burning sensation in anal region 
 Purulent mucous discharge  
 Skin becomes pale and yellow 
 Yellowish discoloration of urine 
Kaposis Sarcoma 
 
 Severe rectal pain 
 Bloody mucous discharge per-rectum 
 Rectal mucosa with hemorrhagic nodules and  a 
necrotic ulcer in the rectum 
 Jaundice hypo attenuated lesions in the liver, 
along with worsening lymphadenopathy.8 
5.Varal Moolam (Figure 5) 
Midukkaga malaththaiyay yirukki kollum 
Miguvaaga rathamathu thuliyaai vizhum 
Adukkaga sadamularthi yazhal kazhikkum 
Aanmaaithaan migapesi sandai kollum 
Udukkaga ullirukku muaigal thaanum 
Oruvarkku theriyaathu odikki vaikkum 
Thidukkaga naal thanilay pelan kuraikkum 
Seyalazhikkum varalmooa sethi thanay. 
 Constipation 
 Bleeding per rectum 
 Increased body temperature 
 Anger speech 
 Invisible mass present in rectum 
 Body strength will gradually come down. 
Colorectal Non- Neoplastic Polyps 
 
 Hyperplastic polyps are the most common non-
neoplastic polyp in the colon. They are small 
nodules or polypoid lesions composed of normal 
cellular components 
 Bleeding per rectum 
 Constipation 
 Polyps are  categorized as sessile if the base is 
attached to the colon wall, or pedunculated if a 
mucosal stalk is interposed between the polyp 
and the wall.6 
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8. Aazhi Moolam (Figure 8) 
Saethiyai neenda valli kizhangu polath 
Thimirthumay yegamulai yaaga kkaanum 
Neethiyaai neerodung seeyumi raththam 
Niranirai yaayiththondri yaemalamung chikkum 
Kaathiyaai kaarangall yaetridathu 
Kadiya balaveenamaandh thegandh thaanum 
Aadhiyaam asaththathanai poruthuk kollum 
Aazhimoo laththinida aanmai thaanay 
• Pile mass is like sweet potato 
• Watery, bloody and pus discharge  
• Constipation 
• Generalized weakness 
• Death will happen after a long time 
 
Strangulated Haemorrhoids 
 
 Acute prolapse, where the haemorrhoidal 
mass becomes trapped by the sphincter 
outside the anus, can lead to obstruction of 
venous return, oedema and strangulation. 
 Constipation 
 If untreated, this can be severely incapacitating 
for several weeks.9 
 
9. Thamaraga Moolam (Figure 9) 
Moolamaam pavaththil ulakkai poon pol 
Muthirntha thaamarai poo polalarnthirukkum 
Noolamaam norukkaa malamumg kaanum 
Nunukaeri yiraththa modu thinavundam 
Vaalamai vayirirainthu neerai poogum 
Vayiroothi pasiyilla mandhang kaanum 
Thaalamaa maelmoochai asathi undaam 
Thamaragama moolathin thanmai thaanay. 
A pile mass is like plunger and lotus flower 
 bleeding and itching in anal region 
 Watery stools 
 Loss of appetite with indigestion 
 Tiredness 
Internal Haemorrhoids 4th Degree 
 
 Hemorrhoids cannot be reduced. They are 
permanently prolapsed  
 bleeding during /after defecation 
 pain 
 prolapse 
 Itching and peri-anal soiling.10 
 
10. Vaatha Moolam (Figure 10) 
Thanmai kovaipazham kudham sivappu  
Thanil adappam poo pola mulai valarnthu  
Kanmai karuppaai miruthuvaai irukum  
Kadppodu thinavu kuttral thimirthalagum 
Vanmai mayir thaan mulaithu malang chikki kendru  
Magathaga karuththu meththa thirandu kaanum 
Venmai vayirvitumay kudalul valiyaagum  
Mikka thalaivali vaatha moolamaamay”  
 Pile mass is like almond flower and red ivy 
gourd fruit in colour 
 Inflammation of the anus, Pain in anus 
 Itching, Retention of  faces  
 constipation, Headache 
Interno-External Hemorrhoids 
 
 Incomplete evacuation or rectal fullness 
 Defecation of hard fecal material.11 
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11. Pitha Moolam (Figure 11) 
Thalaivalithaan migavundaam paruthi kottai 
Thanpolu nerpolum mulaiyundaagum 
Malaivaliyaai malanjikki urundu rundu 
Maavundai thirithiriyaayi rathang seeyaai 
Kulavaliyaayi kuthang kaduththu erivu maagi 
Koochamaai thaaga modu viyarvai yaagum 
Thalaivaiya yaththuyakumamai koba maagum 
Sorpala veenamumpitha moola maamay 
 Pile mass present like a cotton seed and 
paddy 
 Constipation and stools passed like flour ball 
with blood  and pus.  
 Inflammation and burning sensation in anus 
 Thirst 
 Perspiration 
Prolapsed Haemorrhoids 
 
 Patients frequently complain of bleeding with or 
without defecation, a swelling, mild discomfort 
or irritation. 
 Other symptoms may include soilage or mucous 
discharge. 
 pruritis, and a sense of incomplete evacuation.12 
 
12. Silaethuma Moolam (Figure 12) 
Eenamang kuthaththil vellai yaagum 
Yendhnaerathi navathiga merivu maagum 
Kaanamang kaduppudanay seeyundh thaneer 
Kanamana valiyaagi malandha noongumam 
Thonamaa moothirandhaan soodun daagum 
Sorgunaa paethagamaagundh thaathu nasht 
Paanamam paanduvudu arusi yaagum 
Paravu settumamooap paangu thaanay 
 Pile mass looks white in colour 
 Burning sensation present  
 Anal irritation 
 Watery and pus discharge 
 Painful defecation  
 Mood swings 
 Oligospermia 
 Anaemia 
 Tastelessness 
Anal Warts Condyloma 
 
 Itching, and discharge  
 The lesions are benign they cause 
psychological distress and may cause 
problems in relationships because they are 
disfiguring and sexually transmitted.13 
 
13. Thondha Moolam (Figure 13) 
Paangana kudhamirugi kozhi soodu 
Padithathupor ranirukkum nadakka votta 
Vaangana vayirumeththa porumalagum 
Varuthamodu viyarththumay miga nadukkum 
Thaangana thavithumay thaaga maagum 
Thariyaamal vayiruvum bethi yaagum 
Theengana sedamattai porsurukuum 
Thidikumay thondhamendra moolandhaanay. 
 Pile mass is like cocks comb 
 Difficulty in walking 
 Increased sweat and tremor 
 Increased thirst 
 Dairrhoea 
 Weight loss(Body will shrink like leech) 
Rectal Cancer 
 
 IBD are highly encouraged to be screened for 
colorectal cancer on a more frequent basis. 
 Abdominal pain can occur 
 change in bowel habit.14 
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14.Vinai Moolam (Figure 14) 
Thidikittu soruseriyamai yaagum 
Theebanathaa nilamarpi lithae kaagum 
Adukitta adivayitrir kuttra lundaam 
Aangara kobamodu maamung kattum 
Kadukitta kaikaalu mochalagum 
Kanamaaga vayir iraindhu kaandha lundaagum 
Vedukittu narmbella misivu maagum 
Migakadukkum vinaimoola vibarandhaanay. 
 
 Sudden shock 
 Indigestion 
 Belching 
 Abdominal pricking pain 
 Constipation 
 General weakness 
Irritable Bowel Syndrome 
 
 Colicky or cramping is felt in the lower 
abdomen 
 Abdominal boating  
 Constipation and tend to pass infrequent 
pellety stools 
 Chronic fatigue syndrome.15 
 
15. Mega Moolam (Figure 15) 
Vinaiyaaga lingathil vellai yootrum 
Meththavaai kuthathannir uthirang saaikkum 
Sanaiyaaga sathamaai kazhichalaagum 
Thaakkana siruneeru mericha laagum 
Panaiyaaga padukung kaal thalaivalikum 
Barama udamberikkum thirundaagum 
Munaiyaaga moothirandhaan madhuramaagum 
Moorkkamana megamendra moolandh thaanay. 
 Discharge from genital 
 Bleeding per anus 
 Diarrhoea, Burning micturition 
 Sweet taste present in urine 
Gonococcal Proctitis 
 
 The higher incidence in male reflects ano 
receptive transmission. 
 Rectal inflammation 
 Viscous yellow muco purulent anal 
discharge. 
 Rectal bleeding.16 
 
16. Powthira Moolam (Figure 16) 
Moorkamai powthirathir katti yaagi 
Moothiranthaan adikadikku aruvalagum 
Kaarththamaang kaalkaiyung kanappu maagum 
Kanakanakung kuthangkuying saavar sodu 
Poorkamaam poopola mulaigal kaanum 
Porung kovaipazham pola sivappu maagum 
Paarkamang kaarandhaan podath theerum 
Powthirama moolathin panbu thaanay. 
 Perianal abscess will develop 
 Frequent urination 
 A masses looks like mango flower, and cock 
comb, red ivy gourd  fruit colour. 
 Kaaram application will be the cure this 
condition 
Anal Fistula 
 
Occurrence of  
 Skin irritation around the anus 
 Throbbing, constant pain that may be worse 
when  sit down, move around, have a bowel 
movement or cough 
 A discharge of pus or blood when having a 
bowel movement (rectal bleeding).17 
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17. Kirandhi Moolam (Figure 17) 
Panbuthaan lingaththir punnundaagum 
Baaramaik kaalkaiyung kaduppu mundaam 
Gunpathaak kuthathukkul virana maagi 
Kodi kodiyaayi mulaiyundaagi seeyum raththam 
Thanbuthaan thaneerum perugavundaam 
Thanalpola erivodu kaduppu maagum 
Kenbuthaan kettiyaai malam varandu 
Keetraga vediththrangu kirandhi mooolam 
 Ulcer on penis 
 Continuous chain like lesion 
 Purulent and Bloody discharge 
 Constipation 
 Burning sensation in anal region 
Lymphogranuloma Venereum 
 
 Ulcer on penis 
 Fluctuant and suppurative lymph nodes then 
develop, causing the classic “bubo” of LGV. These 
“buboes” may rupture in one-third of patients, 
which may lead to sinus tract formation 
 Patients had gastrointestinal symptoms (eg, bloody 
proctitis with a purulent or mucous anal discharge 
and constipation).18 
 
18. Kutha Moolam (Figure 18) 
Erangumay moongilida kuruththu pola 
Izhuththumay thalidilo vullay pogum 
Pirangumay seeyodu ratham paayum 
Perugiyaay vayiru meththa kanaththu kollum 
Arangumay kaalkaiyum thaippu maagum 
Adikadikku naavarandu thaneerthedum 
Kurangumay migavalikkung kobamundaagum 
Kodiyakutha moolaththin gunama thaamay. 
 Pile mass is like bamboo shoot 
 Pile mass reduce manually 
 Mucous  and bloody discharge 
 Emotional status-Get anger soon 
Rectal Prolapse 
 
 Patients with prolapse most frequently complain of 
protrusion of the rectum during defecation. This may 
reduce spontaneously or require manual reduction. 
 Less frequent presenting symptoms include bleeding, 
pain, mucous discharge, and pruritus. 
 Clinical factors associated with prolapse include 
straining at bowel movements, neurologic diseases 
and mental illness.19 
19. Pura Moolam (Figure 19) 
Gunamathaa yennaipor ranneer polum 
Kootrana kaduppodu seeyu mundaam 
Thinamathaai thinavedukkundh thirpundaagum 
Siru sirangaai melelaang soriyu maagum 
Panamathaaya sanaththir paguppu pola 
Paangaga vithanamai padukai kooda 
Pinamathaai mugamelam vaatamundaam 
Paerana puramoola puthumai thanay 
 Oily, and watery discharge through anus 
 Anal itching 
 Small itchy lesion all over the body 
 Unable to lie down 
Perianal Paget's Disease 
 
 Histologically, PPD is characterized by large 
vacuolated cells with mucin content, called Paget 
cells.18 
 Clinical presentation of PPD is an erythematous 
plaque with squamous areas. 
 Anal itch.20  
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20. Surukku Moolam (Figure 20) 
Puthumaiyaa yaasanaththai surukkik kondu 
Perungkudalil valiyoodu porumalaagum 
Kathumayaaai kudhandh thannir radippun daagum 
Kazhalumay thaneerum rathandhthaanum 
Vethumayaai vevvanalpo lazhandru kaanum 
Vettrudambaai thaanveluththu verippundaagum 
Padhumaipol thegamengum savu kodap 
Panbaana surukkendra moolandh thaanay. 
 Tightening of anal orifice 
 Abdominal distension 
 Watery and bloody diarrhoea 
 Paleness of the skin 
Anal Stenosis 
  
 Anal stenosis may follow almost any condition 
that causes scarring of the anoderm. 
 Inflammatory bowel diseases may cause anal 
stenosis, particularly Crohn’s disease. These 
stenoses are characterized by a transmural 
scarred inflammatory process.21 
 
21. Savvu Moolam (Figure 21) 
Surukkiyay mudhuguthandi lurpavaththu 
Thoppuilay thaamaraipoo pola malrnthu 
Arukkiyay kuttrila kaara maaki 
Adivayitrir lngumay moola rogam 
Sorukkiyay savvupola sanathiay 
Suttriyay nindruthaan seeyundh thaneer 
Parukkiyay kasivaagu mendhnae randhaan 
Panbaana savvaagu moolandh thaanay. 
 Pain starts in low back and it radiates to lower 
abdomen 
 A membranous like structure in anus 
 Pus and purulent discharge 
Perianal Tuberculosis 
 
 Anal pain or discharge 
 Perineal ulcerations 
 Bacilli invasion of the intestinal wall 
 Generalized abdominal  tenderness22 
CONCLUSION 
 From the above comparative analysis, it is 
clear that the literatures of saint Yugi about the 
etiology signs and Symptoms, appearance of pile 
mass in Eruvaimulainoi (ano-rectal diseases) closely 
correlates with that the modern medical literatures. 
The signs and symptoms of the medical conditions 
mentioned in modern literature have already been 
scientifically validated. Therefore the saint Yugi’s  
etiology, signs and symptoms appearance of pile 
mass in Eruvaimulainoi (an ano rectal disease) 
following the close lines of modern medical literature 
automatically stands validated. So it is need of the 
hour to focus n screening and diagnosing various 
types of Eruvaimulainoi (ano rectal diseases) 
mentioned by saint Yugi with respect to modern 
science to reach out various Siddha treatment 
strategies in successful manner. 
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